PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS

The present invention relates to pesticidally active, in particular insecticidally active heterocyclic derivatives containing sulfur substituents, to processes for their preparation, to compositions comprising those compounds, and to their use for controlling animal pests, including arthropods and in particular insects or representatives of the order Acarina.

Heterocyclic compounds with pesticidal action and with sulfur containing substituents are known and described, for example, in WO 2016/091731. There have now been found novel pesticidally active derivatives with sulfur containing substituents which are characterized by a specific (aza)benzimidazol-2-one moiety.

The present invention accordingly relates to compounds of formula I,

embedded image

wherein

A represents CH or N;

X is S, SO or SO₂;

X₁is O, S or NR₃, wherein R₃is C₁-C₄alkyl;

R₁is C₁-C₄alkyl, C₁-C₄haloalkyl or C₃-C₆cycloalkylC₁-C₄alkyl;

R₂is halogen, C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl, C₁-C₄haloalkylsulfonyl or C₁-C₆haloalkoxy;

G₁is N or CH;
G₂is N or CH; and

R₄and R₅, independently from each other, are hydrogen, C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano; and agrochemically acceptable salts, stereoisomers, enantiomers, tautomers and N-oxides of the compounds of formula I.

Compounds of formula I which have at least one basic centre can form, for example, acid addition salts, for example with strong inorganic acids such as mineral acids, for example perchloric acid, sulfuric acid, nitric acid, nitrose acid, a phosphorus acid or a hydrohalic acid, with strong organic carboxylic acids, such as C₁-C₄alkanecarboxylic acids which are unsubstituted or substituted, for example by halogen, for example acetic acid, such as saturated or unsaturated dicarboxylic acids, for example oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as C₁-C₄alkane- or arylsulfonic acids which are unsubstituted or substituted, for example by halogen, for example methane- or p-toluenesulfonic acid. Compounds of formula I which have at least one acidic group can form, for example, salts with bases, for example mineral salts such as alkali metal or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or trihydroxy-lower-alkylamine, for example mono-, di- or triethanolamine.

The alkyl groups occurring in the definitions of the substituents can be straight-chain or branched and are, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, iso-butyl, tert-butyl, pentyl, hexyl and their branched isomers. Alkylsulfanyl, alkylsulfinyl, alkylsulfonyl, alkoxy, alkenyl and alkynyl radicals are derived from the alkyl radicals mentioned. The alkenyl and alkynyl groups can be mono-or polyunsaturated.

Halogen is generally fluorine, chlorine, bromine or iodine. This also applies, correspondingly, to halogen in combination with other meanings, such as haloalkyl or halophenyl.

Haloalkyl groups preferably have a chain length of from 1 to 6 carbon atoms. Haloalkyl is, for example, fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, 2,2,2-trifluoroethyl, 2-fluoroethyl, 2-chloroethyl, pentafluoroethyl, 1,1-difluoro-2,2,2-trichloroethyl, 2,2,3,3-tetrafluoroethyl and 2,2,2-trichloroethyl; preferably trichloromethyl, difluorochloromethyl, difluoromethyl, trifluoromethyl and dichlorofluoromethyl.

Alkoxy groups preferably have a preferred chain length of from 1 to 6 carbon atoms. Alkoxy is, for example, methoxy, ethoxy, propoxy, i-propoxy, n-butoxy, isobutoxy, sec-butoxy and tert-butoxy and also the isomeric pentyloxy and hexyloxy radicals; preferably methoxy and ethoxy.

Alkoxyalkyl groups preferably have a chain length of 1 to 6 carbon atoms, more preferably a chain length of 1 to 4 carbon atoms. Alkoxyalkyl is, for example, methoxymethyl, methoxyethyl, ethoxymethyl, ethoxyethyl, n-propoxymethyl, n-propoxyethyl, isopropoxymethyl or isopropoxyethyl.

Alkylsulfanyl is for example methylsulfanyl, ethylsulfanyl, propylsulfanyl, isopropylsulfanyl, butylsulfanyl, pentylsulfanyl, and hexylsulfanyl.

Alkylsulfinyl is for example methylsulfinyl, ethylsulfinyl, propylsulfinyl, isopropylsulfinyl, a butylsulfinyl, pentylsulfinyl and hexylsulfinyl.

Alkylsulfonyl is for example methylsulfonyl, ethylsulfonyl, propylsulfonyl, isopropylsulfonyl, butylsulfonyl, pentylsulfonyl, and hexylsulfonyl.

The cycloalkyl groups preferably have from 3 to 6 ring carbon atoms, for example cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.

Haloalkoxy groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkoxy is, for example, difluoromethoxy, trifluoromethoxy or 2,2,2-trifluoroethoxy.

Haloalkylsulfanyl groups preferably have a chain length of from 1 to 4 carbon atoms. Haloalkylsulfanyl is, for example, difluoromethylsulfanyl, trifluoromethylsulfanyl or 2,2,2-trifluoroethylsulfanyl. Similar considerations apply to the radicals C₁-C₄haloalkylsulfinyl and C₁-C₄haloalkylsulfonyl, which may be, for example, trifluoromethylsulfinyl, trifluoromethylsulfonyl or 2,2,2-trifluoroethylsulfonyl.

Free radicals represents methyl groups.

The compounds of formula I according to the invention also include hydrates which may be formed during the salt formation.

The compounds of formula I according to the invention also include all suitable isotopic variations of such compounds. An isotopic variation of a compound of the invention is defined as one in which at least one atom is replaced by an atom having the same atomic number but an atomic mass different from the atomic mass usually or predominantly found in nature.

The terms “comprising”, “comprises” and “comprise” when used in the specification include the respective terms “consisting of”, “consists of” and “consist of”.

In one embodiment, a preferred group of compounds of formula I are those wherein R₄and R₅, independently from each other, are hydrogen, C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxy C₁-C₆alkyl, C₁-C₆haloalkoxy.

In another embodiment, compounds of formula I are preferred wherein R₄and R₅, independently from each other, are C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano.

Another preferred group of compounds of formula I is represented by the compounds of formula I-1

embedded image

wherein R₂, X₁, A, R₄and R₅are as defined under formula I above; and wherein Xa₁is S, SO or SO₂; Ra₁is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl.

A preferred embodiment of said compounds of formula I-1 comprises compounds wherein R₄and R₅, independently from each other, are hydrogen, C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxy C₁-C₆alkyl, C₁-C₆haloalkoxy.

Another preferred embodiment of said compounds of formula I-1 comprises compounds wherein R₄and R₅, independently from each other, are C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano.

In a preferred group of compounds of formula I-1, A is preferably N; Xa₁is preferably S or SO₂, more preferably SO₂; and Ra₁is preferably ethyl. In a further preferred group of compounds of formula I-1, A is preferably CH; Xa₁is preferably S or SO₂, more preferably SO₂; and Ra₁is preferably ethyl.

In another preferred group of compounds of formula I-1, X₁is preferably NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl; and R₂is preferably C₁-C₆haloalkyl, more preferably trifluoromethyl.

In compounds of formula I-1 and all of the preferred embodiments of compounds of formula I-1 mentioned above, unless otherwise specified, R₄and R₅are as defined under formula I above. A further preferred embodiment of said compounds of formula I-1 comprises compounds wherein R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, even more preferably hydrogen, methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-1 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, even more preferably methyl or ethyl.

Another preferred embodiment of said compounds of formula I-1 comprises compounds wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Yet another preferred embodiment of said compounds of formula I-1 comprises compounds wherein R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

R₄is C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Another preferred group of compounds of formula I is represented by the compounds of formula I-2

embedded image

wherein

A is CH or N;

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-2 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, preferably methyl or ethyl.

Another preferred embodiment of said preferred group of compounds of formula I-2 comprises compounds wherein R₄and R₅are methyl.

Another preferred group of compounds of formula I is represented by the compounds of the formula I-2 as described above,

wherein

A is CH or N;

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl, trifluoromethylsulfinyl or trifluoromethylsulfonyl; and

R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

In a further preferred group of compounds of formula I-2,

A is CH or N;

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

In yet another preferred group of compounds of formula I-2,

A is CH or N;

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl;

R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

R₄is C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

A further preferred group of compounds of formula I is represented by the compounds of formula I-3

embedded image

wherein R₂, X₁, A, R₄and R₅are as defined under formula I above;

Xa₂is S, SO or SO₂; and

Ra₂is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl.

A preferred embodiment of said compounds of formula I-3 comprises compounds wherein R₄and R₅, independently from each other, are hydrogen, C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxy C₁-C₆alkyl, C₁-C₆haloalkoxy.

Another preferred embodiment of said compounds of formula I-3 comprises compounds wherein R₄and R₅, independently from each other, are C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano.

In a preferred group of compounds of formula I-3, A is preferably N; Xa₂is preferably S or SO₂, more preferably SO₂; and Ra₂is preferably ethyl. In a further preferred group of compounds of formula I-3, A is preferably CH; Xa₂is preferably S or SO₂, more preferably SO₂; and Ra₂is preferably ethyl.

In another preferred group of compounds of formula I-3, X, is preferably NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl; and R₂is preferably C₁-C₆haloalkyl, more preferably trifluoromethyl.

In compounds of formula I-3 and all of the preferred embodiments of compounds of formula I-3 mentioned above, unless otherwise specified, R₄and R₅are as defined under formula I above. A further preferred embodiment of said compounds of formula I-3 comprises compounds wherein R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, even more preferably hydrogen, methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-3 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, even more preferably methyl or ethyl.

Another preferred embodiment of said compounds of formula I-3 comprises compounds wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Yet another preferred embodiment of said compounds of formula I-3 comprises compounds wherein R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

Another preferred group of compounds of formula I is represented by the compounds of formula I-4

embedded image

wherein

A is CH or N;

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, preferably hydrogen,-methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-4 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, preferably methyl or ethyl.

Another preferred embodiment of said compounds of formula I-4 comprises compounds wherein R₄and R₅are methyl.

In another preferred group of compounds of formula I-4,

A is CH or N;

In a further preferred group of compounds of formula I-4,

A is CH or N;

In yet another preferred group of compounds of formula I-4,

A is CH or N;

A further preferred group of compounds of formula I is represented by the compounds of formula I-5

embedded image

wherein R₂, X₁, A, R₄and R₅are as defined under formula I above;

Xa₃is S, SO or SO₂; and

Ra₃is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl.

A preferred embodiment of said compounds of formula I-5 comprises compounds wherein R₄and R₅, independently from each other, are hydrogen, C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxy C₁-C₆alkyl, C₁-C₆haloalkoxy.

Another preferred embodiment of said compounds of formula I-5 comprises compounds wherein R₄and R₅, independently from each other, are C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano.

In a preferred group of compounds of formula I-5, A is preferably N; Xa₃is preferably S or SO₂, more preferably SO₂; and Ra₃is preferably ethyl. In a further preferred group of compounds of formula I-5, A is preferably CH; Xa₃is preferably S or SO₂, more preferably SO₂; and Ra₃is preferably ethyl.

In another preferred group of compounds of formula I-5, X, is preferably NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl; and R₂is preferably C₁-C₆haloalkyl, more preferably trifluoromethyl.

In compounds of formula I-5 and all of the preferred embodiments of compounds of formula I-5 mentioned above, unless otherwise specified, R₄and R₅are as defined under formula I above. A further preferred embodiment of said especially preferred group of compounds of formula I-5 comprises compounds wherein R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, even more preferably hydrogen, methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-5 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, even more preferably methyl or ethyl.

Another preferred embodiment of said compounds of formula I-5 comprises compounds wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Yet another preferred embodiment of said especially preferred group of compounds of formula I-5 comprises compounds wherein

R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

R₄is C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Another preferred group of compounds of formula I is represented by the compounds of formula I-6

embedded image

wherein

A is CH or N;

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl.

In a further preferred embodiment, said compounds of formula I-6 comprise those wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, preferably methyl or ethyl.

Another preferred embodiment of said preferred group of compounds of formula I-6 comprises compounds wherein R₄and R₅are methyl.

In another preferred group of compounds of formula I-6,

A is CH or N;

In a further preferred group of compounds of formula I-6,

A is CH or N;

In yet another preferred group of compounds of formula I-6,

A is CH or N;

A further preferred group of compounds of formula I is represented by the compounds of formula I-7

embedded image

wherein R₂, X₁, and A are as defined under formula I above; and wherein Xa₄is S, SO or SO₂; Ra₄is methyl, ethyl, n-propyl, i-propyl or cyclopropylmethyl; and R₄and R₅, independently from each other, are C₁-C₆alkyl, C₃-C₆alkenyl, C₃-C₆alkynyl, C₃-C₆cycloalkylC₁-C₄alkyl, C₃-C₆cycloalkyl, C₁-C₆haloalkyl, C₃-C₆haloalkenyl, C₃-C₆halocycloalkyl, C₁-C₆alkoxy, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₆haloalkoxy, C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano.

In a preferred group of compounds of formula I-7, A is preferably N; Xa₄is preferably S or SO₂, more preferably SO₂; and Ra₄is preferably ethyl. In a further preferred group of compounds of formula I-7, A is preferably CH; Xa₄is preferably S or SO₂, more preferably SO₂; and Ra₄is preferably ethyl.

In another preferred group of compounds of formula I-7, X₁is preferably O or NR₃, in which R₃is C₁-C₄alkyl, preferably methyl; and R₂is preferably C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl or C₁-C₄haloalkylsulfonyl, more preferably trifluoromethyl, trifluoromethylsulfanyl, trifluoromethylsulfinyl or trifluoromethylsulfonyl. Even more particularly preferred are those compounds wherein X₁is O; and R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, more preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl. Also more particularly preferred are those compounds wherein X₁is NCH₃; and R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, more preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl.

In compounds of formula I-7 and all of the preferred embodiments of compounds of formula I-7 mentioned above, unless otherwise specified, R₄and R₅are as defined under formula I-7 above. A further preferred embodiment of said compounds of formula I-7 comprises compounds wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, even more preferably methyl or ethyl.

Another preferred embodiment of said compounds of formula I-7 comprises compounds wherein R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Yet another preferred embodiment of said compounds of formula I-7 comprises compounds wherein R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

Another preferred group of compounds of formula I is represented by the compounds of formula I-8

embedded image

wherein

A is CH or N;

Another preferred embodiment of said compounds of formula I-8 comprises compounds wherein R₂is C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethylsulfanyl or trifluoromethylsulfonyl.

A further preferred embodiment of said compounds of formula I-8 comprises compounds wherein R₂is C₁-C₆haloalkyl, preferably trifluoromethyl.

Yet another preferred embodiment of said compounds of formula I-8 comprises compounds wherein R₄and R₅are methyl.

An especially preferred embodiment of said compounds of formula I-8 comprises compounds wherein R₂is C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethylsulfanyl or trifluoromethylsulfonyl; and

R₄and R₅are methyl.

Another especially preferred embodiment of said compounds of formula I-8 comprises compounds wherein

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are methyl.

In a further preferred group of compounds of formula I-8,

A is CH or N;

In yet another preferred group of compounds of formula I-8,

A is CH or N;

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl;

R₅is C₁-C₆alkyl, even more preferably methyl or ethyl; and

R₄is C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl.

Another preferred group of compounds of formula I is represented by the compounds of formula I-8a

embedded image

wherein

A is CH or N;

Another preferred embodiment of said compounds of formula I-8a comprises compounds wherein R₂is C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethylsulfanyl or trifluoromethylsulfonyl.

A further preferred embodiment of said compounds of formula I-8a comprises compounds wherein R₂is C₁-C₆haloalkyl, preferably trifluoromethyl.

Yet another preferred embodiment of said compounds of formula I-8a comprises compounds wherein R₄and R₅are methyl.

An especially preferred embodiment of said compounds of formula I-8a comprises compounds wherein

R₂is C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethylsulfanyl or trifluoromethylsulfonyl; and

R₄and R₅are methyl.

Another especially preferred embodiment of said compounds of formula I-8a comprises compounds wherein

R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

R₄and R₅are methyl.

In a further preferred group of compounds of formula I-8a,

A is CH or N;

In yet another preferred group of compounds of formula I-8a,

A is CH or N;

Another preferred group of compounds of formula I is represented by the compounds of formula I-9

embedded image

wherein

A is CH or N;

R₄and R₅are, independently from each other, hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl; and

Q is a radical selected from the group consisting of formula Q1, Q2, Q3 and Q4

embedded image

wherein the arrow denotes the point of attachment to the bicyclic ring incorporating the radical A; and in which

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl, trifluoromethylsulfinyl or trifluoromethylsulfonyl; in particular R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and

X₁is O or NR₃, in which R₃is C₁-C₄alkyl, preferably methyl; in particular X₁is NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl.

In a preferred group of compounds of formula I-9, Q is selected from the group consisting of formula Q₁, Q₂and Q₃;

embedded image

wherein the arrow denotes the point of attachment to the bicyclic ring incorporating the radical A; and in which R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl; in particular R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and X₁is O or NR₃, in which R₃is C₁-C₄alkyl, preferably methyl; in particular X₁is NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl.

In preferred group of compounds of formula I-9, R₄and R₅are, independently from each other, C₁-C₆alkyl, preferably methyl or ethyl.

In another preferred group of compounds of formula I-9, R₂is C₁-C₆haloalkyl, preferably trifluoromethyl; and X₁is NR₃, in which R₃is C₁-C₄alkyl, more preferably methyl.

In another preferred group of compounds of formula I-9,

A is CH or N;

R₂is C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethylsulfanyl, trifluoromethylsulfinyl or trifluoromethylsulfonyl; and

R₄and R₅are, independently from each other, C₁-C₆alkyl, preferably methyl or ethyl.

A further particularly preferred group of compounds of formula I is represented by the compounds of formula I-10

embedded image

wherein

A is CH or N;

R₄and R₅are, independently from each other, C₁-C₆alkyl, C₃-C₆cycloalkylsulfonyl, cyano, C₁-C₄alkylsulfonylC₁-C₄alkyl, C₁-C₄alkylsulfanylC₁-C₄alkyl, C₁-C₆alkoxyC₁-C₆alkyl, C₁-C₆haloalkyl, C₃-C₆cycloalkylcarbonyl or C₁-C₄alkoxycarbonyl, even more preferably methyl, ethyl, cyclopropylsulfonyl, cyano, methylsulfonylmethyl, methylsulfanylmethyl, methoxymethyl, 2,2,2-trifluoroethyl, cyclopropylcarbonyl or ethoxycarbonyl; and

Q is a radical selected from the group consisting of formula Q₁, Q₂, Q₃and Q₄

embedded image

wherein the arrow denotes the point of attachment to the bicyclic ring incorporating the radical A; and in which

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl, C₁-C₄haloalkylsulfinyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl, trifluoromethylsulfinyl or trifluoromethylsulfonyl; and

X₁is O or NR₃, in which R₃is C₁-C₄alkyl, preferably methyl.

Another particularly preferred group of compounds of formula I is represented by the compounds of formula I-11

embedded image

wherein

A is CH or N;

R₄and R₅are methyl; and

Q is a radical selected from the group consisting of formula Q₁, Q₂, Q₃and Q₄

embedded image

The process according to the invention for preparing compounds of formula I is carried out by methods known to those skilled in the art. More specifically, the subgroup of compounds of formula I, wherein X is SO (sulfoxide) and/or SO₂(sulfone), may be obtained by means of an oxidation reaction of the corresponding sulfide compounds of formula I, wherein X is S, involving reagents such as, for example, m-chloroperoxybenzoic acid (mCPBA), hydrogen peroxide, oxone, sodium periodate, sodium hypochlorite or tert-butyl hypochlorite amongst other oxidants. The oxidation reaction is generally conducted in the presence of a solvent. Examples of the solvent to be used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform; alcohols such as methanol and ethanol; acetic acid; water; and mixtures thereof. The amount of the oxidant to be used in the reaction is generally 1 to 3 moles, preferably 1 to 1.2 moles, relative to 1 mole of the sulfide compounds I to produce the sulfoxide compounds I, and preferably 2 to 2.2 moles of oxidant, relative to 1 mole of of the sulfide compounds I to produce the sulfone compounds I. Such oxidation reactions are disclosed, for example, in WO 2013/018928.

Compounds of the formula I wherein X is SO₂, defining compounds of the formula I-a, and wherein A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I,

embedded image

can be prepared (scheme 1) by an oxidation step from the compounds of the formula I wherein X is S, defining compounds of the formula I-b, and wherein A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, under standard oxidation conditions already described above.

Compounds of the formula I-b wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, can be prepared by alkylating compounds of the formula II-b wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, with reagents of the formula R₄-LG, wherein R₄is as defined in formula I, and in which LG is a leaving group such as a halogen, preferably iodine, bromine or chlorine, in presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, in an appropriate solvent such as for example tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide or acetonitrile, at temperatures between 0 and 150° C.

Alternatively, compounds of formula I-a, wherein X is SO₂, may be prepared from compounds of formula II-b wherein X is S, by involving the same chemistry as described above, but by changing the order of the steps (i.e. by running the sequence II-b (X is S) to II-a (X is SO₂) via oxidation, followed by an alkylation step with R₄-LG to form I-a (X is SO₂).

Reagents of the formula R₄-LG, wherein R₄is as defined in formula I, and in which LG is a leaving group such as a halogen, preferably iodine, bromine or chlorine, may be either known, commercially available or may be prepared by methods known to a person skilled in the art. The alkylation preparation conditions described above to produce compounds of the formula I-b (from II-b) and of formula I-a (from II-a) also apply in the particular situation wherein R₄is C₁-C₄alkylsulfonyl, C₃-C₆cycloalkylsulfonyl, C₁-C₄alkylcarbonyl, C₃-C₆cycloalkylcarbonyl, C₁-C₄alkoxycarbonyl or cyano. Typical reagents of the formula R₄-LG are then, for example, cyanogen bromide (R₄═CN), cyclopropanesulfonyl chloride (R₄=cyclopropylsulfonyl), or cyclopropanecarbonyl chloride (R₄=cyclopropylcarbonyl). In such cases, the bases described above may be advantageously replaced by, for example, triethylamine, N,N-diisopropylethylamine or pyridine.

Oxidation of compounds of formula I wherein R₄is C₁-C₄alkylsulfanylC₁-C₄alkyl into compounds of formula I wherein R₄is C₁-C₄alkylsulfonylC₁-C₄alkyl with a suitable oxidizing agent may be achieved under conditions described above and below in this document.

Oxidation of compounds of formula I, I-a and/or I-b wherein R₂is C₁-C₄haloalkylsulfanyl into compounds of formula I, I-a and/or I-b wherein R₂is C₁-C₄haloalkylsulfinyl and/or C₁-C₄haloalkylsulfonyl with a suitable oxidizing agent may be achieved under conditions described above and below in this document. Such processes have also been described, for example, in WO17/146220 and WO14/104407. Compounds of the formula II-b wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, can be prepared (scheme 2) by cyclizing compounds of the formula III, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoro-acetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, in the presence of phosgene COCl₂, or a substitute thereof such as diphosgene or triphosgene, preferably in presence of a base, such as triethylamine, N,N-diisopropyl-ethylamine or pyridine, in an inert solvent at temperatures between 0 and 80° C., preferably between 0 and 50° C. Examples of a solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent.

Alternatively, compounds of the formula II-b can be prepared by cyclizing compounds of the formula III in the presence of tetramethoxymethane, preferably in presence of an acid, advantageously in acetic acid or trifluoroacetic acid which simultaneously serve as a solvent or diluent, at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation.

Compounds of the formula III, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, can be prepared by reduction of compounds of the formula IV, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, under conditions known to a person skilled in the art, such as for example using zinc dust and acetic acid or trifluoroacetic acid, or mixtures thereof, or using molecular hydrogen (H₂), optionally under pressure, usually in the presence of a catalyst such as nickel, palladium (for example palladium on charcoal, typically 5-10% Pd/C) or platinum, in alcoholic solvents (such as for example methanol or ethanol), or in inert solvents (such as for example ethyl acetate), at temperatures between 0° C. and 120° C., preferably between room temperature and reflux temperature.

embedded image

Compounds of the formula IV, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, can be prepared by reacting compounds of the formula V, wherein X is S, and in which A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), with a reagent R₅—NH₂, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₅is as defined in formula I, optionally in presence of an additional base. This transformation is preferably performed in suitable solvents (or diluents) such as alcohols, amides, esters, ethers, nitriles and water, particularly preferred are methanol, ethanol, 2,2,2-trifluoroethanol, propanol, iso-propanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxy-ethane, acetonitrile, ethyl acetate, water or mixtures thereof, at temperatures between 0-150° C., preferably at temperatures ranging from room temperature to the boiling point of the reaction mixture, optionally under microwave irradiation or pressurized conditions using an autoclave.

Compounds of the formula V, wherein X is S, and in which A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), can be prepared (scheme 2 continued) by cyclizing compounds of the formula VI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof, wherein X is S, and in which A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), for example through heating in acetic acid or trifluoroacetic acid (preferably when X₁is NR₃, wherein R₃is C₁-C₄alkyl), at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation. Cyclization of compounds of formula VI may also be achieved in the presence of an acid catalyst, for example methanesulfonic acid, or para-toluenesulfonic acid p-TsOH, in an inert solvent such as N-methyl pyrrolidone or xylene, at temperatures between 25-180° C., preferably 100-170° C. Such processes have been described previously in WO 2010/125985. Alternatively, compounds of formula VI may be converted into compounds of formula V (preferably when X₁is O) using triphenylphosphine, di-isopropyl azodicarboxylate (or di-ethyl azodicarboxylate) in an inert solvent such as tetrahydrofuran THF at temperatures between 20-50° C. Such Mitsunobu conditions have been previously described for these transformations (see WO 2009/131237).

Compounds of the formula VI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof, wherein X is S, and in which A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), can be prepared by

i) Activation of compound of formula VII, wherein X is S, and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), by methods known to those skilled in the art and described in, for example, Tetrahedron, 2005, 61 (46), 10827-10852, to form an activated species VII-a, wherein X is S, and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), and wherein X₀₀is halogen, preferably chlorine. For example, compounds VII-a where X₀₀is halogen, preferably chlorine, are formed by treatment of VII with, for example, oxalyl chloride (COCl)₂or thionyl chloride SOCl₂in the presence of catalytic quantities of N,N-dimethylformamide DMF in inert solvents such as methylene chloride CH₂Cl₂or tetrahydrofuran THF at temperatures between 20 to 100° C., preferably 25° C. Alternatively, treatment of compounds of formula VII with, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbo-diimide EDC or dicyclohexyl carbodiimide DCC will generate an activated species VII-a, wherein X₀₀is X₀₁or X₀₂respectively, in an inert solvent, such as pyridine or tetrahydrofuran THF, optionally in the presence of a base, such as triethylamine, at temperatures between 50-180° C.; followed by

ii) Treament of the activated species VII-a with compounds of the formula IX, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₂, X₁, G₁and G₂are as defined in formula I, in the presence of a base, such as triethylamine, N,N-diisopropyl-ethylamine or pyridine, in an inert solvents such as dichloromethane, tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, ethyl acetate or toluene, at temperatures between 0 and 50° C., to form the compounds of formula VI.

Compounds of formula VI may structurally form as drawn, or may form as a regioisomer thereof (a position isomer of VI), or even may arise as a mixture of regioisomeric acylation products as described, for example, in WO 16/091731. This invention covers all such isomer forms, and mixtures thereof in all proportions.

Compounds of formula VII, wherein X is S, and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), can be prepared by reacting compounds of formula (X), wherein A is as defined in formula I, and in which Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), with a reagent of the formula VIII

R₁—SH (VIII),

or a salt thereof, wherein R₁is as defined in formula I, optionally in the presence of a suitable base, such as alkali metal carbonates, for example sodium carbonate and potassium carbonate, or alkali metal hydrides such as sodium hydride, or alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, or sodium or potassium tert-butoxide, in an inert solvent at temperatures preferably between 25-120° C. Examples of solvent to be used include ethers such as tetrahydrofuran THF, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone NMP or dimethyl sulfoxide. Examples of salts of the compound of formula VIII include compounds of the formula Villa

R₁—S-M (VIIIa),

wherein R₁is as defined above and wherein M is, for example, sodium or potassium. Such a process to prepare compounds of formula VII can be found, for example, in WO16/091731.

Compounds of formula (X), wherein A is as defined in formula I, and in which Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), may be either known, commercially available or may be prepared by methods known to a person skilled in the art.

Reagents of the formula R₅—NH₂, or a salt thereof, wherein R₅is as defined above, may be either known, commercially available or may be prepared by methods known to a person skilled in the art.

Compounds of the formula IX, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₂, X₁, G₁and G₂are as defined in formula I, may be either known, commercially available or may be prepared by methods known to a person skilled in the art. See in particular WO16/005263 (IX wherein R₂═CF₃; G₁=N; G₂=CH; and X₁═NCH₃), WO16/142327 (IX wherein R₂═CF₃; G₁=CH; G₂=N; and X₁═NCH₃), WO16/059145 (IX wherein R₂═CF₃; G₁=N; G₂=N; and X₁═NCH₃), WO15/198859 (IX wherein R₂═SCF₃; G₁=CH; G₂=CH; and X₁═NCH₃), U.S. Pat. No. 3,361,750 (IX wherein R₂═SCF₃; G₁=CH; G₂=CH; and X₁═O), and JP7082267 (IX wherein R₂═SO₂CF₃; G₁=CH; G₂=CH; and X₁═O).

Compounds of formula V may also be prepared

embedded image

by condensing (scheme 2a) compounds of formula VII and compounds of formula IX, wherein the substituent definitions are as described above, optionally in the presence of activating agents, under various formal dehydration conditions, for example in the presence of a dehydrating agent such as polyphosphoric acid, at temperature between 150° C. to 250° C., and without isolation of intermediacy compounds of the formula VI, or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof.

Such processes are well known and have been described for example in WO 2011/040629 or WO 2009/131237 (X₁is oxygen), and J. Am. Chem. Soc., 132(5), 1545-1557, 2010 or WO 2008/128968 (X₁is NR₃).

Alternatively, compounds of formula I-a, wherein X is SO₂, respectively compounds of formula I-b, wherein X is S, may be prepared from compounds of formula VII, wherein X is S, by involving the same chemistry as described above in schemes 1 and 2, but by changing the order of the steps as illustrated in scheme 3. Compounds of formula I-b, wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I,

embedded image

can be prepared by cyclizing compounds of the formula XI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof, wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, for example through heating in acetic acid or trifluoroacetic acid (preferably when X₁is NR₃, wherein R₃is C₁-C₄alkyl), at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation. Cyclization of compounds of formula XI may also be achieved in the presence of an acid catalyst, for example methanesulfonic acid, or para-toluenesulfonic acid p-TsOH, in an inert solvent such as N-methyl pyrrolidone or xylene, at temperatures between 25-180° C., preferably 100-170° C. Such processes have been described previously in WO 2010/125985. Alternatively, compounds of formula XI may be converted into compounds of formula I-b (preferably when X₁is O) using triphenylphosphine, di-isopropyl azodicarboxylate (or di-ethyl azodicarboxylate) in an inert solvent such as tetrahydrofuran THF at temperatures between 20-50° C. Such Mitsunobu conditions have been previously described for these transformations (see WO 2009/131237).

Compounds of the formula XI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof, wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, can be prepared by

i) Activation of compound of formula XIII, wherein X is S, and in which A, R₁, R₄and R₅are as defined in formula I, by methods known to those skilled in the art and described in, for example, Tetrahedron, 2005, 61 (46), 10827-10852, to form an activated species XII, wherein X is S, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein X₀₀is halogen, preferably chlorine. For example, compounds XII where X₀₀is halogen, preferably chlorine, are formed by treatment of XIII with, for example, oxalyl chloride (COCl)₂or thionyl chloride SOCl₂in the presence of catalytic quantities of N,N-dimethylformamide DMF in inert solvents such as methylene chloride CH₂Cl₂or tetrahydrofuran THF at temperatures between 20 to 100° C., preferably 25° C. Alternatively, treatment of compounds of formula XIII with, for example, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide EDC or dicyclohexyl carbodiimide DCC will generate an activated species XII, wherein X₀₀is X₀₁or X₀₂respectively, in an inert solvent, such as pyridine or tetrahydrofuran THF, optionally in the presence of a base, such as triethylamine, at temperatures between 50-180° C.; followed by

ii) Treament of the activated species XII with compounds of the formula IX, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₂, X₁, G₁and G₂are as defined in formula I, in the presence of a base, such as triethylamine, N,N-diisopropylethylamine or pyridine, in an inert solvents such as dichloromethane, tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide, acetonitrile, ethyl acetate or toluene, at temperatures between 0 and 50° C., to form the compounds of formula XI.

Compounds of formula XI may structurally form as drawn, or may form as a regioisomer thereof (a position isomer of XI), or even may arise as a mixture of regioisomeric acylation products as described, for example, in WO 16/091731. This invention covers all such isomer forms, and mixtures thereof in all proportions.

Compounds of formula XIII, wherein X is S, and in which A, R₁, R₄and R₅are as defined in formula I, can be prepared by saponification of compounds of the formula XIV, wherein X is S, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl. Conditions for such a reaction, typically hydrolysis by water in presence of a base, are known to a person skilled in the art (using for example: aqueous sodium, potassium or lithium hydroxide in methanol, ethanol, tetrahydrofuran or dioxane at room temperature or up to refluxing conditions; or alternatively treating compounds of formula XIV with an acid, such as for example a hydrohalide acid, preferably hydrochloride or hydrobromide acid, or trifluoroacetic acid, optionally in presence of a solvent, such as tetrahydrofuran, dioxane or dichloromethane, at temperatures between 0 and 150° C.).

Compounds of the formula XIV, wherein X is S, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by alkylating compounds of the formula XV, wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, with reagents of the formula R₄-LG, wherein R₄is as defined in formula I, and in which LG is a leaving group such as a halogen, preferably iodine, bromine or chlorine, in presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, in an appropriate solvent such as for example tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethyl-acetamide or acetonitrile, at temperatures between 0 and 150° C.

Compounds of the formula XV, wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared (scheme 3 continued) by cyclizing compounds of the formula XVI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydro-bromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, in the presence of phosgene COCl₂, or a substitute thereof such as diphosgene or triphosgene, preferably in presence of a base, such as triethylamine, N,N-diisopropylethylamine or pyridine, in an inert solvent at temperatures between 0 and 80° C., preferably between 0 and 50° C. Examples of a solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Alternatively, compounds of the formula XV can be prepared by cyclizing compounds of the formula XVI in the presence of tetramethoxymethane, preferably in presence of an acid, advantageously in acetic acid or trifluoroacetic acid which simultaneously serve as a solvent or diluent, at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation. Compounds of the formula XVI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by reduction of compounds of the formula XVII, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, under conditions known to a person skilled in the art, such as for example using zinc dust and acetic acid or trifluoroacetic acid, or mixtures thereof, or using molecular hydrogen (H₂), optionally under pressure, usually in the presence of a catalyst such as nickel, palladium (for example palladium on charcoal, typically 5-10% Pd/C) or platinum, in alcoholic solvents (such as for example methanol or ethanol), or in inert solvents (such as for example ethyl acetate), at temperatures between 0° C. and 120° C., preferably between room temperature and reflux temperature.

Compounds of the formula XVII, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is S, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by reacting compounds of the formula XVIII, wherein X is S, and in which A and R₁are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), with a reagent R₅—NH₂, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₅is as defined in formula I, optionally in presence of an additional base. This transformation is preferably performed in suitable solvents (or diluents) such as alcohols, amides, esters, ethers, nitriles and water, particularly preferred are methanol, ethanol, 2,2,2-trifluoroethanol, propanol, iso-propanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, water or mixtures thereof, at temperatures between 0-150° C., preferably at temperatures ranging from room temperature to the boiling point of the reaction mixture, optionally under microwave irradiation or pressurized conditions using an autoclave.

Compounds of the formula XVIII, wherein X is S, and in which A and R₁are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), can be prepared from the corresponding carboxylic acid compounds of formula VII, wherein X is S, and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, fluorine, chlorine or bromine (preferably fluorine or chlorine), by reaction with an alcohol of formula R₀₀OH, wherein R₀₀is C₁-C₄alkyl, optionally in the presence of an acid (such as sulfuric acid), or alternatively optionally in presence of an activating agent, such as for example oxalyl chloride (COCl)₂. Such esterification methods are well known to a person skilled in the art. Compounds of of formula VII were described above (see scheme 2).

Alcohol compounds of formula R₀₀OH, wherein R₀₀is C₁-C₄alkyl, may be either known, commercially available or may be prepared by methods known to a person skilled in the art.

Alternatively, compounds of formula XIV and XIII can also be prepared according to chemistry described in scheme 3a. Compounds of formula XIII, wherein X is SO₂, and in which A, R₁, R₄and R₅are as defined in formula I,

embedded image

can be prepared by saponification of compounds of the formula XIV, wherein X is SO₂, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl under conditions already described above (see scheme 3).

Compounds of the formula XIV, wherein X is SO₂, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by cyclizing compounds of the formula XXV, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, in the presence of phosgene COCl₂, or a substitute thereof such as diphosgene or triphosgene, preferably in presence of a base, such as triethylamine, N,N-diisopropyl-ethylamine or pyridine, in an inert solvent at temperatures between 0 and 80° C., preferably between 0 and 50° C. Examples of a solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Alternatively, compounds of the formula XIV can be prepared by cyclizing compounds of the formula XXV in the presence of tetramethoxymethane, preferably in presence of an acid, advantageously in acetic acid or trifluoroacetic acid which simultaneously serve as a solvent or diluent, at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation.

Compounds of the formula XXV, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁, R₄and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by reacting compounds of the formula XXVI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl and Hal′ is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), with a reagent R₄—NH₂, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₄is as defined in formula I, optionally in presence of an additional base. This transformation is preferably performed in suitable solvents (or diluents) such as alcohols, amides, esters, ethers, nitriles and water, particularly preferred are methanol, ethanol, 2,2,2-trifluoroethanol, propanol, isopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, water or mixtures thereof, at temperatures between 0-150° C., preferably at temperatures ranging from room temperature to the boiling point of the reaction mixture, optionally under microwave irradiation or pressurized conditions using an autoclave.

Compounds of the formula XXVI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl and Hal′ is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), can be prepared by a halogenation reaction, which involves for example, reacting compounds of the formula XXVII, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, with halogenating reagents such as N-chlorosuccinimide (NCS), N-bromosuccinimide (NBS) or N-iodosuccinimide (NIS), or alternatively chlorine, bromine or iodine. Such halogenation reactions are carried out in an inert solvent, such as chloroform, carbon tetrachloride, 1,2-dichloroethane, acetic acid, ethers, acetonitrile or N,N-dimethylformamide, at temperatures between 20-200° C., preferably room temperature to 100° C.

Compounds of the formula XXVII, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X is SO₂, and in which A, R₁and R₅are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl, can be prepared by reacting compounds of the formula XXVIII-a, wherein X is SO₂, and in which A and R₁are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl and Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), with a reagent R₅—NH₂, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₅is as defined in formula I, optionally in presence of an additional base, and optionally in presence of a catalyst, for example a copper-based catalyst, such as copper powder or copper(I)iodide. This transformation is preferably performed in suitable solvents (or diluents) such as alcohols, amides, esters, ethers, nitriles and water, particularly preferred are methanol, ethanol, 2,2,2-trifluoroethanol, propanol, isopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, water or mixtures thereof, at temperatures between 0-150° C., preferably at temperatures ranging from room temperature to the boiling point of the reaction mixture, optionally under microwave irradiation or pressurized conditions using an autoclave.

Oxidation of compounds of the formula XXVIII-b, wherein X is S or SO (preferably S), and in which A and R₁are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl and Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), with a suitable oxidizing agent, into corresponding compounds of the formula XXVIII-a, wherein X is SO₂, can be achieved under conditions already described above.

Compounds of the formula XXVIII-b, wherein X is S or SO (preferably S), and in which A and R₁are as defined in formula I, and wherein R₀₀is C₁-C₄alkyl and Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), can be prepared from the corresponding carboxylic acid compounds of formula XXX (G=OH), wherein X is S or SO (preferably S), and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), by reaction with an alcohol of formula R₀₀OH, wherein R₀₀is C₁-C₄alkyl, optionally in the presence of an acid (such as sulfuric acid), under esterification methods well known to a person skilled in the art. Alternatively, compounds of the formula XXVIII-b, can also be prepared from the corresponding activated carboxylic acid derivatives of formula XXIX, wherein the substituents are as defined above, and in which X₀₀is, for example, chlorine (G=Cl), by reaction with the alcohol of formula R₀₀OH, wherein R₀₀is C₁-C₄alkyl, preferably in presence of a base, such as triethylamine, N,N-diisopropyl-ethylamine or pyridine, in an inert solvents such as dichloromethane, tetrahydrofuran, dioxane or toluene, at temperatures between 0 and 80° C., optionally in presence of a catalyst such as, for example, 4-dimethylaminopyridine.

Compounds of formula XXX (G=OH), wherein X is S, and in which A and R₁are as defined in formula I, and wherein Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), may be either known, commercially available or may be prepared by methods known to a person skilled in the art. See for example, WO16/030229 (compound XXX wherein X═S, A=N, R₁═CH₂CH₃, Hal=Br and G=OH), which also describes activation of compounds of formula XXX to form a corresponding activated species XXIX (G=Cl) in presence of an activating agent, such as for example oxalyl chloride (COCl)₂.

Compounds of formula I-b may also be prepared

embedded image

by condensing (scheme 3b) compounds of formula XIII and compounds of formula IX, wherein the substituent definitions are as described above, optionally in the presence of activating agents, under various formal dehydration conditions, for example in the presence of a dehydrating agent such as polyphosphoric acid, at temperature between 150° C. to 250° C., and without isolation of intermediacy compounds of the formula XI, or a regioisomer thereof, or an isomeric mixture (in any ratio) thereof. Such processes are well known and have been described for example in WO 2011/040629 or WO 2009/131237 (X₁is oxygen), and J. Am. Chem. Soc., 132(5), 1545-1557, 2010 or WO 2008/128968 (X₁is NR₃).

Alternatively, compounds of formula I-a, wherein X is SO₂, respectively compounds of formula I-b, wherein X is S, and in which A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I,

embedded image

can be prepared (scheme 4) by cyclizing compounds of the formula XIX, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, in the presence of phosgene COCl₂, or a substitute thereof such as diphosgene or triphosgene, preferably in presence of a base, such as triethylamine, N,N-diisopropylethylamine or pyridine, in an inert solvent at temperatures between 0 and 80° C., preferably between 0 and 50° C. Examples of a solvent to be used include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butylmethyl ether, and 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile or polar aprotic solvents such as N,N-dimethylformamide, N,N-dimethylacetamide, N-methyl-2-pyrrolidone or dimethyl sulfoxide. Certain bases, such as pyridine and triethylamine, may be employed successfully as both base and solvent. Alternatively, compounds of the formula I-a, respectively compounds of formula I-b, can be prepared by cyclizing compounds of the formula XIX in the presence of tetramethoxymethane, preferably in presence of an acid, advantageously in acetic acid or trifluoroacetic acid which simultaneously serve as a solvent or diluent, at temperatures between 0 and 180° C., preferably between 20 and 150° C., optionally under microwave irradiation.

Compounds of the formula XIX, or a salt thereof (such as a hydrohalide salt, preferably a hydro-chloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂, R₄and R₅are as defined in formula I, can be prepared by reacting compounds of the formula XX, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydro-bromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, and wherein Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), with a reagent R₄—NH₂, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein R₄is as defined in formula I, optionally in presence of an additional base. This transformation is preferably performed in suitable solvents (or diluents) such as alcohols, amides, esters, ethers, nitriles and water, particularly preferred are methanol, ethanol, 2,2,2-trifluoroethanol, propanol, isopropanol, N,N-dimethylformamide, N,N-dimethylacetamide, dioxane, tetrahydrofuran, dimethoxyethane, acetonitrile, ethyl acetate, water or mixtures thereof, at temperatures between 0-150° C., preferably at temperatures ranging from room temperature to the boiling point of the reaction mixture, optionally under microwave irradiation or pressurized conditions using an autoclave.

Compounds of the formula XX, or a salt thereof (such as a hydrohalide salt, preferably a hydro-chloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, and wherein Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably chlorine or bromine), can be prepared by a halogenation reaction, which involves for example, reacting compounds of the formula XXI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, with halogenating reagents such as N-chlorosuccinimide (NCS), N-bromo-succinimide (NBS) or N-iodosuccinimide (NIS), or alternatively chlorine, bromine or iodine. Such halogenation reactions are carried out in an inert solvent, such as chloroform, carbon tetrachloride, 1,2-dichloroethane, acetic acid, ethers, acetonitrile or N,N-dimethylformamide, at temperatures between 20-200° C., preferably room temperature to 100° C.

Compounds of the formula XXI, or a salt thereof (such as a hydrohalide salt, preferably a hydrochloride or a hydrobromide salt, or a trifluoroacetic acid salt, or any other equivalent salt), wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, can be prepared (scheme 4 continued) by treating compounds of the formula XXII, wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, and in which RPG is C₁-C₆alkyl, C₁-C₆alkoxy (for example tert-butyloxy), benzyloxy or benzyloxy substituted by one or two methoxy, preferably R_PGis tert-butyloxy, with an acid, such as for example a hydrohalide acid, preferably hydrochloride or hydrobromide acid, or trifluoroacetic acid, optionally in presence of water, optionally in presence of a solvent, such as tetrahydrofuran, dioxane or dichloromethane, at temperatures between 0 and 150° C.

Compounds of the formula XXII, wherein X, A, R₁, R₂, X₁, G₁, G₂and R₅are as defined in formula I, and in which R_PGis C₁-C₆alkyl, C₁-C₆alkoxy (for example tert-butyloxy), benzyloxy or benzyloxy substituted by one or two methoxy, preferably R_PGis tert-butyloxy, can be prepared by reacting compounds of the formula XXIII, wherein X, A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and in which R_PGis C₁-C₆alkyl, C₁-C₆alkoxy (for example tert-butyloxy), benzyloxy or benzyloxy substituted by one or two methoxy, preferably R_PGis tert-butyloxy, with a reagent of formula R₅-LG, wherein R₅is as defined in formula I and in which LG is a leaving group such as halogen, preferably iodine, bromine or chlorine, in presence of a base, such as sodium carbonate, potassium carbonate or cesium carbonate, or sodium hydride, in a appropriate solvent such as for example tetrahydrofuran, dioxane, N,N-dimethylformamide, N,N-dimethylacetamide or acetonitrile, at temperatures between 0 and 150° C.

Compounds of the formula XXIII, wherein X, A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and in which R_PGis C₁-C₆alkyl, C₁-C₆alkoxy (for example tert-butyloxy), benzyloxy or benzyloxy substituted by one or two methoxy, preferably R_PGis tert-butyloxy, can be prepared by reacting compounds of formula XXIV, wherein X, A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and in which Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably bromine or iodine), with a reagent of formula R_PGC(O)NH₂, wherein R_PGis C₁-C₆alkyl, C₁-C₆alkoxy (for example tert-butyloxy), benzyloxy or benzyloxy substituted by one or two methoxy, preferably R_PGis tert-butyloxy, in presence of a palladium based catalyst, for example tetrakis(triphenylphosphine)palladium(0), or palladium(II) acetate or tris(dibenzylideneacetone)dipalladium(0) in presence of a phosphine ligand, such as 2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl tricyclohexylphosphane XPhos, (1,1′bis(diphenyl-phosphino)ferrocene)dichloropalladium-dichloromethane (1:1 complex) or chloro(2-dicyclo-hexylphosphino-2′,4′,6′-triisopropyl-1,1′-biphenyl)[2-(2′-amino-1,1′-biphenyl)]palladium(II) (XPhos palladacycle), in presence of a base, like sodium, potassium or cesium carbonate, tripotassium phosphate or cesium fluoride, in a solvent or a solvent mixture, like, for example dioxane, acetonitrile or N,N-dimethylformamide, preferably under inert atmosphere. The reaction temperature can preferentially range from room temperature to the boiling point of the reaction mixture, or the reaction may be performed under microwave irradiation.

Reagents of the formula R₄—NH₂, or a salt thereof, wherein R₄is as defined above, and of the formula R₅-LG, wherein R₅is as defined in formula I, and in which LG is a leaving group such as a halogen, preferably iodine, bromine or chlorine, may be either known, commercially available or may be prepared by methods known to a person skilled in the art.

Reagents of the formula R_PGC(O)NH₂, wherein R_PGis as defined above, may be either known, commercially available or may be prepared by methods known to a person skilled in the art.

Compounds of formula XXIV, wherein X, A, R₁, R₂, X₁, G₁and G₂are as defined in formula I, and in which Hal is a halogen such as, for example, chlorine, bromine or iodine (preferably bromine or iodine), are known compounds and may be prepared by methods described, for example, in WO 2016/026848.

Oxidation of any compounds of formula XIX to XXIV (scheme 4), wherein the substituents are as defined above, and in which X is S (sulfide), with a suitable oxidizing agent, into corresponding compounds wherein X is SO (sulfoxide) or SO₂(sulfone) may be achieved under conditions already described above.

In one embodiment, the compounds of formula XIVx, XIIIx, XIIx, II-ab and XIx are provided and are particularly useful for the preparation of the compounds of formula I. The following formulae describe the compounds of formula XIVx, XIIIx, XIIx, II-ab and XIx in more detail:

Compounds of formula XIVx,

embedded image

wherein

A is CH or N;

X is S, SO or SO₂, preferably S or SO₂, even more preferably S;

R₁is C₁-C₄alkyl, preferably ethyl;

R₀₀is C₁-C₄alkyl, preferably methyl, ethyl or tert-butyl; and

R_4xand R_5x, independently from each other, are hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl, more preferably hydrogen or methyl, even more preferably methyl.

Compounds of formula XIIIx,

embedded image

wherein

A is CH or N;

X is S, SO or SO₂, preferably S or SO₂, even more preferably S;

R₁is C₁-C₄alkyl, preferably ethyl; and

R_4xand R_5x, independently from each other, are hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl, more preferably hydrogen or methyl, even more preferably methyl.

Compounds of formula XIIx,

embedded image

wherein

A is CH or N;

Compounds of formula II-ab,

embedded image

wherein

A is CH or N, preferably CH;

X is S, SO or SO₂, preferably S or SO₂, even more preferably S;

R₁is C₁-C₄alkyl, preferably ethyl;

X_1Xis 0 or NCH₃;

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl, even more preferably trifluoromethyl;

G₁is N or CH;
G₂is N or CH; and

R_5yis C₁-C₆alkyl, preferably methyl or ethyl, even more preferably methyl.

Compounds of formula XIx,

embedded image

or a regioisomer thereof, or an isomeric mixture (In any ratio) thereof;

wherein

A is CH or N, preferably CH;

X is S, SO or SO₂, preferably S or SO₂, even more preferably S;

R₁is C₁-C₄alkyl, preferably ethyl;

X_1Xis O or NCH₃;

R₂is C₁-C₆haloalkyl, C₁-C₄haloalkylsulfanyl or C₁-C₄haloalkylsulfonyl, preferably trifluoromethyl, trifluoromethylsulfanyl or trifluoromethylsulfonyl, even more preferably trifluoromethyl;

G₁is N or CH;
G₂is N or CH; and

R_4xand R_5x, independently from each other, are hydrogen or C₁-C₆alkyl, preferably hydrogen, methyl or ethyl, more preferably hydrogen or methyl, even more preferably methyl.

The reactants can be reacted in the presence of a base. Examples of suitable bases are alkali metal or alkaline earth metal hydroxides, alkali metal or alkaline earth metal hydrides, alkali metal or alkaline earth metal amides, alkali metal or alkaline earth metal alkoxides, alkali metal or alkaline earth metal acetates, alkali metal or alkaline earth metal carbonates, alkali metal or alkaline earth metal dialkylamides or alkali metal or alkaline earth metal alkylsilylamides, alkylamines, alkylenediamines, free or N-alkylated saturated or unsaturated cycloalkylamines, basic heterocycles, ammonium hydroxides and carbocyclic amines. Examples which may be mentioned are sodium hydroxide, sodium hydride, sodium amide, sodium methoxide, sodium acetate, sodium carbonate, potassium tert-butoxide, potassium hydroxide, potassium carbonate, potassium hydride, lithium diisopropylamide, potassium bis(trimethylsilyl)amide, calcium hydride, triethylamine, diisopropylethylamine, triethylenediamine, cyclohexylamine, N-cyclohexyl-N,N-dimethylamine, N,N-diethylaniline, pyridine, 4-(N,N-dimethylamino)pyridine, quinuclidine, N-methylmorpholine, benzyltrimethylammonium hydroxide and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU).

The reactants can be reacted with each other as such, i.e. without adding a solvent or diluent. In most cases, however, it is advantageous to add an inert solvent or diluent or a mixture of these. If the reaction is carried out in the presence of a base, bases which are employed in excess, such as triethylamine, pyridine, N-methylmorpholine or N,N-diethylaniline, may also act as solvents or diluents.

The reaction is advantageously carried out in a temperature range from approximately −80° C. to approximately +140° C., preferably from approximately −30° C. to approximately +100° C., in many cases in the range between ambient temperature and approximately +80° C.

A compound of formula I can be converted in a manner known per se into another compound of formula I by replacing one or more substituents of the starting compound of formula I in the customary manner by (an)other substituent(s) according to the invention.

Depending on the choice of the reaction conditions and starting materials which are suitable in each case, it is possible, for example, in one reaction step only to replace one substituent by another substituent according to the invention, or a plurality of substituents can be replaced by other substituents according to the invention in the same reaction step.

Salts of compounds of formula I can be prepared in a manner known per se. Thus, for example, acid addition salts of compounds of formula I are obtained by treatment with a suitable acid or a suitable ion exchanger reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchanger reagent.

Salts of compounds of formula I can be converted in the customary manner into the free compounds I, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchanger reagent and salts with bases, for example, by treatment with a suitable acid or with a suitable ion exchanger reagent.

Salts of compounds of formula I can be converted in a manner known per se into other salts of compounds of formula I, acid addition salts, for example, into other acid addition salts, for example by treatment of a salt of inorganic acid such as hydrochloride with a suitable metal salt such as a sodium, barium or silver salt, of an acid, for example with silver acetate, in a suitable solvent in which an inorganic salt which forms, for example silver chloride, is insoluble and thus precipitates from the reaction mixture.

Depending on the procedure or the reaction conditions, the compounds of formula I, which have salt-forming properties can be obtained in free form or in the form of salts.

The compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can be present in the form of one of the isomers which are possible or as a mixture of these, for example in the form of pure isomers, such as antipodes and/or diastereomers, or as isomer mixtures, such as enantiomer mixtures, for example racemates, diastereomer mixtures or racemate mixtures, depending on the number, absolute and relative configuration of asymmetric carbon atoms which occur in the molecule and/or depending on the configuration of non-aromatic double bonds which occur in the molecule; the invention relates to the pure isomers and also to all isomer mixtures which are possible and is to be understood in each case in this sense hereinabove and hereinbelow, even when stereochemical details are not mentioned specifically in each case.

Diastereomer mixtures or racemate mixtures of compounds of formula I, in free form or in salt form, which can be obtained depending on which starting materials and procedures have been chosen can be separated in a known manner into the pure diasteromers or racemates on the basis of the physicochemical differences of the components, for example by fractional crystallization, distillation and/or chromatography.

Enantiomer mixtures, such as racemates, which can be obtained in a similar manner can be resolved into the optical antipodes by known methods, for example by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example high-performance liquid chromatography (HPLC) on acetyl celulose, with the aid of suitable microorganisms, by cleavage with specific, immobilized enzymes, via the formation of inclusion compounds, for example using chiral crown ethers, where only one enantiomer is complexed, or by conversion into diastereomeric salts, for example by reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example camphor, tartaric or malic acid, or sulfonic acid, for example camphorsulfonic acid, and separating the diastereomer mixture which can be obtained in this manner, for example by fractional crystallization based on their differing solubilities, to give the diastereomers, from which the desired enantiomer can be set free by the action of suitable agents, for example basic agents.

Pure diastereomers or enantiomers can be obtained according to the invention not only by separating suitable isomer mixtures, but also by generally known methods of diastereoselective or enantioselective synthesis, for example by carrying out the process according to the invention with starting materials of a suitable stereochemistry.

N-oxides can be prepared by reacting a compound of the formula I with a suitable oxidizing agent, for example the H₂O₂/urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. Such oxidations are known from the literature, for example from J. Med. Chem., 32 (12), 2561-73, 1989 or WO 00/15615.

It is advantageous to isolate or synthesize in each case the biologically more effective isomer, for example enantiomer or diastereomer, or isomer mixture, for example enantiomer mixture or diastereomer mixture, if the individual components have a different biological activity.

The compounds of formula I and, where appropriate, the tautomers thereof, in each case in free form or in salt form, can, if appropriate, also be obtained in the form of hydrates and/or include other solvents, for example those which may have been used for the crystallization of compounds which are present in solid form.

The compounds according to the following Tables 1 to 12 below can be prepared according to the methods described above. The examples which follow are intended to illustrate the invention and show preferred compounds of formula I.

Table 1: This table discloses the 72 compounds 1.001 to 1.072 of the formula I-1a:

embedded image

wherein X₁₁is S, and A, R₁₁, X₁, R₂, R₄and R₅are as defined below:

TABLE 1

Comp.

No
A
R₁₁
X₁
R₂
R₄
R₅

1.001
N
—CH₂CH₃
NCH₃
CF₃
H
CH₃

1.002
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

1.003
N
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

1.004
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

1.005
CH
—CH₂CH₃
NCH₃
CF₃
H
CH₃

1.006
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

1.007
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

1.008
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

1.009
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

1.010
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

1.011
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

1.012
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

1.013
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

1.014
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

1.015
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

1.016
N
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

1.017
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

1.018
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

1.019
CH
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

1.020
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

1.021
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

1.022
N
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

1.023
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

1.024
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

1.025
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

1.026
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

1.027
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

1.028
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

1.029
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

1.030
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

1.031
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

1.032
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

1.033
N
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

1.034
N
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

1.035
N
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

1.036
N
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

1.037
N
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

1.038
N
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

1.039
N
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

1.040
N
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

1.041
N
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

1.042
N
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

1.043
N
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

1.044
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

1.045
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

1.046
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

1.047
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

1.048
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

1.049
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

1.050
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

1.051
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

1.052
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

1.053
CH
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

1.054
CH
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

1.055
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

1.056
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

1.057
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

1.058
CH
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

1.059
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

1.060
CH
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

1.061
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

1.062
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

1.063
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

1.064
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

1.065
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

1.066
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

1.067
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

1.068
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

1.069
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

1.070
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

1.071
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

1.072
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

and the N-oxides of the compounds of Table 1. CycloC3 represents the cyclopropyl group.

Table 2: This table discloses the 72 compounds 2.001 to 2.072 of the formula I-1a, wherein X₁₁is SO, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 1.

Table 3: This table discloses the 72 compounds 3.001 to 3.072 of the formula I-1a, wherein X₁₁is SO₂, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 1.

Table 4: This table discloses the 72 compounds 4.001 to 4.072 of the formula I-2a:

embedded image

wherein X₁₁is S, and A, R₁₁, X₁, R₂, R₄and R₅are as defined below:

TABLE 4

Comp.

No
A
R₁₁
X₁
R₂
R₄
R₅

4.001
N
—CH₂CH₃
NCH₃
CF₃
H
CH₃

4.002
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

4.003
N
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

4.004
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

4.005
CH
—CH₂CH₃
NCH₃
CF₃
H
CH₃

4.006
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

4.007
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

4.008
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

4.009
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

4.010
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

4.011
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

4.012
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

4.013
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

4.014
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

4.015
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

4.016
N
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

4.017
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

4.018
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

4.019
CH
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

4.020
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

4.021
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

4.022
N
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

4.023
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

4.024
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

4.025
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

4.026
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

4.027
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

4.028
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

4.029
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

4.030
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

4.031
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

4.032
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

4.033
N
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

4.034
N
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

4.035
N
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

4.036
N
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

4.037
N
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

4.038
N
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

4.039
N
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

4.040
N
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

4.041
N
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

4.042
N
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

4.043
N
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

4.044
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

4.045
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

4.046
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

4.047
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

4.048
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

4.049
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

4.050
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

4.051
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

4.052
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

4.053
CH
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

4.054
CH
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

4.055
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

4.056
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

4.057
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

4.058
CH
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

4.059
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

4.060
CH
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

4.061
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

4.062
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

4.063
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

4.064
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

4.065
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

4.066
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

4.067
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

4.068
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

4.069
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

4.070
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

4.071
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

4.072
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

and the N-oxides of the compounds of Table 4. CycloC3 represents the cyclopropyl group.

Table 5: This table discloses the 72 compounds 5.001 to 5.072 of the formula I-2a, wherein X₁₁is SO, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 4.

Table 6: This table discloses the 72 compounds 6.001 to 6.072 of the formula I-2a, wherein X₁₁is SO₂, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 4.

Table 7: This table discloses the 72 compounds 7.001 to 7.072 of the formula I-3a:

embedded image

wherein X₁₁is S, and A, R₁₁, X₁, R₂, R₄and R₅are as defined below:

TABLE 7

Comp.

No
A
R₁₁
X₁
R₂
R₄
R₅

7.001
N
—CH₂CH₃
NCH₃
CF₃
H
CH₃

7.002
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

7.003
N
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

7.004
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

7.005
CH
—CH₂CH₃
NCH₃
CF₃
H
CH₃

7.006
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

7.007
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

7.008
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

7.009
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

7.010
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

7.011
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

7.012
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

7.013
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

7.014
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

7.015
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

7.016
N
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

7.017
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

7.018
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

7.019
CH
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

7.020
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

7.021
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

7.022
N
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

7.023
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

7.024
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

7.025
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

7.026
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

7.027
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

7.028
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

7.029
N
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

7.030
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₃

7.031
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₂CH₃
CH₃

7.032
CH
—CH₂CH₃
NCH₃
SO₂CF₃
CH₃
CH₂CH₃

7.033
N
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

7.034
N
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

7.035
N
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

7.036
N
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

7.037
N
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

7.038
N
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

7.039
N
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

7.040
N
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

7.041
N
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

7.042
N
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

7.043
N
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

7.044
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

7.045
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

7.046
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

7.047
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

7.048
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

7.049
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

7.050
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

7.051
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

7.052
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

7.053
CH
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

7.054
CH
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

7.055
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

7.056
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

7.057
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

7.058
CH
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

7.059
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

7.060
CH
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

7.061
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

7.062
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

7.063
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

7.064
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

7.065
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

7.066
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

7.067
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

7.068
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

7.069
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

7.070
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

7.071
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

7.072
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

and the N-oxides of the compounds of Table 7. CycloC3 represents the cyclopropyl group.

Table 8: This table discloses the 72 compounds 8.001 to 8.072 of the formula I-3a, wherein X₁₁is SO, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 7.

Table 9: This table discloses the 72 compounds 9.001 to 9.072 of the formula I-3a, wherein X₁₁is SO₂, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 7.

Table 10: This table discloses the 140 compounds 10.001 to 10.140 of the formula I-4a:

embedded image

wherein X₁₁is S, and A, R₁₁, X₁, R₂, R₄and R₅are as defined below:

TABLE 10

Comp.

No
A
R₁₁
X₁
R₂
R₄
R₅

10.001
N
—CH₂CH₃
O
CF₃
CH₃
CH₃

10.002
N
—CH₂CH₃
O
CF₃
CH₂CH₃
CH₃

10.003
N
—CH₂CH₃
O
CF₃
CH₃
CH₂CH₃

10.004
CH
—CH₂CH₃
O
CF₃
CH₃
CH₃

10.005
CH
—CH₂CH₃
O
CF₃
CH₂CH₃
CH₃

10.006
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂CH₃

10.007
N
—CH₂CH₃
O
CF₂CF₃
CH₃
CH₃

10.008
N
—CH₂CH₃
O
CF₂CF₃
CH₂CH₃
CH₃

10.009
N
—CH₂CH₃
O
CF₂CF₃
CH₃
CH₂CH₃

10.010
CH
—CH₂CH₃
O
CF₂CF₃
CH₃
CH₃

10.011
CH
—CH₂CH₃
O
CF₂CF₃
CH₂CH₃
CH₃

10.012
CH
—CH₂CH₃
O
CF₂CF₃
CH₃
CH₂CH₃

10.013
N
—CH₂CH₃
O
SCF₃
CH₃
CH₃

10.014
N
—CH₂CH₃
O
SCF₃
CH₂CH₃
CH₃

10.015
N
—CH₂CH₃
O
SCF₃
CH₃
CH₂CH₃

10.016
CH
—CH₂CH₃
O
SCF₃
CH₃
CH₃

10.017
CH
—CH₂CH₃
O
SCF₃
CH₂CH₃
CH₃

10.018
CH
—CH₂CH₃
O
SCF₃
CH₃
CH₂CH₃

10.019
N
—CH₂CH₃
O
SOCF₃
CH₃
CH₃

10.020
N
—CH₂CH₃
O
SOCF₃
CH₂CH₃
CH₃

10.021
N
—CH₂CH₃
O
SOCF₃
CH₃
CH₂CH₃

10.022
CH
—CH₂CH₃
O
SOCF₃
CH₃
CH₃

10.023
CH
—CH₂CH₃
O
SOCF₃
CH₂CH₃
CH₃

10.024
CH
—CH₂CH₃
O
SOCF₃
CH₃
CH₂CH₃

10.025
N
—CH₂CH₃
O
SOCF₃
CH₃
CH₃

10.026
N
—CH₂CH₃
O
SOCF₃
CH₂CH₃
CH₃

10.027
N
—CH₂CH₃
O
SOCF₃
CH₃
CH₂CH₃

10.028
CH
—CH₂CH₃
O
SOCF₃
CH₃
CH₃

10.029
CH
—CH₂CH₃
O
SOCF₃
CH₂CH₃
CH₃

10.030
CH
—CH₂CH₃
O
SOCF₃
CH₃
CH₂CH₃

10.031
N
—CH₂CH₃
O
CF₃
SO₂-cycloC3
CH₃

10.032
N
—CH₂CH₃
O
CF₃
CN
CH₃

10.033
N
—CH₂CH₃
O
CF₃
CH₂SCH₃
CH₃

10.034
N
—CH₂CH₃
O
CF₃
CH₂SOCH₃
CH₃

10.035
N
—CH₂CH₃
O
CF₃
CH₂SO₂CH₃
CH₃

10.036
N
—CH₂CH₃
O
CF₃
CH₂OCH₃
CH₃

10.037
N
—CH₂CH₃
O
CF₃
CH₂CF₃
CH₃

10.038
N
—CH₂CH₃
O
CF₃
CO-cycloC3
CH₃

10.039
N
—CH₂CH₃
O
CF₃
COOCH₃
CH₃

10.040
N
—CH₂CH₃
O
CF₃
COOCH₂CH₃
CH₃

10.041
N
—CH₂CH₃
O
CF₃
CH₃
SO₂-cycloC3

10.042
N
—CH₂CH₃
O
CF₃
CH₃
CN

10.043
N
—CH₂CH₃
O
CF₃
CH₃
CH₂SCH₃

10.044
N
—CH₂CH₃
O
CF₃
CH₃
CH₂SOCH₃

10.045
N
—CH₂CH₃
O
CF₃
CH₃
CH₂SO₂CH₃

10.046
N
—CH₂CH₃
O
CF₃
CH₃
CH₂OCH₃

10.047
N
—CH₂CH₃
O
CF₃
CH₃
CH₂CF₃

10.048
N
—CH₂CH₃
O
CF₃
CH₃
CO-cycloC3

10.049
N
—CH₂CH₃
O
CF₃
CH₃
COOCH₃

10.050
N
—CH₂CH₃
O
CF₃
CH₃
COOCH₂CH₃

10.051
CH
—CH₂CH₃
O
CF₃
SO₂-cycloC3
CH₃

10.052
CH
—CH₂CH₃
O
CF₃
CN
CH₃

10.053
CH
—CH₂CH₃
O
CF₃
CH₂SCH₃
CH₃

10.054
CH
—CH₂CH₃
O
CF₃
CH₂SOCH₃
CH₃

10.055
CH
—CH₂CH₃
O
CF₃
CH₂SO₂CH₃
CH₃

10.056
CH
—CH₂CH₃
O
CF₃
CH₂OCH₃
CH₃

10.057
CH
—CH₂CH₃
O
CF₃
CH₂CF₃
CH₃

10.058
CH
—CH₂CH₃
O
CF₃
CO-cycloC3
CH₃

10.059
CH
—CH₂CH₃
O
CF₃
COOCH₃
CH₃

10.060
CH
—CH₂CH₃
O
CF₃
COOCH₂CH₃
CH₃

10.061
CH
—CH₂CH₃
O
CF₃
CH₃
SO₂-cycloC3

10.062
CH
—CH₂CH₃
O
CF₃
CH₃
CN

10.063
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂SCH₃

10.064
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂SOCH₃

10.065
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂SO₂CH₃

10.066
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂OCH₃

10.067
CH
—CH₂CH₃
O
CF₃
CH₃
CH₂CF₃

10.068
CH
—CH₂CH₃
O
CF₃
CH₃
CO-cycloC3

10.069
CH
—CH₂CH₃
O
CF₃
CH₃
COOCH₃

10.070
CH
—CH₂CH₃
O
CF₃
CH₃
COOCH₂CH₃

10.071
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

10.072
N
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

10.073
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

10.074
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₃

10.075
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CH₃
CH₃

10.076
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CH₃

10.077
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

10.078
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

10.079
N
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

10.080
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₃

10.081
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₂CH₃
CH₃

10.082
CH
—CH₂CH₃
NCH₃
CF₂CF₃
CH₃
CH₂CH₃

10.083
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

10.084
N
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

10.085
N
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

10.086
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₃

10.087
CH
—CH₂CH₃
NCH₃
SCF₃
CH₂CH₃
CH₃

10.088
CH
—CH₂CH₃
NCH₃
SCF₃
CH₃
CH₂CH₃

10.089
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

10.090
N
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

10.091
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

10.092
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

10.093
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

10.094
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

10.095
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

10.096
N
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

10.097
N
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

10.098
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₃

10.099
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₂CH₃
CH₃

10.100
CH
—CH₂CH₃
NCH₃
SOCF₃
CH₃
CH₂CH₃

10.101
N
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

10.102
N
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

10.103
N
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

10.104
N
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

10.105
N
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

10.106
N
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

10.107
N
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

10.108
N
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

10.109
N
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

10.110
N
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

10.111
N
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

10.112
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

10.113
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

10.114
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

10.115
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

10.116
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

10.117
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

10.118
N
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

10.119
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

10.120
N
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

10.121
CH
—CH₂CH₃
NCH₃
CF₃
SO₂-cycloC3
CH₃

10.122
CH
—CH₂CH₃
NCH₃
CF₃
CN
CH₃

10.123
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SCH₃
CH₃

10.124
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SOCH₃
CH₃

10.125
CH
—CH₂CH₃
NCH₃
CF₃
CH₂SO₂CH₃
CH₃

10.126
CH
—CH₂CH₃
NCH₃
CF₃
CH₂OCH₃
CH₃

10.127
CH
—CH₂CH₃
NCH₃
CF₃
CH₂CF₃
CH₃

10.128
CH
—CH₂CH₃
NCH₃
CF₃
CO-cycloC3
CH₃

10.129
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₃
CH₃

10.130
CH
—CH₂CH₃
NCH₃
CF₃
COOCH₂CH₃
CH₃

10.131
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
SO₂-cycloC3

10.132
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CN

10.133
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SCH₃

10.134
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SOCH₃

10.135
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂SO₂CH₃

10.136
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂OCH₃

10.137
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CH₂CF₃

10.138
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
CO-cycloC3

10.139
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₃

10.140
CH
—CH₂CH₃
NCH₃
CF₃
CH₃
COOCH₂CH₃

and the N-oxides of the compounds of Table 10. CycloC3 represents the cyclopropyl group.

Table 11: This table discloses the 140 compounds 11.001 to 11.140 of the formula I-4a, wherein X₁₁is SO, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 10.

Table 12: This table discloses the 140 compounds 12.001 to 12.140 of the formula I-4a, wherein X₁₁is SO₂, and A, R₁₁, X₁, R₂, R₄and R₅are as defined in Table 10.

The compounds of formula I according to the invention may possess any number of benefits including, inter alia, advantageous levels of biological activity for protecting plants against insects or superior properties for use as agrochemical active ingredients (for example, greater biological activity, an advantageous spectrum of activity, an increased safety profile, improved physico-chemical properties, or increased biodegradability). In particular, it has been surprisingly found that certain compounds of formula (I) may show an advantageous safety profile with respect to non-target arthropods, in particular pollinators such as honey bees, solitary bees, and bumble bees. Most particularly, Apis mellifera.

In particular, the compounds of formula I according to the invention are preventively and/or curatively valuable active ingredients in the field of pest control, even at low rates of application, which have a very favorable biocidal spectrum and are well tolerated by warm-blooded species, fish and plants. The active ingredients according to the invention act against all or individual developmental stages of normally sensitive, but also resistant, animal pests, such as insects or representatives of the order Acarina. The insecticidal or acaricidal activity of the active ingredients according to the invention can manifest itself directly, i. e. in destruction of the pests, which takes place either immediately or only after some time has elapsed, for example during ecdysis, or indirectly, for example in a reduced oviposition and/or hatching rate, a good activity corresponding to a destruction rate (mortality) of at least 50 to 60%.

Examples of the abovementioned animal pests are:

from the order Acarina, for example,

Acalitus spp, Aculus spp, Acaricalus spp, Aceria spp, Acarus siro, Amblyomma spp., Argas spp., Boophilus spp., Brevipalpus spp., Bryobia spp, Calipitrimerus spp., Chorioptes spp., Dermanyssus gallinae, Dermatophagoides spp, Eotetranychus spp, Eriophyes spp., Hemitarsonemus spp, Hyalomma spp., Ixodes spp., Olygonychus spp, Ornithodoros spp., Polyphagotarsone latus, Panonychus spp., Phyllocoptruta oleivora, Phytonemus spp, Polyphagotarsonemus spp, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Steneotarsonemus spp, Tarsonemus spp. and Tetranychus spp.;

from the order Anoplura, for example,

Haematopinus spp., Linognathus spp., Pediculus spp., Pemphigus spp. and Phylloxera spp.;

from the order Coleoptera, for example,

Agriotes spp., Amphimallon majale, Anomala orientalis, Anthonomus spp., Aphodius spp, Astylus atromaculatus, Ataenius spp, Atomaria linearis, Chaetocnema tibialis, Cerotoma spp, Conoderus spp, Cosmopolites spp., Cotinis nitida, Curculio spp., Cyclocephala spp, Dermestes spp., Diabrotica spp., Diloboderus abderus, Epilachna spp., Eremnus spp., Heteronychus arator, Hypothenemus hampei, Lagria vilosa, Leptinotarsa decemLineata, Lissorhoptrus spp., Liogenys spp, Maecolaspis spp, Maladera castanea, Megascelis spp, Melighetes aeneus, Melolontha spp., Myochrous armatus, Orycaephilus spp., Otiorhynchus spp., Phyllophaga spp, Phlyctinus spp., Popillia spp., Psylliodes spp., Rhyssomatus aubtilis, Rhizopertha spp., Scarabeidae, Sitophilus spp., Sitotroga spp., Somaticus spp, Sphenophorus spp, Sternechus subsignatus, Tenebrio spp., Tribolium spp. and Trogoderma spp.;

from the order Diptera, for example,

Aedes spp., Anopheles spp, Antherigona soccata, Bactrocea oleae, Bibio hortulanus, Bradysia spp, Calliphora erythrocephala, Ceratitis spp., Chrysomyia spp., Culex spp., Cuterebra spp., Dacus spp., Delia spp, Drosophila melanogaster, Fannia spp., Gastrophilus spp., Geomyza tripunctata, Glossina spp., Hypoderma spp., Hyppobosca spp., Liriomyza spp., Lucilia spp., Melanagromyza spp., Musca spp., Oestrus spp., Orseolia spp., Oscinella frit, Pegomyia hyoscyami, Phorbia spp., Rhagoletis spp, Rivelia quadrifasciata, Scatella spp, Sciara spp., Stomoxys spp., Tabanus spp., Tannia spp. and Tipula spp.;

from the order Hemiptera, for example,

Acanthocoris scabrator, Acrosternum spp, Adelphocoris lineolatus, Amblypelta nitida, Bathycoelia thalassina, Blissus spp, Cimex spp., Clavigralla tomentosicollis, Creontiades spp, Distantiella theobroma, Dichelops furcatus, Dysdercus spp., Edessa spp, Euchistus spp., Eurydema pulchrum, Eurygaster spp., Halyomorpha halys, Horcias nobilellus, Leptocorisa spp., Lygus spp, Margarodes spp, Murgantia histrionic, Neomegalotomus spp, Nesidiocoris tenuis, Nezara spp., Nysius simulans, Oebalus insularis, Piesma spp., Piezodorus spp, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophara spp., Thyanta spp, Triatoma spp., Vatiga illudens;
Acyrthosium pisum, Adalges spp, Agalliana ensigera, Agonoscena targionii, Aleurodicus spp, Aleurocanthus spp, Aleurolobus barodensis, Aleurothrixus floccosus, Aleyrodes brassicae, Amarasca biguttula, Amritodus atkinsoni, Aonidiella spp., Aphididae, Aphis spp., Aspidiotus spp., Aulacorthum solani, Bactericera cockerelli, Bemisia spp, Brachycaudus spp, Brevicoryne brassicae, Cacopsylla spp, Cavariella aegopodii Scop., Ceroplaster spp., Chrysomphalus aonidium, Chrysomphalus dictyospermi, Cicadella spp, Cofana spectra, Cryptomyzus spp, Cicadulina spp, Coccus hesperidum, Dalbulus maidis, Dialeurodes spp, Diaphorina citri, Diuraphis noxia, Dysaphis spp, Empoasca spp., Eriosoma larigerum, Erythroneura spp., Gascardia spp., Glycaspis brimblecombei, Hyadaphis pseudobrassicae, Hyalopterus spp, Hyperomyzus pallidus, Idioscopus clypealis, Jacobiasca lybica, Laodelphax spp., Lecanium corni, Lepidosaphes spp., Lopaphis erysimi, Lyogenys maidis, Macrosiphum spp., Mahanarva spp, Metcalfa pruinosa, Metopolophium dirhodum, Myndus crudus, Myzus spp., Neotoxoptera sp, Nephotettix spp., Nilaparvata spp., Nippolachnus piri Mats, Odonaspis ruthae, Oregma lanigera Zehnter, Parabemisia myricae, Paratrioza cockerelli, Parlatoria spp., Pemphigus spp., Peregrinus maidis, Perkinsiella spp, Phorodon humuli, Phylloxera spp, Planococcus spp., Pseudaulacaspis spp., Pseudococcus spp., Pseudatomoscelis seriatus, Psylla spp., Pulvinaria aethiopica, Quadraspidiotus spp., Quesada gigas, Recilia dorsalis, Rhopalosiphum spp., Saissetia spp., Scaphoideus spp., Schizaphis spp., Sitobion spp., Sogatella furcifera, Spissistilus festinus, Tarophagus Proserpina, Toxoptera spp, Trialeurodes spp, Tridiscus sporoboli, Trionymus spp, Trioza erytreae, Unaspis citri, Zygina flammigera, Zyginidia scutellaris;

from the order Hymenoptera, for example,

Acromyrmex, Arge spp, Atta spp., Cephus spp., Diprion spp., Diprionidae, Gilpinia polytoma, Hoplo-campa spp., Lasius spp., Monomorium pharaonis, Neodiprion spp., Pogonomyrmex spp, Slenopsis invicta, Solenopsis spp. and Vespa spp.;

from the order Isoptera, for example,

Coptotermes spp, Corniternes cumulans, Incisitermes spp, Macrotermes spp, Mastotermes spp, Microtermes spp, Reticulitermes spp.; Solenopsis geminate

from the order Lepidoptera, for example,

Acleris spp., Adoxophyes spp., Aegeria spp., Agrotis spp., Alabama argillaceae, Amylois spp., Anticarsia gemmatalis, Archips spp., Argyresthia spp, Argyrotaenia spp., Autographa spp., Bucculatrix thurberiella, Busseola fusca, Cadra cautella, Carposina nipponensis, Chilo spp., Choristoneura spp., Chrysoteuchia topiaria, Clysia ambiguella, Cnaphalocrocis spp., Cnephasia spp., Cochylis spp., Coleophora spp., Colias lesbia, Cosmophila flava, Crambus spp, Crocidolomia binotalis, Cryptophlebia leucotreta, Cydalima perspectalis, Cydia spp., Diaphania perspectalis, Diatraea spp., Diparopsis castanea, Earias spp., Eldana saccharina, Ephestia spp., Epinotia spp, Estigmene acrea, Etiella zinckinella, Eucosma spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia jaculiferia, Gra-pholita spp., Hedya nubiferana, Heliothis spp., Hellula undalis, Herpetogramma spp, Hyphantria cunea, Keiferia lycopersicella, Lasmopalpus lignosellus, Leucoptera scitella, Lithocollethis spp., Lobesia botrana, Loxostege bifidalis, Lymantria spp., Lyonetia spp., Malacosoma spp., Mamestra brassicae, Manduca sexta, Mythimna spp, Noctua spp, Operophtera spp., Orniodes indica, Ostrinia nubilalis, Pammene spp., Pandemis spp., Panolis flammea, Papaipema nebris, Pectinophora gossypi-ela, Perileucoptera coffeella, Pseudaletia unipuncta, Phthorimaea operculella, Pieris rapae, Pieris spp., Plutella xylostella, Prays spp., Pseudoplusia spp, Rachiplusia nu, Richia albicosta, Scirpophaga spp., Sesamia spp., Sparganothis spp., Spodoptera spp., Sylepta derogate, Synanthedon spp., Thaumetopoea spp., Tortrix spp., Trichoplusia ni, Tuta absoluta, and Yponomeuta spp.; from the order Mallophaga, for example,

Damalinea spp. and Trichodectes spp.;

from the order Orthoptera, for example,

Blatta spp., Blattella spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Neocurtilla hexadactyla, Periplaneta spp., Scapteriscus spp, and Schistocerca spp.;

from the order Psocoptera, for example,

Liposcelis spp.;

from the order Siphonaptera, for example,

Ceratophyllus spp., Ctenocephalides spp. and Xenopsylla cheopis;

from the order Thysanoptera, for example,

Calliothrips phaseoli, Frankliniella spp., Heliothrips spp, Hercinothrips spp., Parthenothrips spp, Scirtothrips aurantii, Sericothrips variabilis, Taeniothrips spp., Thrips spp;

from the order Thysanura, for example, Lepisma saccharina.

The active ingredients according to the invention can be used for controlling, i. e. containing or destroying, pests of the abovementioned type which occur in particular on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forests, or on organs, such as fruits, flowers, foliage, stalks, tubers or roots, of such plants, and in some cases even plant organs which are formed at a later point in time remain protected against these pests.

Suitable target crops are, in particular, cereals, such as wheat, barley, rye, oats, rice, maize or sorghum; beet, such as sugar or fodder beet; fruit, for example pomaceous fruit, stone fruit or soft fruit, such as apples, pears, plums, peaches, almonds, cherries or berries, for example strawberries, raspberries or blackberries; leguminous crops, such as beans, lentils, peas or soya; oil crops, such as oilseed rape, mustard, poppies, olives, sunflowers, coconut, castor, cocoa or ground nuts; cucurbits, such as pumpkins, cucumbers or melons; fibre plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruit or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes or bell peppers; Lauraceae, such as avocado, Cinnamonium or camphor; and also tobacco, nuts, coffee, eggplants, sugarcane, tea, pepper, grapevines, hops, the plantain family and latex plants.

The compositions and/or methods of the present invention may be also used on any ornamental and/or vegetable crops, including flowers, shrubs, broad-leaved trees and evergreens.

For example the invention may be used on any of the following ornamental species: Ageratum spp., Alonsoa spp., Anemone spp., Anisodontea capsenisis, Anthemis spp., Antirrhinum spp., Aster spp., Begonia spp. (e.g. B. elatior, B. semperflorens, B. tubéreux), Bougainvillea spp., Brachycome spp., Brassica spp. (ornamental), Calceolaria spp., Capsicum annuum, Catharanthus roseus, Canna spp., Centaurea spp., Chrysanthemum spp., Cineraria spp. (C. maritime), Coreopsis spp., Crassula coccinea, Cuphea ignea, Dahlia spp., Delphinium spp., Dicentra spectabilis, Dorotheantus spp., Eustoma grandiflorum, Forsythia spp., Fuchsia spp., Geranium gnaphalium, Gerbera spp., Gomphrena globosa, Heliotropium spp., Helianthus spp., Hibiscus spp., Hortensia spp., Hydrangea spp., Hypoestes phyllostachya, Impatiens spp. (I. Walleriana), Iresines spp., Kalanchoe spp., Lantana camara, Lavatera trimestris, Leonotis leonurus, Lilium spp., Mesembryanthemum spp., Mimulus spp., Monarda spp., Nemesia spp., Tagetes spp., Dianthus spp. (carnation), Canna spp., Oxalis spp., Bellis spp., Pelargonium spp. (P. peltatum, P. Zonale), Viola spp. (pansy), Petunia spp., Phlox spp., Plecthranthus spp., Poinsettia spp., Parthenocissus spp. (P. quinquefolia, P. tricuspidata), Primula spp., Ranunculus spp., Rhododendron spp., Rosa spp. (rose), Rudbeckia spp., Saintpaulia spp., Salvia spp., Scaevola aemola, Schizanthus wisetonensis, Sedum spp., Solanum spp., Surfinia spp., Tagetes spp., Nicotinia spp., Verbena spp., Zinnia spp. and other bedding plants.

For example the invention may be used on any of the following vegetable species: Allium spp. (A. sativum, A. cepa, A. oschaninii, A. Porrum, A. ascalonicum, A. fistulosum), Anthriscus cerefolium, Apium graveolus, Asparagus officinalis, Beta vulgarus, Brassica spp. (B. Oleracea, B. Pekinensis, B. rapa), Capsicum annuum, Cicer arietinum, Cichorium endivia, Cichorum spp. (C. intybus, C. endivia), Citrillus lanatus, Cucumis spp. (C. sativus, C. melo), Cucurbita spp. (C. pepo, C. maxima), Cyanara spp. (C. scolymus, C. cardunculus), Daucus carota, Foeniculum vulgare, Hypericum spp., Lactuca sativa, Lycopersicon spp. (L. esculentum, L. lycopersicum), Mentha spp., Ocimum basilicum, Petroselinum crispum, Phaseolus spp. (P. vulgaris, P. coccineus), Pisum sativum, Raphanus sativus, Rheum rhaponticum, Rosemarinus spp., Salvia spp., Scorzonera hispanica, Solanum melongena, Spinacea oleracea, Valerianella spp. (V. locusta, V. eriocarpa) and Vicia faba.

Preferred ornamental species include African violet, Begonia, Dahlia, Gerbera, Hydrangea, Verbena, Rosa, Kalanchoe, Poinsettia, Aster, Centaurea, Coreopsis, Delphinium, Monarda, Phlox, Rudbeckia, Sedum, Petunia, Viola, Impatiens, Geranium, Chrysanthemum, Ranunculus, Fuchsia, Salvia, Hortensia, rosemary, sage, St. Johnswort, mint, sweet pepper, tomato and cucumber.

The active ingredients according to the invention are especially suitable for controlling Aphis craccivora, Diabrotica balteata, Heliothis virescens, Myzus persicae, Plutella xylostella and Spodoptera littoralis in cotton, vegetable, maize, rice and soya crops. The active ingredients according to the invention are further especially suitable for controlling Mamestra (preferably in vegetables), Cydia pomonella (preferably in apples), Empoasca(preferably in vegetables, vineyards), Leptinotarsa (preferably in potatos) and Chilo supressalis (preferably in rice).

In a further aspect, the invention may also relate to a method of controlling damage to plant and parts thereof by plant parasitic nematodes (Endoparasitic-, Semiendoparasitic- and Ectoparasitic nematodes), especially plant parasitic nematodes such as root knot nematodes, Meloidogyne hapla, Meloidogyne incognita, Meloidogyne javanica, Meloidogyne arenaria and other Meloidogyne species; cyst-forming nematodes, Globodera rostochiensis and other Globodera species; Heterodera avenae, Heterodera glycines, Heterodera schachtii, Heterodera trifolii, and other Heterodera species; Seed gall nematodes, Anguina species; Stem and foliar nematodes, Aphelenchoides species; Sting nematodes, Belonolaimus longicaudatus and other Belonolaimus species; Pine nematodes, Bursaphelenchus xylophilus and other Bursaphelenchus species; Ring nematodes, Criconema species, Criconemella species, Criconemoides species, Mesocriconema species; Stem and bulb nematodes, Ditylenchus destructor, Ditylenchus dipsaci and other Ditylenchus species; Awl nematodes, Dolichodorus species; Spiral nematodes, Heliocotylenchus multicinctus and other Helicotylenchus species; Sheath and sheathoid nematodes, Hemicycliophora species and Hemicriconemoides species; Hirshmanniella species; Lance nematodes, Hoploaimus species; false rootknot nematodes, Nacobbus species; Needle nematodes, Longidorus elongatus and other Longidorus species; Pin nematodes, Pratylenchus species; Lesion nematodes, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus curvitatus, Pratylenchus goodeyi and other Pratylenchus species; Burrowing nematodes, Radopholus similis and other Radopholus species; Reniform nematodes, Rotylenchus robustus, Rotylenchus reniformis and other Rotylenchus species; Scutellonema species; Stubby root nematodes, Trichodorus primitivus and other Trichodorus species, Paratrichodorus species; Stunt nematodes, Tylenchorhynchus claytoni, Tylenchorhynchus dubius and other Tylenchorhynchus species; Citrus nematodes, Tylenchulus species; Dagger nematodes, Xiphinema species; and other plant parasitic nematode species, such as Subanguina spp., Hypsoperine spp., Macroposthonia spp., Melinius spp., Punctodera spp., and Quinisulcius spp.

The compounds of the invention may also have activity against the molluscs. Examples of which include, for example, Ampullariidae; Arion (A. ater, A. circumscriptus, A. hortensis, A. rufus); Bradybaenidae (Bradybaena fruticum); Cepaea (C. hortensis, C. Nemoralis); ochlodina; Deroceras (D. agrestis, D. empiricorum, D. laeve, D. reticulatum); Discus (D. rotundatus); Euomphalia; Galba (G. trunculata); Helicelia (H. itala, H. obvia); Helicidae Helicigona arbustorum); Helicodiscus; Helix (H. aperta); Limax (L. cinereoniger, L. flavus, L. marginatus, L. maximus, L. tenellus); Lymnaea; Milax (M. gagates, M. marginatus, M. sowerbyi); Opeas; Pomacea (P. canaticulata); Vallonia and Zanitoides.

The term “crops” is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising one or more selectively acting toxins, such as are known, for example, from toxin-producing bacteria, especially those of the genus Bacillus.

Toxins that can be expressed by such transgenic plants include, for example, insecticidal proteins, for example insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as 8-endotoxins, e.g. Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g. Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins of bacteria colonising nematodes, for example Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or snowdrop lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin, papain inhibitors; ribosome-inactivating proteins (RIP), such as ricin, maize-RIP, abrin, luffin, saporin or bryodin; steroid metabolism enzymes, such as 3-hydroxysteroidoxidase, ecdysteroid-UDP-glycosyl-transferase, cholesterol oxidases, ecdysone inhibitors, HMG-COA-reductase, ion channel blockers, such as blockers of sodium or calcium channels, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases and glucanases.

In the context of the present invention there are to be understood by 8-endotoxins, for example Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example Vip1, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are produced recombinantly by a new combination of different domains of those proteins (see, for example, WO 02/15701). Truncated toxins, for example a truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are replaced. In such amino acid replacements, preferably non-naturally present protease recognition sequences are inserted into the toxin, such as, for example, in the case of Cry3A055, a cathepsin-G-recognition sequence is inserted into a Cry3A toxin (see WO 03/018810). Examples of such toxins or transgenic plants capable of synthesising such toxins are disclosed, for example, in EP-A-0 374 753, WO 93/07278, WO 95/34656, EP-A-0 427 529, EP-A-451 878 and WO 03/052073.

The processes for the preparation of such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. Cry1-type deoxyribonucleic acids and their preparation are known, for example, from WO 95/34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90/13651.

The toxin contained in the transgenic plants imparts to the plants tolerance to harmful insects. Such insects can occur in any taxonomic group of insects, but are especially commonly found in the beetles (Coleoptera), two-winged insects (Diptera) and moths (Lepidoptera).

Transgenic plants containing one or more genes that code for an insecticidal resistance and express one or more toxins are known and some of them are commercially available. Examples of such plants are: YieldGard® (maize variety that expresses a Cry1Ab toxin); YieldGard Rootworm® (maize variety that expresses a Cry3Bb1 toxin); YieldGard Plus® (maize variety that expresses a Cry1Ab and a Cry3Bb1 toxin); Starlink® (maize variety that expresses a Cry9C toxin); Herculex I® (maize variety that expresses a Cry1 Fa2 toxin and the enzyme phosphinothricine N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety that expresses a Cry1Ac toxin); Bollgard I® (cotton variety that expresses a Cry1Ac toxin); Bollgard II® (cotton variety that expresses a Cry1Ac and a Cry2Ab toxin); VipCot® (cotton variety that expresses a Vip3A and a Cry1Ab toxin); NewLeaf® (potato variety that expresses a Cry3A toxin); NatureGard®, Agrisure® GT Advantage (GA21 glyphosate-tolerant trait), Agrisure® CB Advantage (Bt11 corn borer (CB) trait) and Protecta®.

Further examples of such transgenic crops are:

1. Bt11 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

2. Bt176 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Genetically modified Zea mays which has been rendered resistant to attack by the European corn borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a Cry1Ab toxin. Bt176 maize also transgenically expresses the enzyme PAT to achieve tolerance to the herbicide glufosinate ammonium.

3. MIR604 Maize from Syngenta Seeds SAS, Chemin de I'Hobit 27, F-31 790 St. Sauveur, France, registration number C/FR/96/05/10. Maize which has been rendered insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by insertion of a cathepsin-G-protease recognition sequence. The preparation of such transgenic maize plants is described in WO 03/018810.

4. MON 863 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/DE/02/9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects.

5. IPC 531 Cotton from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/ES/96/02.

6. 1507 Maize from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C/NL/00/10. Genetically modified maize for the expression of the protein Cry1F for achieving resistance to certain Lepidoptera insects and of the PAT protein for achieving tolerance to the herbicide glufosinate ammonium.

7. NK603×MON 810 Maize from Monsanto Europe S.A. 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C/GB/02/M3/03. Consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. NK603×MON 810 Maize transgenically expresses the protein CP4 EPSPS, obtained from Agrobacterium sp. strain CP4, which imparts tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. kurstaki which brings about tolerance to certain Lepidoptera, include the European corn borer.

Transgenic crops of insect-resistant plants are also described in BATS (Zentrum für Biosicherheit und Nachhaltigkeit, Zentrum BATS, Clarastrasse 13, 4058 Basel, Switzerland) Report 2003, (http://bats.ch).

The term “crops” is to be understood as including also crop plants which have been so transformed by the use of recombinant DNA techniques that they are capable of synthesising antipathogenic substances having a selective action, such as, for example, the so-called “pathogenesis-related proteins” (PRPs, see e.g. EP-A-0 392 225). Examples of such antipathogenic substances and transgenic plants capable of synthesising such antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95/33818 and EP-A-0 353 191. The methods of producing such transgenic plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.

Antipathogenic substances which can be expressed by such transgenic plants include, for example, ion channel blockers, such as blockers for sodium and calcium channels, for example the viral KP1, KP4 or KP6 toxins; stilbene synthases; bibenzyl synthases; chitinases; glucanases; the so-called “pathogenesis-related proteins” (PRPs; see e.g. EP-A-0 392 225); antipathogenic substances produced by microorganisms, for example peptide antibiotics or heterocyclic antibiotics (see e.g. WO 95/33818) or protein or polypeptide factors involved in plant pathogen defence (so-called “plant disease resistance genes”, as described in WO 03/000906).

Further areas of use of the compositions according to the invention are the protection of stored goods and store rooms and the protection of raw materials, such as wood, textiles, floor coverings or buildings, and also in the hygiene sector, especially the protection of humans, domestic animals and productive livestock against pests of the mentioned type.

The present invention also provides a method for controlling pests (such as mosquitoes and other disease vectors; see also http://www.who.int/malaria/vector_control/irs/en/). In one embodiment, the method for controlling pests comprises applying the compositions of the invention to the target pests, to their locus or to a surface or substrate by brushing, rolling, spraying, spreading or dipping. By way of example, an IRS (indoor residual spraying) application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention. In another embodiment, it is contemplated to apply such compositions to a substrate such as non-woven or a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

In one embodiment, the method for controlling such pests comprises applying a pesticidally effective amount of the compositions of the invention to the target pests, to their locus, or to a surface or substrate so as to provide effective residual pesticidal activity on the surface or substrate. Such application may be made by brushing, rolling, spraying, spreading or dipping the pesticidal composition of the invention. By way of example, an IRS application of a surface such as a wall, ceiling or floor surface is contemplated by the method of the invention so as to provide effective residual pesticidal activity on the surface. In another embodiment, it is contemplated to apply such compositions for residual control of pests on a substrate such as a fabric material in the form of (or which can be used in the manufacture of) netting, clothing, bedding, curtains and tents.

Substrates including non-woven, fabrics or netting to be treated may be made of natural fibres such as cotton, raffia, jute, flax, sisal, hessian, or wool, or synthetic fibres such as polyamide, polyester, polypropylene, polyacrylonitrile or the like. The polyesters are particularly suitable. The methods of textile treatment are known, e.g. WO 2008/151984, WO 2003/034823, U.S. Pat. No. 5,631,072, WO 2005/64072, WO2006/128870, EP 1724392, WO2005113886 or WO 2007/090739.

Further areas of use of the compositions according to the invention are the field of tree injection/trunk treatment for all ornamental trees as well all sort of fruit and nut trees.

In the field of tree injection/trunk treatment, the compounds according to the present invention are especially suitable against wood-boring insects from the order Lepidoptera as mentioned above and from the order Coleoptera, especially against woodborers listed in the following tables A and B:

TABLE A

Examples of exotic woodborers of economic importance.

Family
Species
Host or Crop Infested

Buprestidae

Agrilus planipennis

Ash

Cerambycidae

Anoplura glabripennis

Hardwoods

Xylosandrus crassiusculus

Hardwoods

Scolytidae

X. mutilatus

Hardwoods

Tomicus piniperda

Conifers

TABLE B

Examples of native woodborers of economic importance.

Family
Species
Host or Crop Infested

Buprestidae

Agrilus anxius

Birch

Agrilus politus

Willow, Maple

Agrilus sayi

Bayberry, Sweetfern

Agrilus vittaticolllis

Apple, Pear, Cranberry,

Serviceberry, Hawthorn

Chrysobothris femorata

Apple, Apricot, Beech,

Boxelder, Cherry, Chestnut,

Currant, Elm, Hawthorn,

Hackberry, Hickory,

Horsechestnut, Linden, Maple,

Mountain-ash, Oak, Pecan,

Pear, Peach, Persimmon, Plum,

Poplar, Quince, Redbud,

Serviceberry, Sycamore,

Walnut, Willow

Texania campestris

Basswood, Beech, Maple, Oak,

Sycamore, Willow, Yellow-

poplar

Cerambycidae

Goes pulverulentus

Beech, Elm, Nuttall, Willow,

Black oak, Cherrybark oak,

Water oak, Sycamore

Goes tigrinus

Oak

Neoclytus acuminatus

Ash, Hickory, Oak, Walnut,

Birch, Beech, Maple, Eastern

hophornbeam, Dogwood,

Persimmon, Redbud, Holly,

Hackberry, Black locust,

Honeylocust, Yellow-poplar,

Chestnut, Osage-orange,

Sassafras, Lilac, Mountain-

mahogany, Pear, Cherry, Plum,

Peach, Apple, Elm, Basswood,

Sweetgum

Neoptychodes trilineatus

Fig, Alder, Mulberry, Willow,

Netleaf hackberry

Oberea ocellata

Sumac, Apple, Peach, Plum,

Pear, Currant, Blackberry

Oberea tripunctata

Dogwood, Viburnum, Elm,

Sourwood, Blueberry,

Rhododendron, Azalea, Laurel,

Poplar, Willow, Mulberry

Oncideres cingulata

Hickory, Pecan, Persimmon,

Elm, Sourwood, Basswood,

Honeylocust, Dogwood,

Eucalyptus, Oak, Hackberry,

Maple, Fruit trees

Saperda calcarata

Poplar

Strophiona nitens

Chestnut, Oak, Hickory,

Walnut, Beech, Maple

Scolytidae

Corthylus columbianus

Maple, Oak, Yellow-poplar,

Beech, Boxelder, Sycamore,

Birch, Basswood, Chestnut,

Elm

Dendroctonus frontalis

Pine

Dryocoetes betulae

Birch, Sweetgum, Wild cherry,

Beech, Pear

Monarthrum fasciatum

Oak, Maple, Birch, Chestnut,

Sweetgum, Blackgum, Poplar,

Hickory, Mimosa, Apple,

Peach, Pine

Phloeotribus liminaris

Peach, Cherry, Plum, Black

cherry, Elm, Mulberry,

Mountain-ash

Pseudopityophthorus

Oak, American beech, Black

pruinosus

cherry, Chickasaw plum,

Chestnut, Maple, Hickory,

Hornbeam, Hophornbeam

Sesiidae

Paranthrene simulans

Oak, American chestnut

Sannina uroceriformis

Persimmon

Synanthedon exitiosa

Peach, Plum, Nectarine, Cherry,

Apricot, Almond, Black cherry

Synanthedon pictipes

Peach, Plum, Cherry, Beach,

Black Cherry

Synanthedon rubrofascia

Tupelo

Synanthedon scitula

Dogwood, Pecan, Hickory,

Oak, Chestnut, Beech, Birch,

Black cherry, Elm, Mountain-

ash, Viburnum, Willow, Apple,

Loquat, Ninebark, Bayberry

Vitacea polistiformis

Grape

The present invention may be also used to control any insect pests that may be present in turfgrass, including for example beetles, caterpillars, fire ants, ground pearls, millipedes, sow bugs, mites, mole crickets, scales, mealybugs ticks, spittlebugs, southern chinch bugs and white grubs. The present invention may be used to control insect pests at various stages of their life cycle, including eggs, larvae, nymphs and adults.

In particular, the present invention may be used to control insect pests that feed on the roots of turfgrass including white grubs (such as Cyclocephala spp. (e.g. masked chafer, C. lurida), Rhizotrogus spp. (e.g. European chafer, R. majalis), Cotinus spp. (e.g. Green June beetle, C. nitida), Popillia spp. (e.g. Japanese beetle, P. japonica), Phyllophaga spp. (e.g. May/June beetle), Ataenius spp. (e.g. Black turfgrass ataenius, A. spretulus), Maladera spp. (e.g. Asiatic garden beetle, M. castanea) and Tomarus spp.), ground pearls (Margarodes spp.), mole crickets (tawny, southern, and short-winged; Scapteriscus spp., Gryllotalpa africana) and leatherjackets (European crane fly, Tipula spp.).

The present invention may also be used to control insect pests of turfgrass that are thatch dwelling, including armyworms (such as fall armyworm Spodoptera frugiperda, and common armyworm Pseudaletia unipuncta), cutworms, billbugs (Sphenophorus spp., such as S. venatus verstitus and S. parvulus), and sod webworms (such as Crambus spp. and the tropical sod webworm, Herpetogramma phaeopteralis).

The present invention may also be used to control insect pests of turfgrass that live above the ground and feed on the turfgrass leaves, including chinch bugs (such as southern chinch bugs, Blissus insularis), Bermudagrass mite (Eriophyes cynodoniensis), rhodesgrass mealybug (Antonina graminis), two-lined spittlebug (Propsapia bicincta), leafhoppers, cutworms (Noctuidae family), and greenbugs. The present invention may also be used to control other pests of turfgrass such as red imported fire ants (Solenopsis invicta) that create ant mounds in turf.

In the hygiene sector, the compositions according to the invention are active against ectoparasites such as hard ticks, soft ticks, mange mites, harvest mites, flies (biting and licking), parasitic fly larvae, lice, hair lice, bird lice and fleas.

Examples of such parasites are:

Of the order Anoplurida: Haematopinus spp., Linognathus spp., Pediculus spp. and Phtirus spp., Solenopotes spp.

Of the order Mallophagida: Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Damalina spp., Trichodectes spp. and Felicola spp.

Of the order Diptera and the suborders Nematocerina and Brachycerina, for example Aedes spp., Anopheles spp., Culex spp., Simulium spp., Eusimulium spp., Phlebotomus spp., Lutzomyia spp., Culicoides spp., Chrysops spp., Hybomitra spp., Atylotus spp., Tabanus spp., Haematopota spp., Philipomyia spp., Braula spp., Musca spp., Hydrotaea spp., Stomoxys spp., Haematobia spp., Morellia spp., Fannia spp., Glossina spp., Calliphora spp., Lucilia spp., Chrysomyia spp., Wohlfahrtia spp., Sarcophaga spp., Oestrus spp., Hypoderma spp., Gasterophilus spp., Hippobosca spp., Lipoptena spp. and Melophagus spp.

Of the order Siphonapterida, for example Pulex spp., Ctenocephalides spp., Xenopsylla spp., Ceratophyllus spp.

Of the order Heteropterida, for example Cimex spp., Triatoma spp., Rhodnius spp., Panstrongylus spp.,

Of the order Blattarida, for example Blatta orientalis, Periplaneta americana, Blattelagermanica and Supella spp.

Of the subclass Acaria (Acarida) and the orders Meta- and Meso-stigmata, for example Argas spp., Ornithodorus spp., Otobius spp., Ixodes spp., Amblyomma spp., Boophilus spp., Dermacentor spp., Haemophysalis spp., Hyalomma spp., Rhipicephalus spp., Dermanyssus spp., Raillietia spp., Pneumonyssus spp., Sternostoma spp. and Varroa spp.

Of the orders Actinedida (Prostigmata) and Acaridida (Astigmata), for example Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergatesspp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp., Knemidocoptes spp., Cytodites spp. and Laminosioptes spp.

The compositions according to the invention are also suitable for protecting against insect infestation in the case of materials such as wood, textiles, plastics, adhesives, glues, paints, paper and card, leather, floor coverings and buildings.

The compositions according to the invention can be used, for example, against the following pests: beetles such as Hylotrupes bajulus, Chlorophorus pilosis, Anobium punctatum, Xestobium rufovillosum, Ptilinuspecticornis, Dendrobium pertinex, Ernobius mollis, Priobium carpini, Lyctus brunneus, Lyctus africanus, Lyctus planicollis, Lyctus linearis, Lyctus pubescens, Trogoxylon aequale, Minthesrugicollis, Xyleborus spec., Tryptodendron spec., Apate monachus, Bostrychus capucins, Heterobostrychus brunneus, Sinoxylon spec. and Dinoderus minutus, and also hymenopterans such as Sirex juvencus, Urocerus gigas, Urocerus gigas taignus and Urocerus augur, and termites such as Kalotermes flavicollis, Cryptotermes brevis, Heterotermes indicola, Reticulitermes flavipes, Reticulitermes santonensis, Reticulitermes lucifugus, Mastotermes darwiniensis, Zootermopsis nevadensis and Coptotermes formosanus, and bristletails such as Lepisma saccharina.

The compounds according to the invention can be used as pesticidal agents in unmodified form, but they are generally formulated into compositions in various ways using formulation adjuvants, such as carriers, solvents and surface-active substances. The formulations can be in various physical forms, e.g. in the form of dusting powders, gels, wettable powders, water-dispersible granules, water-dispersible tablets, effervescent pellets, emulsifiable concentrates, microemulsifiable concentrates, oil-in-water emulsions, oil-flowables, aqueous dispersions, oily dispersions, suspo-emulsions, capsule suspensions, emulsifiable granules, soluble liquids, water-soluble concentrates (with water or a water-miscible organic solvent as carrier), impregnated polymer films or in other forms known e.g. from the Manual on Development and Use of FAO and WHO Specifications for Pesticides, United Nations, First Edition, Second Revision (2010). Such formulations can either be used directly or diluted prior to use. The dilutions can be made, for example, with water, liquid fertilisers, micronutrients, biological organisms, oil or solvents.

The formulations can be prepared e.g. by mixing the active ingredient with the formulation adjuvants in order to obtain compositions in the form of finely divided solids, granules, solutions, dispersions or emulsions. The active ingredients can also be formulated with other adjuvants, such as finely divided solids, mineral oils, oils of vegetable or animal origin, modified oils of vegetable or animal origin, organic solvents, water, surface-active substances or combinations thereof.

The active ingredients can also be contained in very fine microcapsules. Microcapsules contain the active ingredients in a porous carrier. This enables the active ingredients to be released into the environment in controlled amounts (e.g. slow-release). Microcapsules usually have a diameter of from 0.1 to 500 microns. They contain active ingredients in an amount of about from 25 to 95% by weight of the capsule weight. The active ingredients can be in the form of a monolithic solid, in the form of fine particles in solid or liquid dispersion or in the form of a suitable solution. The encapsulating membranes can comprise, for example, natural or synthetic rubbers, cellulose, styrene/butadiene copolymers, polyacrylonitrile, polyacrylate, polyesters, polyamides, polyureas, polyurethane or chemically modified polymers and starch xanthates or other polymers that are known to the person skilled in the art. Alternatively, very fine microcapsules can be formed in which the active ingredient is contained in the form of finely divided particles in a solid matrix of base substance, but the microcapsules are not themselves encapsulated.

The formulation adjuvants that are suitable for the preparation of the compositions according to the invention are known per se. As liquid carriers there may be used: water, toluene, xylene, petroleum ether, vegetable oils, acetone, methyl ethyl ketone, cyclohexanone, acid anhydrides, acetonitrile, acetophenone, amyl acetate, 2-butanone, butylene carbonate, chlorobenzene, cyclohexane, cyclohexanol, alkyl esters of acetic acid, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, dimethyl sulfoxide, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkylpyrrolidone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethyl lactate, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol acetate, glycerol diacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, isooctane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, laurylamine, mesityl oxide, methoxy-propanol, methyl isoamyl ketone, methyl isobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol, propionic acid, propyl lactate, propylene carbonate, propylene glycol, propylene glycol methyl ether, p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, propylene glycol methyl ether, diethylene glycol methyl ether, methanol, ethanol, isopropanol, and alcohols of higher molecular weight, such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, ethylene glycol, propylene glycol, glycerol, N-methyl-2-pyrrolidone and the like.

Suitable solid carriers are, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, limestone, calcium carbonate, bentonite, calcium montmorillonite, cottonseed husks, wheat flour, soybean flour, pumice, wood flour, ground walnut shells, lignin and similar substances.

A large number of surface-active substances can advantageously be used in both solid and liquid formulations, especially in those formulations which can be diluted with a carrier prior to use. Surface-active substances may be anionic, cationic, non-ionic or polymeric and they can be used as emulsifiers, wetting agents or suspending agents or for other purposes. Typical surface-active substances include, for example, salts of alkyl sulfates, such as diethanolammonium lauryl sulfate; salts of alkylarylsulfonates, such as calcium dodecybenzenesulfonate; alkylphenol/alkylene oxide addition products, such as nonylphenol ethoxylate; alcohol/alkylene oxide addition products, such as tridecylalcohol ethoxylate; soaps, such as sodium stearate; salts of alkylnaphthalenesulfonates, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride, polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and di-alkylphosphate esters; and also further substances described e.g. in McCutcheon's Detergents and Emulsifiers Annual, MC Publishing Corp., Ridgewood New Jersey (1981).

Further adjuvants that can be used in pesticidal formulations include crystallisation inhibitors, viscosity modifiers, suspending agents, dyes, anti-oxidants, foaming agents, light absorbers, mixing auxiliaries, antifoams, complexing agents, neutralising or pH-modifying substances and buffers, corrosion inhibitors, fragrances, wetting agents, take-up enhancers, micronutrients, plasticisers, glidants, lubricants, dispersants, thickeners, antifreezes, microbicides, and liquid and solid fertilisers.

The compositions according to the invention can include an additive comprising an oil of vegetable or animal origin, a mineral oil, alkyl esters of such oils or mixtures of such oils and oil derivatives. The amount of oil additive in the composition according to the invention is generally from 0.01 to 10%, based on the mixture to be applied. For example, the oil additive can be added to a spray tank in the desired concentration after a spray mixture has been prepared. Preferred oil additives comprise mineral oils or an oil of vegetable origin, for example rapeseed oil, olive oil or sunflower oil, emulsified vegetable oil, alkyl esters of oils of vegetable origin, for example the methyl derivatives, or an oil of animal origin, such as fish oil or beef tallow. Preferred oil additives comprise alkyl esters of C₈-C₂₂fatty acids, especially the methyl derivatives of C₁₂-C₁₈fatty acids, for example the methyl esters of lauric acid, palmitic acid and oleic acid (methyl laurate, methyl palmitate and methyl oleate, respectively). Many oil derivatives are known from the Compendium of Herbicide Adjuvants, 10^thEdition, Southern Illinois University, 2010.

The inventive compositions generally comprise from 0.1 to 99% by weight, especially from 0.1 to 95% by weight, of compounds of the present invention and from 1 to 99.9% by weight of a formulation adjuvant which preferably includes from 0 to 25% by weight of a surface-active substance. Whereas commercial products may preferably be formulated as concentrates, the end user will normally employ dilute formulations.

The rates of application vary within wide limits and depend on the nature of the soil, the method of application, the crop plant, the pest to be controlled, the prevailing climatic conditions, and other factors governed by the method of application, the time of application and the target crop. As a general guideline compounds may be applied at a rate of from 1 to 2000 I/ha, especially from 10 to 1000 I/ha.

Preferred formulations can have the following compositions (weight %):

Emulsifiable concentrates:

active ingredient: 1 to 95%, preferably 60 to 90%

surface-active agent: 1 to 30%, preferably 5 to 20%

liquid carrier: 1 to 80%, preferably 1 to 35%

Dusts:

active ingredient: 0.1 to 10%, preferably 0.1 to 5%

solid carrier: 99.9 to 90%, preferably 99.9 to 99%

Suspension concentrates:

active ingredient: 5 to 75%, preferably 10 to 50%

water: 94 to 24%, preferably 88 to 30%

surface-active agent: 1 to 40%, preferably 2 to 30%

Wettable powders:

active ingredient: 0.5 to 90%, preferably 1 to 80%

surface-active agent: 0.5 to 20%, preferably 1 to 15%

solid carrier: 5 to 95%, preferably 15 to 90%

Granules:

active ingredient: 0.1 to 30%, preferably 0.1 to 15%

solid carrier: 99.5 to 70%, preferably 97 to 85%

The following Examples further illustrate, but do not limit, the invention.

Wettable powders
a)
b)
c)

active ingredients
25%
50%
75%

sodium lignosulfonate
5%
5%
—

sodium lauryl sulfate
3%
—
5%

sodium diisobutylnaphthalenesulfonate
—
6%
10%

phenol polyethylene glycol ether (7-8
—
2%
—

mol of ethylene oxide)

highly dispersed silicic acid
5%
10%
10%

Kaolin
62%
27%
—

The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording wettable powders that can be diluted with water to give suspensions of the desired concentration.

Powders for dry seed treatment
a)
b)
c)

active ingredients
25%
50%
75%

light mineral oil
5%
5%
5%

highly dispersed silicic acid
5%
5%
—

Kaolin
65%
40%
—

Talcum
—

20%

The combination is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, affording powders that can be used directly for seed treatment.

Emulsifiable concentrate

active ingredients
10%

octylphenol polyethylene glycol ether (4-5 mol of
3%

ethylene oxide)

calcium dodecylbenzenesulfonate
3%

castor oil polyglycol ether (35 mol of ethylene oxide)
4%

Cyclohexanone
30%

xylene mixture
50%

Emulsions of any required dilution, which can be used in plant protection, can be obtained from this concentrate by dilution with water.

Dusts
a)
b)
c)

Active ingredients
5%
6%
4%

Talcum
95%
—
—

Kaolin
—
94%
—

mineral filler
—
—
96%

Ready-for-use dusts are obtained by mixing the combination with the carrier and grinding the mixture in a suitable mill. Such powders can also be used for dry dressings for seed.

Extruder granules

Active ingredients
15%

sodium lignosulfonate
2%

carboxymethylcellulose
1%

Kaolin
82%

The combination is mixed and ground with the adjuvants, and the mixture is moistened with water. The mixture is extruded and then dried in a stream of air.

Coated granules

Active ingredients
8%

polyethylene glycol (mol. wt. 200)
3%

Kaolin
89%

The finely ground combination is uniformly applied, in a mixer, to the kaolin moistened with polyethylene glycol. Non-dusty coated granules are obtained in this manner.

Suspension Concentrate

active ingredients
40%

propylene glycol
10%

nonylphenol polyethylene glycol ether (15 mol of ethylene oxide)
6%

Sodium lignosulfonate
10%

carboxymethylcellulose
1%

silicone oil (in the form of a 75% emulsion in water)
1%

Water
32%

The finely ground combination is intimately mixed with the adjuvants, giving a suspension concentrate from which suspensions of any desired dilution can be obtained by dilution with water. Using such dilutions, living plants as well as plant propagation material can be treated and protected against infestation by microorganisms, by spraying, pouring or immersion.

Flowable Concentrate for Seed Treatment

active ingredients
40%

propylene glycol
5%

copolymer butanol PO/EO
2%

Tristyrenephenole with 10-20 moles EO
2%

1,2-benzisothiazolin-3-one (in the form of a 20% solution in water)
0.5%

monoazo-pigment calcium salt
5%

Silicone oil (in the form of a 75% emulsion in water)
0.2%

Water
45.3%

Slow Release Capsule Suspension

28 parts of the combination are mixed with 2 parts of an aromatic solvent and 7 parts of toluene diisocyanate/polymethylene-polyphenylisocyanate-mixture (8:1). This mixture is emulsified in a mixture of 1.2 parts of polyvinylalcohol, 0.05 parts of a defoamer and 51.6 parts of water until the desired particle size is achieved. To this emulsion a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts of water is added. The mixture is agitated until the polymerization reaction is completed. The obtained capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The medium capsule diameter is 8-15 microns. The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose.

Formulation types include an emulsion concentrate (EC), a suspension concentrate (SC), a suspo-emulsion (SE), a capsule suspension (CS), a water dispersible granule (WG), an emulsifiable granule (EG), an emulsion, water in oil (EO), an emulsion, oil in water (EW), a micro-emulsion (ME), an oil dispersion (OD), an oil miscible flowable (OF), an oil miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume liquid (UL), a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder (WP), a soluble granule (SG) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.

PREPARATORY EXAMPLES

“Mp” means melting point in ° C. Free radicals represent methyl groups. ¹H NMR measurements were recorded on a Brucker 400 MHz spectrometer, chemical shifts are given in ppm relevant to a TMS standard. Spectra measured in deuterated solvents as indicated. Either one of the LCMS methods below was used to characterize the compounds. The characteristic LCMS values obtained for each compound were the retention time (“Rt”, recorded in minutes) and the measured molecular ion (M+H)⁺ or (M−H)⁻.

LCMS and GCMS Methods:
Method 1:

Spectra were recorded on a Mass Spectrometer from Waters (ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150° C., Desolvation Temperature: 350° C., Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, Temp: 60° C., DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A=water+5% MeOH+0.05% HCOOH, B=Acetonitrile+0.05% HCOOH: gradient: 0 min 0% B, 100% A; 1.2-1.5 min 100% B; Flow (ml/min) 0.85.

Method 2:

Spectra were recorded on a Mass Spectrometer from Waters (SQD or ZQ Single quadrupole mass spectrometer) equipped with an electrospray source (Polarity: positive or negative ions, Capillary: 3.00 kV, Cone range: 30-60 V, Extractor: 2.00 V, Source Temperature: 150° C., Desolvation Temperature: 350° C., Cone Gas Flow: 0 L/Hr, Desolvation Gas Flow: 650 L/Hr, Mass range: 100 to 900 Da) and an Acquity UPLC from Waters: Binary pump, heated column compartment and diode-array detector. Solvent degasser, binary pump, heated column compartment and diode-array detector. Column: Waters UPLC HSS T3, 1.8 μm, 30×2.1 mm, Temp: 60° C., DAD Wavelength range (nm): 210 to 500, Solvent Gradient: A=water+5% MeOH+0.05% HCOOH, B=Acetonitrile+0.05% HCOOH; gradient: 0 min 0% B, 100% A; 2.7-3.0 min 100% B; Flow (ml/min) 0.85.

Method 3:

Spectra were recorded on a Mass Spectrometer from Agilent Technologies (6410 Triple Quadruple Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch, Capillary: 4.00 kV, Fragmentor: 100.00 V, Gas Temperature: 350° C., Gas Flow: 11 L/min, Nebulizer Gas: 45 psi, Mass range: 110-1000 Da, DAD Wavelength range: 210-400 nm). Column: KINETEX EVO C18, length 50 mm, diameter 4.6 mm, particle size 2.6 μm. Column oven temperature 40° C. Solvent gradient: A=Water with 0.1% formic acid: Acetonitrile (95:5 v/v). B=Acetonitrile with 0.1% formic acid. Gradient=0 min 90% A, 10% B; 0.9-1.8 min 0% A, 100% B, 2.2-2.5 min 90% A, 10% B. Flow rate 1.8 mL/min.

Method 4:

Spectra were recorded on a Mass Spectrometer from Waters (Acquity SDS Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Switch, Capillary: 3.00 kV, Cone Voltage: 41.00 V, Source temperature: 150° C., Desolvation Gas Flow: 1000 L/Hr, Desolvation temperature: 500° C., Gas Flow @Cone: 50 L/hr, Mass range: 110-800 Da, PDA wavelength range: 210-400 nm. Column: Acquity UPLC HSS T3 C₁₈, length 30 mm, diameter 2.1 mm, particle size 1.8 μm. Column oven temperature 40° C. Solvent gradient: A=Water with 0.1% formic acid: Acetonitrile (95:5 v/v). B=Acetonitrile with 0.05% formic acid. Gradient=0 min 90% A, 10% B; 0.2 min 50% A, 50% B; 0.7-1.3 min 0% A, 100% B; 1.4-1.6 min 90% A, 10% B. Flow rate 0.8 mL/min.

a) Typical Synthesis of Intermediates
Example P1: Preparation of 5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b] pyridin-2-yl]-1H-benzimidazol-2-one (Compound I10)

embedded image

Step 1: Preparation of 4-chloro-2-ethylsulfanyl-N-[2-(methylamino)-5-(trifluoromethyl)-3-pyridyl]-5-nitro-benzamide (Compound I1)

embedded image

To a 0° C. cooled solution of 4-chloro-2-ethylsulfanyl-5-nitro-benzoic acid (500 mg, 1.91 mmol, 1.00 equiv., prepared according to WO 2016091731) in dichloromethane (15 mL) containing also N,N-dimethylformamide (0.05 mL, 0.60 mmol, 0.30 equiv), was added oxalyl chloride (323 μL, 3.82 mmol, 2.00 equiv) dropwise. After stirring for 2 hours at 0° C., the reaction mixture was concentrated under reduced pressure and the crude material used directly.

A suspension of 4-chloro-2-ethylsulfanyl-5-nitro-benzoyl chloride (500 mg, 1.78 mmol, 1.00 equiv., obtained above) in tetrahydrofuran (20 mL) was added slowly to a prestirred solution of N2-methyl-5-(trifluoromethyl)pyridine-2,3-diamine (682 mg, 3.57 mmol, 2.00 equiv., prepared as described in WO 2016142327) and triethylamine (746 μL, 5.35 mmol, 3.00 equiv.) in tetrahydrofuran (30 mL). The reaction mixture was stirred for 2 hours at room temperature after complete addition. The mixture was then poured over water, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was triturated in methanol to afford the desired product. This material was used in the next step without further purification. LCMS (method 4): 435/437 (M+H)⁺; retention time: 0.94 min.

Step 2: Preparation of 2-(4-chloro-2-ethylsulfanyl-5-nitro-phenyl)-3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine (Compound I2)

embedded image

A solution of 4-chloro-2-ethylsulfanyl-N-[2-(methylamino)-5-(trifluoromethyl)-3-pyridyl]-5-nitro-benzamide (450 mg, 1.04 mmol, compound I1 prepared above) in acetic acid (20 mL) was heated at 110° C. and stirred for 2 hours. After cooling to room temperature, the reaction mixture was directly evaporated. The crude material was used in the next step without purification. LCMS (method 4): 417/419 (M+H)⁺; retention time: 1.03 min.

Step 3: Preparation of 5-ethylsulfanyl-N-methyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-nitro-aniline (Compound I3)

embedded image

A solution of 2-(4-chloro-2-ethylsulfanyl-5-nitro-phenyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine (500 mg, 1.20 mmol, compound I2 prepared above) in a methylamine solution (2.0 mol/L in tetrahydrofuran, 5.0 mL, 10.0 mmol) was heated at 60° C. for 2 hours. After cooling down to room temperature, the reaction mixture was concentrated under reduced pressure. The material was dissolved again in ethyl acetate, the organic phase was washed with water, the aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was triturated in methanol to afford the desired product. LCMS (method 4): 412 (M+H)⁺; retention time: 0.96 min.

Step 4: Preparation of 4-ethylsulfanyl-N2-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzene-1,2-diamine (Compound I4)

embedded image

A solution of 5-ethylsulfanyl-N-methyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-nitro-aniline (4.00 g, 9.72 mmol, compound I3 prepared above) in ethanol (40 mL) set up in an autoclave, was evacuated and backfilled with nitrogen, before adding Pd/C 10% (400 mg, 0.37 mmol, 0.04 equiv.). The mixture was evacuated and backfilled with nitrogen again, then with hydrogen, and stirred under 5 bar hydrogen pressure for 2 hours at room temperature. After evacuation and purge with nitrogen, the resulting mixture was filtered though Celite, and the obtained filtrate was concentrated under reduced pressure. Two repeated trituration of the crude material in diethyl ether afforded the desired product, which was used in the next step directly without further purification. LCMS (method 4): 382 (M+H)⁺; retention time: 0.85 min.

Step 5: Preparation of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (Compound I5)

embedded image

A 20% wt solution of phosgene in toluene (6.25 g, 12.7 mmol, 1.20 equiv.) was added dropwise to a 0° C. cooled solution of crude 4-ethylsulfanyl-N2-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzene-1,2-diamine (4.00 g, 10.5 mmol, 1.00 equiv, compound I4 prepared above) and triethylamine (2.92 mL, 21.0 mmol, 2.00 equiv.) in dichloromethane (30 mL). After stirring for 40 min at 0° C., the reaction mixture was diluted with dichloromethane and slowly quenched with water. The aqueous phase was extracted with dichloromethane, the combined organic phases were dried over sodium sulfate, filtered and concentrated. The product was precipitated from a mixture of dichloromethane and cyclohexane, and used as it is without further purification. LCMS (method 4): 408 (M+H)⁺; retention time: 0.81 min.

Step 6: Preparation of 5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (Compound I10)

embedded image

3-Chloroperbenzoic acid 70% mass (180 mg, 0.73 mmol, 2.00 equiv.) was added portionwise to a 0° C. cooled solution of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (150 mg, 0.37 mmol, 1.00 equiv, compound I5 prepared above) in dichloromethane (30 mL). After stirring for 1 hour at room temperature, the reaction mixture was slowly quenched with a 5% sodium hydroxide solution, the organic phase was washed with water, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired compound. LCMS (method 4): 440 (M+H)⁺; retention time: 0.71 min.

Example P2: Preparation of 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylic acid (Compound I38)

embedded image

Step 1: Preparation of tert-butyl 5-bromo-3-ethylsulfanyl-pyridine-2-carboxylate (Compound I32)

embedded image

A solution of 5-bromo-3-ethylsulfanyl-pyridine-2-carbonyl chloride (WO 2016/030229) (5.00 g, 17.8 mmol) in tetrahydrofuran (13 mL) was slowly added at room temperature to tert-butanol (17.0 mL, 13.2 g, 178 mmol), N,N-diisopropylethylamine (7.70 mL, 5.82 g, 44.6 mmol) and 4-dimethylaminopyridine (2.29 g, 17.8 mmol) dissolved in tetrahydrofuran (40 mL). The reaction mixture was heated to 60° C. and stirred for 21 hours. A saturated aqueous NH₄Cl solution was added and the aqueous phase extracted three times with ethyl acetate. The organic phases were combined, washed with water and brine, dried over sodium sulfate, filtered and evaporated. The residue was purified by Combiflash to afford tert-butyl 5-bromo-3-ethylsulfanyl-pyridine-2-carboxylate (compound I32). ¹H NMR (400 MHz, CDCl₃) δ ppm 1.40 (t, 3H), 1.65 (s, 9H), 2.93 (q, 2H), 7.75 (d, 1H), 8.45 (d, 1H).

Step 2: Preparation of tert-butyl 5-bromo-3-ethylsulfonyl-pyridine-2-carboxylate (Compound I33)

embedded image

To a solution of tert-butyl 5-bromo-3-ethylsulfanyl-pyridine-2-carboxylate (1.5 g, 4.7 mmol) in dichloromethane (27 mL) at 0° C. was added 3-chloroperbenzoic acid 75% (2.2 g, 9.7 mmol) in portions. The reaction mixture was stirred at 0° C. for 40 minutes, then at room temperature for 2 hours. An aqueous sodium thiosulfate solution (10 ml) and aqueous 1N NaOH solution (10 ml) were added, and the aqueous layer extracted with three times with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered and evaporated under reduced pressure to afford tert-butyl 5-bromo-3-ethylsulfonyl-pyridine-2-carboxylate (compound I33). The crude material was used in the next step without further purification. ¹H NMR (400 MHz, CDCl₃) δ ppm 1.35 (t, 3H,) 1.65 (s, 9H), 3.53 (q, 2H), 8.45 (d, 1H), 8.87 (d, 1H).

Step 3: Preparation of tert-butyl 3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (Compound I34)

embedded image

A vial was charged with tert-butyl 5-bromo-3-ethylsulfonyl-pyridine-2-carboxylate (1.3 g, 3.7 mmol), tetrahydrofuran (4 mL), methylamine (40% in water) and copper powder (0.2 equiv., 0.74 mmol). The vessel was sealed and the mixture heated at 100° C. for 8 hours. The reaction mixture was quenched with water and the aqueous layer extracted three times with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated under reduced pressure to afford tert-butyl 3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (compound I34). The crude material was used in the next step without further purification. ¹H NMR (400 MHz, CDCl₃) δ ppm 1.37 (t, 3H), 1.63 (s, 9H), 2.94 (s, 3H), 3.59 (q, 2H), 7.27 (d, 1H), 7.39 (d, 1H), 8.3 (br s, 1H).

Step 4: Preparation of tert-butyl 6-bromo-3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (Compound I35)

embedded image

N-Bromosuccinimide (1.1 equiv., 3.66 mmol) was added to a solution of tert-butyl 3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (1.0 g, 3.33 mmol) in dry N,N-dimethylformamide (10 mL) and the reaction mixture was stirred at room temperature for 2 hours. Water was added and the product extracted with twice with ethyl acetate. The combined organic layers were washed with water, dried over sodium sulfate, filtered and evaporated under reduced pressure to afford tert-butyl 6-bromo-3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (compound I35). The crude material was used in the next step without further purification. ¹H NMR (400 MHz, CDCl₃) δ ppm 1.35 (t, 3H), 1.63 (s, 9H), 3.00 (s, 3H), 3.57 (q, 2H), 5.0 (br s, 1H), 7.28 (s, 1H).

Step 5: Preparation of tert-butyl 3-ethylsulfonyl-5,6-bis(methylamino)pyridine-2-carboxylate (Compound I36)

embedded image

To a solution of tert-butyl 6-bromo-3-ethylsulfonyl-5-(methylamino)pyridine-2-carboxylate (800 mg, 2.64 mmol) in anhydrous tetrahydrofuran (8 mL) was added a methylamine solution (2M in THF, 2 mL, 4 mmol). The vessel was sealed and the mixture stirred at 100° C. for 7 hours. Upon completion of the reaction, the solvent was evaporated under reduced pressure, the residue diluted with water and the product extracted twice with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered and evaporated under reduced pressure to afford tert-butyl 3-ethylsulfonyl-5,6-bis(methylamino)pyridine-2-carboxylate (compound I36). The crude material was used in the next step without further purification. ¹H NMR (400 MHz, CDCl₃) δ ppm 1.32 (t, 3H), 1.63 (s, 9H), 2.86 (s, 3H), 3.04 (s, 3H), 3.40 (q, 2H), 4.76 (br s, 1H), 7.06 (s, 1H).

Step 6: Preparation of tert-butyl 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylate (Compound I37)

embedded image

Triphosgene (1.2 equiv., 2.44 mmol) was added at 0° C. to a solution of tert-butyl 3-ethylsulfonyl-5,6-bis(methylamino)pyridine-2-carboxylate (670 mg, 2.03 mmol) and triethylamine (3.0 equiv., 6.10 mmol) in anhydrous tetrahydrofuran (20 mL). The reaction mixture was stirred at 0° C. for one hour, then at room temperature for 2 hours. The reaction mixture was quenched with water and extracted with dichloromethane. The combined organic layers were washed with water and brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by column chromatography (ethyl acetate/hexane 8:2) to afford tert-butyl 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylate (compound I37). ¹H NMR (400 MHz, CDCl₃) δ ppm 1.33 (t, 3H), 1.66 (s, 9H), 3.48 (q, 2H), 3.50 (s, 3H), 3.56 (s, 3H), 7.68 (s, 1H).

Step 7: Preparation of 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylic acid (Compound I38)

embedded image

2,2,2-Trifluoroacetic acid (0.40 g, 3.5 mmol) was added to a solution of tert-butyl 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylate (compound I37) (250 mg, 0.70 mmol) in anhydrous dichloromethane (2 mL). The reaction mixture was stirred at room temperature for 3 hours, then concentrated to dryness under reduced pressure to afford 6-ethylsulfonyl-1,3-dimethyl-2-oxo-imidazo[4,5-b]pyridine-5-carboxylic acid (compound I38). LCMS (method 4): 298 (M−H)⁻; retention time: 0.31 min. ¹H NMR (400 MHz, d₆-DMSO) δ ppm 1.19 (t, 3H), 3.38 (s, 3H), 3.44 (s, 3H), 3.49 (q, 2H), 7.92 (s, 1H)

b) Synthesis of Examples of Compounds of Formula (I)
Example P3: Preparation of 5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (Compound P3)

embedded image

Step 1: Preparation of 5-ethylsulfanyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P12)

embedded image

Methyl iodide (709 μL, 11.4 mmol, 1.10 equiv.) was added dropwise to a mixture of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (4.22 g, 10.4 mmol, 1.00 equiv., compound I5 prepared above) and cesium carbonate (6.76 g, 20.7 mmol, 2.00 equiv.) in N,N-dimethylformamide (20 mL). After stirring for 2 hours at room temperature, the reaction mixture was quenched with water, and the aqueous phases was extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired product. LCMS (method 4): 422 (M+H)⁺; retention time: 1.05 min.

Step 2: Preparation of 5-ethylsulfonyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P3)

embedded image

3-Chloroperbenzoic acid 70% mass (4.22 g, 17.1 mmol, 2.20 equiv.) was added portionwise to a 0° C. cooled solution of 5-ethylsulfanyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (3.30 g, 7.83 mmol, 1.00 equiv, compound P12 prepared above) in dichloromethane (100 mL). After stirring for 2 hours at room temperature, the reaction mixture was slowly quenched with a 10% potassium carbonate solution, the organic phase was washed with water, brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired compound. LCMS (method 4): 454 (M+H)⁺; retention time: 0.91 min.

Example P4: Preparation of 1-ethyl-6-ethylsulfonyl-3-methyl-5-[3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P4)

embedded image

Step 1: Preparation of 4-chloro-2-ethylsulfanyl-N-[5-(methylamino)-2-(trifluoromethyl)-4-pyridyl]-5-nitro-benzamide (Compound I6)

embedded image

To a 0° C. cooled solution of 4-chloro-2-ethylsulfanyl-5-nitro-benzoic acid (5.00 g, 19.1 mmol, 1.00 equiv., prepared according to WO 2016091731) in dichloromethane (50 mL) containing also 1 drop of N,N-dimethylformamide, was added oxalyl chloride (3.06 mL, 34.4 mmol, 1.80 equiv) dropwise. After stirring for 2 h at 0° C., the reaction mixture was concentrated under reduced pressure and the crude material used directly.

A solution of of 4-chloro-2-ethylsulfanyl-5-nitro-benzoyl chloride (19.1 mmol, 1.00 equiv., obtained above) in tetrahydrofuran (20 mL) was added slowly to a prestirred solution N3-methyl-6-(trifluoromethyl)pyridine-3,4-diamine (4.38 g, 22.9 mmol, 1.20 equiv., prepared as described in WO 2016005263) and triethylamine (6.73 mL, 47.8 mmol, 2.50 equiv.) in ethyl acetate (50 mL). The reaction was stirred for 1 hour at room temperature after complete addition. The mixture was then concentrated under reduced pressure and the crude material was used in the next step without further purification. LCMS (method 1): 435/437 (M+H)⁺; retention time: 0.97 min.

Step 2: Preparation of 2-(4-chloro-2-ethylsulfanyl-5-nitro-phenyl)-3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine (Compound I7)

embedded image

A solution of 4-chloro-2-ethylsulfanyl-N-[5-(methylamino)-2-(trifluoromethyl)-4-pyridyl]-5-nitro-benzamide (10.0 g, 23.0 mmol, compound I6 prepared above) in acetic acid (125 mL) was refluxed for 5 hours. After cooling to room temperature, the reaction mixture was directly evaporated. The crude material was triturated in methanol to afford the desired material as a yellow solid. The product was used in the next step without purification. LCMS (method 1): 417/419 (M+H)⁺; retention time: 1.06 min.

Step 3: Preparation of N-ethyl-5-ethylsulfanyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-2-nitro-aniline (Compound I8)

embedded image

A solution of 2-(4-chloro-2-ethylsulfanyl-5-nitro-phenyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine (500 mg, 1.20 mmol, compound I7 prepared above) in an ethylamine solution (2.0 mol/L in tetrahydrofuran, 6.0 mL, 12.0 mmol, 10.0 equiv.) was refluxed for 2 hours. After cooling down to room temperature, the reaction mixture was filtered, the solids were washed with ethyl acetate, and the resulting filtrate was concentrated under reduced pressure. The crude material was directly purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired product as a yellow solid. LCMS (method 1): 426 (M+H)⁺; retention time: 1.05 min.

Step 4: Preparation of N2-ethyl-4-ethylsulfanyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzene-1,2-diamine (Compound I9)

embedded image

A solution of N-ethyl-5-ethylsulfanyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-2-nitro-aniline (459 mg, 1.08 mmol, compound I8 prepared above) in ethanol (15 mL), was evacuated and backfilled with argon, before adding Pd/C 10% (459 mg, 0.43 mmol, 0.4 equiv.). The mixture was evacuated and backfilled with argon again, then hydrogen, and then stirred under hydrogen pressure (with a balloon) for 6 hours at room temperature. After evacuation and purge with argon, the resulting mixture was filtered though Celite, the filter was washed with ethyl acetate, and the obtained filtrate was concentrated under reduced pressure. Purification by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, afforded the desired product. LCMS (method 1): 396 (M+H)⁺; retention time: 0.96 min.

Step 5: Preparation of 1-ethyl-6-ethylsulfanyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P1)

embedded image

A solution of N2-ethyl-4-ethylsulfanyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzene-1,2-diamine (340 mg, 0.86 mmol, 1.00 equiv., compound I9 prepared above) and tetramethoxymethane (128 μL, 0.95 mmol, 1.10 equiv.) in acetic acid (15 mL), was heated at 80° C. and stirred for 3 hours. After cooling down to room temperature, the reaction mixture was concentrated under vaccum. The residue was diluted in ethyl acetate, the organic phase was washed with a saturated sodium hydrogenocarbonate solution, dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford a mixture of 3-ethyl-5-ethylsulfanyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-1H-benzimidazol-2-one and 2-(1-ethyl-6-ethylsulfanyl-2-methoxy-benzimidazol-5-yl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridine which was used in the next step directly.

The mixture obtained above was dissolved in N,N-dimethylformamide (5.0 mL), and cesium carbonate (332 mg, 1.72 mmol, 2.00 equiv.) followed by methyl iodide (59 μL, 0.95 mmol, 1.10 equiv.) were added. After stirring overnight at room temperature, the reaction mixture was poured into water, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was purififed by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to give the desired product. LCMS (method 1): 436 (M+H)⁺; retention time: 0.95 min.

Step 6: Preparation of 1-ethyl-6-ethylsulfonyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P4)

embedded image

3-Chloroperbenzoic acid 70% mass (132 mg, 0.57 mmol, 2.10 equiv.) was added portionwise to a 0° C. cooled solution of 1-ethyl-6-ethylsulfanyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (119 mg, 0.27 mmol, 1.00 equiv, compound I10 prepared above) in dichloromethane (5.0 mL). After stirring for 2 hours at room temperature, the reaction mixture was slowly quenched with a saturated sodium thiosulfate solution, the organic phase was washed with a 1M sodium hydroxide solution, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired compound. LCMS (method 1): 468 (M+H)⁺; retention time: 0.86 min.

Example P5: Preparation of 1-ethyl-6-ethylsulfonyl-3-methyl-5-[3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P5)

embedded image

Step 1: Preparation of N-ethyl-5-ethylsulfanyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-nitro-aniline (Compound I11)

embedded image

A solution of 2-(4-chloro-2-ethylsulfanyl-5-nitro-phenyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine (4.00 g, 9.60 mmol, compound I2, prepared as described in Step 2 of Example P1 above) in an ethylamine solution (2.0 mol/L in tetrahydrofuran, 20 mL, 40.0 mmol, 4.17 equiv.) was heated at 80° C. for 3 hours. More ethylamine solution was added (80 mL, 160 mmol, 20.8 equiv.) to complete the reaction. After cooling down to room temperature, the reaction mixture was concentrated under reduced pressure. The material was dissolved again in ethyl acetate, the organic phase was washed with water, brine, dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired product. LCMS (method 4): 426 (M+H)⁺; retention time: 1.22 min.

Step 2: Preparation of N2-ethyl-4-ethylsulfanyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzene-1,2-diamine (Compound I12)

embedded image

A solution of N-ethyl-5-ethylsulfanyl-4-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-nitro-aniline (1.70 g, 4.00 mmol, compound I1l prepared above) in a mixture of ethyl acetate (50 mL), methanol (100 mL) and tetrahydrofuran (10 mL), was evacuated and backfilled with nitrogen, before adding Pd/C 10% (210 mg, 0.20 mmol, 0.05 equiv.). The mixture was evacuated and backfilled with nitrogen again, then with hydrogen, and stirred under hydrogen pressure (with a balloon) for 6 hours at room temperature. After evacuation and purge with nitrogen, the resulting mixture was filtered though Celite, and the obtained filtrate was concentrated under reduced pressure. The crude material was used in the next step directly without further purification. LCMS (method 4): 396 (M+H)⁺; retention time: 1.05 min.

Step 3: Preparation of 3-ethyl-5-ethylsulfanyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (Compound I13)

embedded image

A 20% wt solution of phosgene in toluene (2.3 mL, 2.2 g, 4.5 mmol, 1.1 equiv.) was added dropwise to a 0° C. cooled solution of crude N2-ethyl-4-ethylsulfanyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzene-1,2-diamine (1.6 g, 4.0 mmol, 1.00 equiv, compound I12 prepared above) and triethylamine (1.7 mL, 12 mmol, 3.0 equiv.) in dichloromethane (100 mL). After stirring for 1 hour at 0° C. and further at room temperature, the reaction mixture was diluted with dichloromethane and slowly quenched with water. The aqueous phase was extracted with dichloromethane, the combined organic phases were washed with water, dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired compound. LCMS (method 4): 422 (M+H)⁺; retention time: 0.99 min.

Step 4: Preparation of 1-ethyl-6-ethylsulfanyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P2)

embedded image

Methyl iodide (194 μL, 3.11 mmol, 1.20 equiv.) was added dropwise to a mixture of 3-ethyl-5-ethylsulfanyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (1.09 g, 2.59 mmol, 1.00 equiv., compound I13 prepared above) and cesium carbonate (2.53 g, 7.76 mmol, 3.00 equiv.) in N,N-dimethylformamide (40 mL). After stirring for 2 hours at room temperature, the reaction mixture was quenched with water, and the aqueous phases was extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired product. LCMS (method 4): 436 (M+H)⁺; retention time: 1.06 min.

Step 5: Preparation of 1-ethyl-6-ethylsulfonyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P5)

embedded image

3-Chloroperbenzoic acid 70% mass (1.09 g, 3.79 mmol, 2.20 equiv.) was added portionwise to a 0° C. cooled solution of 1-ethyl-6-ethylsulfanyl-3-methyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (750 mg, 1.72 mmol, 1.00 equiv, compound P2 prepared above) in dichloromethane (100 mL). After stirring overnight at room temperature, the reaction mixture was slowly quenched with water, diluted with dichloromethane, and a saturated sodium hydrogenocarbonate solution. After stirring for 10 min, the aqueous phase was extracted twice with dichloromethane. The combined organic phases were washed with a saturated sodium hydrogenocarbonate solution, a 1N potassium hydroxide solution, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, followed by recrystallization from ethanol, afforded the desired compound as a white solid. LCMS (method 4): 468 (M+H)⁺; retention time: 0.95 min.

Example P6: Preparation of 1-ethyl-5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P6)

embedded image

Step 1: Preparation of 1-ethyl-5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P7)

embedded image

Ethyl iodide (440 μL, 5.4 mmol, 1.10 equiv.) was added dropwise to a mixture of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (2.0 g, 4.9 mmol, 1.00 equiv., compound I5 prepared above) and cesium carbonate (3.2 g, 9.8 mmol, 2.00 equiv.) in N,N-dimethylformamide (20 mL). After stirring for 2 hours at room temperature, the reaction mixture was quenched with water, and the aqueous phases was extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, afforded the desired product. LCMS (method 4): 436 (M+H)⁺; retention time: 1.08 min.

Step 2: Preparation of 1-ethyl-5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (Compound P6)

embedded image

3-Chloroperbenzoic acid 70% mass (1.9 g, 7.6 mmol, 2.20 equiv.) was added portionwise to a 0° C. cooled solution of 1-ethyl-5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (1.5 g, 3.4 mmol, 1.00 equiv, compound P7 prepared above) in dichloromethane (50 mL). After stirring for 2 hours at room temperature, the reaction mixture was slowly quenched with a 20% sodium hydroxide solution, the organic phase was washed with water, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired compound. LCMS (method 4): 468 (M+H)⁺; retention time: 0.94 min.

Example P8: Preparation of 6-ethylsulfonyl-1,3-dimethyl-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]imidazo[4,5-b]pyridin-2-one (Compound P8)

embedded image

Step 1: Preparation of tert-butyl N-[5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-3-pyridyl]carbamate (Compound I15)

embedded image

To a solution of 2-(5-bromo-3-ethylsulfonyl-2-pyridyl)-3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridine (7 g, 15.6 mmol, 1.00 equiv., prepared as described in WO 2016/026848) in 1,4-dioxane (100 mL) were successively added tert-butyl carbamate (2.19 g, 18.7 mmol, 1.2 equiv.), cesium carbonate (7.11 g, 21.8 mmol, 1.4 equiv.) and XPHOS (1.36 g, 2.81 mmol, 0.18 equiv.). After degassing the reaction mixture for 30 min with argon, palladium acetate was added (212 mg, 0.94 mmol, 0.06 equiv.). After degassing again for additional 30 min, the reaction mixture was heated at 110° C. overnight. The reaction mixture was cooled down to room temperature and poured into brine. The aqueous phase was extracted three times with ethyl acetate, the combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. The crude material was used in the next step directly without purification. LCMS (method 4): 486 (M+H)⁺; retention time: 1.08 min.

Step 2: Preparation of tert-butyl N-[5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-3-pyridyl]-N-methyl-carbamate (Compound I16)

embedded image

Potassium carbonate (1.71 g, 12.4 mmol, 1.20 equiv.) followed by methyl iodide (770 μL, 12.4 mmol, 1.20 equiv.) were added to a solution of crude tert-butyl N-[5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-3-pyridyl]carbamate (5.00 g, 10.3 mmol, compound I15 prepared above) in N,N-dimethylformamide (40 mL). After stirring overnight at room temperature, the reaction mixture was poured into water, and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were washed three times with brine, dried over sodium sulfate, filtered and concentrated. The crude material was pure enough to be engaged in the next step without purification. LCMS (method 4): 500 (M+H)⁺; retention time: 1.03 min.

Step 3: Preparation of 5-ethylsulfonyl-N-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridin-3-amine (Compound I17)

embedded image

Trifluoroacetic acid (7.7 mL, 100 mmol, 10.0 equiv.) was added dropwise to a solution of crude tert-butyl N-[5-ethylsulfonyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]-3-pyridyl]-N-methyl-carbamate (5.1 g, 10.0 mmo, 1.00 equiv., compound I16 prepared above) in dichloromethane (100 mL). After stirring overnight at room temperature, the reaction mixture was concentrated. The crude material was carefully neutralized with a saturated potassium carbonate solution, and the aqueous phase was extracted five times with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was pure enough to be engaged in the next step without purification. LCMS (method 3): 400 (M+H)⁺; retention time: 1.48 min.

Step 4: Preparation of 2-bromo-5-ethylsulfonyl-N-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridin-3-amine (Compound I18)

embedded image

N-bromosuccinimide (2.6 g, 14.4 mmol, 1.20 equiv.) was added in four equal portions to a solution of crude 5-ethylsulfonyl-N-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridin-3-amine (4.9 g, 12.0 mmol, 1.00 equiv., compound I17 prepared above) in N,N-dimethylformamide (50 mL). After stirring for 4 hours at room temperature, the reaction mixture was poured over water (100 mL). Most of the product precipitated from the mixture. Filtration afforded the desired material, pure enough to be engaged in the next step directly. LCMS (method 3): 478/480 (M+H)⁺; retention time: 1.48 min.

Step 5: Preparation of 5-ethylsulfonyl-N2,N3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-2,3-diamine (Compound I19)

embedded image

A solution of crude 2-bromo-5-ethylsulfonyl-N-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridin-3-amine (400 mg, 0.84 mmol, compound I18 prepared above) in a methylamine solution (2.0 M in tetrahydrofuran, 3.3 mL, 6.60 mmol, 7.86 equiv.) was heated at 100° C. for 3 hours in a pressure vessel. After cooling down to room temperature, the reaction mixture was poured into water, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were washed with water, brine, dried over sodium sulfate, filtered and concentrated. The crude material was pure enough to be engaged in the next step directly. LCMS (method 4): 429 (M+H)⁺; retention time: 0.93 min.

Step 6: Preparation of 6-ethylsulfonyl-1,3-dimethyl-5-[3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]imidazo[4,5-b]pyridin-2-one (Compound P8)

embedded image

A 20% wt solution of phosgene in toluene (487 μL, 450 mg, 0.91 mmol, 1.3 equiv.) was added dropwise to a 0° C. cooled solution of crude 5-ethylsulfonyl-N2,N3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]pyridine-2,3-diamine (300 mg, 0.70 mmol, 1.00 equiv, compound I19 prepared above) and triethylamine (585 μL, 4.2 mmol, 6.0 equiv.) in dichloromethane (100 mL). After stirring for 30 min at 0° C. and further at room temperature, the reaction mixture was slowly quenched with water. The aqueous phase was extracted with dichloromethane, the combined organic phases were washed with water, brine, dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired compound. LCMS (method 4): 455 (M+H)⁺; retention time: 0.83 min.

Example P9: Preparation of 5-ethylsulfonyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P9)

embedded image

Step 1: Preparation of ethyl 4-chloro-2-ethylsulfanyl-5-nitro-benzoate (Compound I20)

embedded image

Concentrated sulfuric acid (4.6 mL, 84.8 mmol, 3.00 equiv.) was added dropwise to a solution of 4-chloro-2-ethylsulfanyl-5-nitro-benzoic acid (10.0 g, 28.3 mmol, 1.00 equiv., prepared according to WO 2016091731) in ethanol (150 mL). The reaction mixture was heated to reflux and stirred overnight. After cooling down to room temperature, the reaction mixture was concentrated under reduced pressure, and the residue was diluted with water. The aqueous phase was extracted three times with ethyl acetate, the combined organic phases were washed with saturated sodium bicarbonate solution, water, dried over sodium sulfate, filtered and concentrated. The crude material was pure enough to be engaged in the next step directly. LCMS (method 3): 290/292 (M+H)⁺; retention time: 1.62 min.

Step 2: Preparation of ethyl 2-ethylsulfanyl-4-(methylamino)-5-nitro-benzoate (Compound I21)

embedded image

A methylamine solution (2.0 M in tetrahydrofuran, 155 mL, 310 mmol, 3.00 equiv.) was carefully added to a solution of crude ethyl 4-chloro-2-ethylsulfanyl-5-nitro-benzoate (30.0 g, 104 mmol, compound I20 prepared above) in tetrahydrofuran (80 mL) under vigorous stirring. After stirring for 2 hours at room temperature, the reaction mixture was concentrated under reduced pressure. The residue was diluted in a mixture of dichloromethane (200 mL) and chloroform (100 mL). The organic phase was washed with water (500 mL), dried over sodium sulfate, filtered and concentrated. The crude material was pure enough to be engaged in the next step directly. LCMS (method 4): 285 (M+H)⁺; retention time: 1.12 min.

Step 3: Preparation of ethyl 5-amino-2-ethylsulfanyl-4-(methylamino)benzoate (Compound I22)

embedded image

A solution of ethyl 2-ethylsulfanyl-4-(methylamino)-5-nitro-benzoate (2.75 g, 9.67 mmol, compound I21 prepared above) in methanol (35 mL) was evacuated and backfilled with nitrogen, before adding Pd/C 10% (300 mg, 0.28 mmol, 0.03 equiv.). The mixture was evacuated and backfilled with nitrogen again, then with hydrogen, and stirred under hydrogen pressure (with a balloon) for 4.5 hours at room temperature. After evacuation and purge with nitrogen, the resulting mixture was filtered though Celite, and the obtained filtrate was concentrated under reduced pressure. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired material. LCMS (method 4): 255 (M+H)⁺; retention time: 0.83 min.

Step 4: Preparation of ethyl 6-ethylsulfanyl-1-methyl-2-oxo-3H-benzimidazole-5-carboxylate (Compound I23)

embedded image

A 20% wt solution of phosgene in toluene (1.37 mL, 1.26 g, 2.66 mmol, 1.33 equiv.) was added dropwise to a 0° C. cooled solution of ethyl 5-amino-2-ethylsulfanyl-4-(methylamino)benzoate (500 mg, 2.00 mmol, 1.00 equiv, compound I22 prepared above) and triethylamine (1.64 mL, 11.8 mmol, 5.90 equiv.) in dichloromethane (75 mL). After stirring for 1 hour at 0° C., the reaction mixture was slowly quenched with water. The aqueous phase was extracted with dichloromethane, the combined organic phases were washed with water, brine, dried over sodium sulfate, filtered and concentrated. The crude material was purified by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, to afford the desired compound as a white solid. LCMS (method 4): 281 (M+H)⁺; retention time: 0.85 min.

Step 5: Preparation of ethyl 6-ethylsulfanyl-1,3-dimethyl-2-oxo-benzimidazole-5-carboxylate (Compound I24)

embedded image

Cesium carbonate (349 mg, 1.07 mmol, 3.00 equiv.) followed by methyl iodide (44 μL, 0.71 mmol, 2.00 equiv.) were added to a solution of ethyl 6-ethylsulfanyl-1-methyl-2-oxo-3H-benzimidazole-5-carboxylate (100 mg, 0.355 mmol, compound I23 prepared above) in N,N-dimethylformamide (5.0 mL). After stirring for 3 hours at room temperature, the reaction mixture was poured into water, and the aqueous phase was extracted with ethyl acetate. The combined organic phases were washed with water, brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, afforded the desired compound. LCMS (method 4): 295 (M+H)⁺; retention time: 0.91 min.

Step 6: Preparation of 6-ethylsulfanyl-1,3-dimethyl-2-oxo-benzimidazole-5-carboxylic acid (Compound 125)

embedded image

Sodium hydroxide (81 mg, 2.04 mmol, 6.00 equiv.) was added to a solution of ethyl 6-ethylsulfanyl-1,3-dimethyl-2-oxo-benzimidazole-5-carboxylate (100 mg, 0.34 mmol, compound I24 prepared above) in tetrahydrofuran (10 mL) and water (1.0 mL). The reaction mixture was heated to reflux and stirred for 2 hours. After cooling down to room temperature, the reaction mixture was poured into a 2N hydrochloric acid solution, and the aqueous phase was extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. The crude material was engaged in the next step directly. LCMS (method 4): 267 (M+H)⁺; retention time: 0.69 min.

Step 7: Preparation of 6-ethylsulfanyl-1,3-dimethyl-N-[5-(methylamino)-2-(trifluoromethyl)-4-pyridyl]-2-oxo-benzimidazole-5-carboxamide (Compound I26)

embedded image

To a 0° C. cooled solution of of 6-ethylsulfanyl-1,3-dimethyl-2-oxo-benzimidazole-5-carboxylic acid (600 mg, 2.25 mmol, 1.00 equiv., compound I25 prepared above) in dichloromethane (12 mL) containing also one drop of N,N-dimethylformamide, was added oxalyl chloride (238 μL, 2.70 mmol, 1.20 equiv) dropwise. After stirring for 1.5 hours at room temperature, the reaction mixture was concentrated under reduced pressure and the crude material used directly.

A suspension of 6-ethylsulfanyl-1,3-dimethyl-2-oxo-benzimidazole-5-carbonyl chloride (641 mg, 2.25 mmol, 1.00 equiv., obtained above) in dichloromethane (12 mL) was added slowly to a 0° C. cooled and prestirred solution of N3-methyl-6-(trifluoromethyl)pyridine-3,4-diamine (430 mg, 2.25 mmol, 1.00 equiv., prepared as described in WO 2016005263) and triethylamine (1.88 mL, 13.5 mmol, 6.00 equiv.) in dichloromethane (12 mL). The reaction mixture was stirred for 2 hours at room temperature after complete addition. The mixture was then poured over water, and the aqueous phase was extracted with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered and concentrated. The crude material was used in the next step without further purification. LCMS (method 4): 440 (M+H)⁺; retention time: 0.87 min.

Step 8: Preparation of 5-ethylsulfanyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P10)

embedded image

A solution of 4 6-ethylsulfanyl-1,3-dimethyl-N-[5-(methylamino)-2-(trifluoromethyl)-4-pyridyl]-2-oxo-benzimidazole-5-carboxamide (650 mg, 1.54 mmol, compound I26 prepared above) in acetic acid (10 mL) was heated at 150° C. and stirred for 1 hour in a microwave vial. After cooling to room temperature, the reaction mixture was poured into water, and the aqueous phase was extracted with dichloromethane. The combined organic phases were dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane, afforded the desired compound as a white solid. LCMS (method 4): 422 (M+H)⁺; retention time: 0.93 min.

Step 9: Preparation of 5-ethylsulfonyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (Compound P9)

embedded image

3-Chloroperbenzoic acid 70% mass (322 mg, 1.31 mmol, 2.20 equiv.) was added portionwise to a 0° C. cooled solution of 5-ethylsulfanyl-1,3-dimethyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-c]pyridin-2-yl]benzimidazol-2-one (250 mg, 0.59 mmol, 1.00 equiv, compound P10 prepared above) in dichloromethane (20 mL). After stirring for 2 hours at room temperature, the reaction mixture was slowly quenched with a 10% potassium carbonate solution. The aquoues phase was extracted with dichloromethane, the combined organic phases were washed with water, brine, dried over sodium sulfate, filtered and concentrated. Purification of the crude material by flash chromatography over silica gel, eluting with ethyl acetate in cyclohexane afforded the desired compound. LCMS (method 4): 454 (M+H)⁺; retention time: 0.73 min.

Example P15: Preparation of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-oxo-benzimidazole-1-carbonitrile (Compound P15)

embedded image

To a solution of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (compound I5 prepared above) (300 mg, 0.736 mmol) in N,N-dimethylformamide (10 mL) at 0° C. was added sodium hydride (55%, 38.6 mg, 0.884 mmol). The reaction was stirred for 30 minutes, then cyanogen bromide (1.3 equiv., 0.957 mmol) was added and stirring continued for an additional one hour. The reaction mixture was poured into cold water and the aqueous phase extracted twice with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography over silica gel (30% ethyl acetate in cyclohexane) to afford 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-2-oxo-benzimidazole-1-carbonitrile (compound P15) as a solid, mp 255-257° C. LCMS (method 4): 433 (M+H)⁺; retention time: 1.06 min.

Example P29: Preparation of 5-ethylsulfonyl-1,3-dimethyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]benzimidazol-2-one (Compound P29)

embedded image

To a solution of 5-ethylsulfanyl-1,3-dimethyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]benzimidazol-2-one (compound P28) (400 mg, 0.910 mmol) at 0° C. in dichloromethane (10.0 mL) was added meta-chloroperoxybenzoic acid (471 mg, 70%, 1.911 mmol, 2.1 eq.) at 0° C. and the mixture was stirred for one hour. The reaction mixture was quenched with an aqueous 2M sodium hydroxide solution, and the aqueous phase extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. The residue was purified by flash chromatography over silica gel (30% ethyl acetate in cyclohexane) to afford 5-ethylsulfonyl-1,3-dimethyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]benzimidazol-2-one (compound P29) as a white solid, mp 234-236° C. LCMS (method 4): 472 (M+H)⁺; retention time: 1.18 min.

Similarly, 5-ethylsulfonyl-1,3-dimethyl-6-[5-(trifluoromethylsulfonyl)-1,3-benzoxazol-2-yl]benzimidazol-2-one (compound P25, white solid, mp 216-218° C.) was obtained from 5-ethylsulfanyl-1,3-dimethyl-6-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]benzimidazol-2-one (compound P28) (300 mg, 0.683 mmol) and meta-chloroperoxybenzoic acid (724 mg, 70%, 2.935 mmol, 4.3 eq.) in dichloromethane (10.0 mL). The reaction mixture was stirred at room temperature for 16 hours. LCMS (method 4) for compound P25: 504 (M+H)⁺; retention time: 1.13 min.

Example P30: Preparation of 1-cyclopropylsulfonyl-5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (compound P30)

embedded image

To a solution of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (compound I5 prepared above) (300 mg, 0.736 mmol) in tetrahydrofuran (4 mL) were added N-ethyldiisopropylamine (0.386 mL, 2.209 mmol), followed by cyclopropanesulfonyl chloride (0.0912 mL, 0.884 mmol) dropwise. The reaction mixture was stirred at room temperature for 12 hours, poured into water and the aqueous phase was extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. The residue was purified by flash chromatography over silica gel (40% ethyl acetate in cyclohexane) to afford 1-cyclopropylsulfonyl-5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]benzimidazol-2-one (compound P30) as a solid. LCMS (method 4): 512 (M+H)⁺; retention time: 1.08 min.

Similarly, 1-(cyclopropanecarbonyl)-5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl) imidazo[4,5-b]94yridine-2-yl]benzimidazol-2-one (compound P33) was obtained from 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (compound I5 prepared above) (200 mg, 0.491 mmol), N-ethyldiisopropylamine (0.257 mL, 1.473 mmol), and cyclopropane-carbonyl chloride (0.0546 mL, 0.589 mmol) in tetrahydrofuran (5 mL). The reaction mixture was stirred at room temperature for 4 hours. LCMS (method 4) for compound P33: 476 (M+H)⁺; retention time: 1.19 min.

Example P31: Preparation of 5-ethylsulfanyl-1-(methoxymethyl)-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine-2-yl]benzimidazol-2-one (Compound P31)

embedded image

A solution of 5-ethylsulfanyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (compound I5 prepared above) (300 mg, 0.736 mmol), cesium carbonate (360 mg, 1.105 mmol) and chloro(methoxy)methane (0.0883 mL, 95%, 1.105 mmol) in N,N-dimethylformamide (4 mL) was stirred at room temperature overnight. The reaction mixture was poured into water and the aqueous phase extracted three times with ethyl acetate. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by flash chromatography over silica gel (40% ethyl acetate in cyclohexane) to afford 5-ethylsulfanyl-1-(methoxymethyl)-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine-2-yl]benzimidazol-2-one (compound P31). LCMS (method 4): 452 (M+H)⁺; retention time: 1.04 min.

Similarly, 6-ethylsulfonyl-1-methyl-3-(methylsulfanylmethyl)-5-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridine-2-yl]benzimidazol-2-one (compound P17, solid, mp 214-216° C.) was obtained from 5-ethylsulfonyl-3-methyl-6-[3-methyl-6-(trifluoromethyl)imidazo[4,5-b]pyridin-2-yl]-1H-benzimidazol-2-one (compound I10 prepared above) (200 mg, 0.455 mmol), cesium carbonate (223 mg, 0.683 mmol) and chloro(methylsulfanyl)-methane (0.0597 mL, 96%, 0.683 mmol) in N,N-dimethylformamide (2.5 mL).

The reaction mixture was stirred at room temperature for 5 hours. LCMS (method 4) for compound P17: 500 (M+H)⁺; retention time: 0.95 min.

Example P45: Preparation of 6-ethylsulfonyl-1,3-dimethyl-5-[5-(trifluoromethylsulfinyl)-1,3-benzoxazol-2-yl]imidazo[4,5-b]pyridin-2-one (compound P45) and 6-ethylsulfonyl-1,3-dimethyl-5-[5-(trifluoromethylsulfonyl)-1,3-benzoxazol-2-yl]imidazo[4,5-b]pyridine-2-one (Compound P26)

embedded image

To a solution of 6-ethylsulfonyl-1,3-dimethyl-5-[5-(trifluoromethylsulfanyl)-1,3-benzoxazol-2-yl]imidazo[4,5-b]pyridin-2-one (compound P35) (50 mg, 0.106 mmol) at 0° C. in dichloromethane (1 mL) was added meta-chloroperoxybenzoic acid (104 mg, 70%, 0.423 mmol) at 0° C. and the mixture was stirred at room temperature for 24 hours. The reaction mixture was quenched with an aqueous 2M sodium hydroxide solution, and the aqueous phase extracted three times with dichloromethane. The combined organic phases were washed with brine, dried over sodium sulfate, filtered and concentrated. The residue was purified by flash chromatography over silica gel (40% ethyl acetate in cyclohexane) to afford 6-ethyl-sulfonyl-1,3-dimethyl-5-[5-(trifluoromethylsulfonyl)-1,3-benzoxazol-2-yl]imidazo[4,5-b]pyridine-2-one (compound P26) as a solid (20 mg), mp 247-249° C. and 6-ethylsulfonyl-1,3-dimethyl-5-[5-(trifluoromethylsulfinyl)-1,3-benzoxazol-2-yl]imidazo[4,5-b]pyridin-2-one (compound P45) as a solid (30 mg), mp 230-232° C. LCMS compound P26 (method 4): 505 (M+H)⁺; retention time: 1.03 min and LCMS compound P45 (method 4): 489 (M+H)⁺; retention time: 0.95 min.

TABLE P

Examples of compounds of formula (I), I-a, I-b, IIa and II-b

LCMS

[M + H]⁺

Mp

No.
IUPAC name
Structures
R_t(min)
(measured)
Method
(° C.)

P1
1-ethyl-6-ethylsulfanyl-3- methyl-5-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]benzimidazol-2- one

embedded image

0.95
436
1

P2
1-ethyl-6-ethylsulfanyl-3- methyl-5-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]benzimidazol-2- one

embedded image

1.06
436
4
186- 188

P3
5-ethylsulfonyl-1,3-dimethyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzimidazol-2-one

embedded image

0.91
454
4
213- 215

P4
1-ethyl-6-ethylsulfonyl-3- methyl-5-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]benzimidazol-2- one

embedded image

0.86
468
1

P5
1-ethyl-6-ethylsulfonyl-3- methyl-5-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]benzimidazol-2- one

embedded image

0.95
468
4
218- 220

P6
1-ethyl-5-ethylsulfonyl-3- methyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]benzimidazol-2- one

embedded image

0.94
468
4
201- 203

P7
1-ethyl-5-ethylsulfanyl-3- methyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]benzimidazol-2- one

embedded image

1.08
436
4
186- 188

P8
6-ethylsulfonyl-1,3-dimethyl-5- [3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]imidazo[4,5-b]pyridin-2-one

embedded image

0.83
455
4
252- 254

P9
5-ethylsulfonyl-1,3-dimethyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]benzimidazol-2-one

embedded image

0.73
454
4
262- 264

P10
5-ethylsulfanyl-1,3-dimethyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]benzimidazol-2-one

embedded image

0.93
422
4

P11
5-ethylsulfonyl-1,3-dimethyl-6- [7-methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]benzimidazol-2-one

embedded image

0.76
455
4
279- 281

P12
5-ethylsulfanyl-1,3-dimethyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzimidazol-2-one

embedded image

1.05
422
4

P13
1-cyclopropylsulfonyl-5- ethylsulfonyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzimidazol-2-one

embedded image

1.01
544
4
222- 224

P14
5-ethylsulfonyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-2- oxo-benzimidazole-1- carbonitrile

embedded image

0.97
465
4
258- 260

P15
5-ethylsulfanyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-2- oxo-benzimidazole-1- carbonitrile

embedded image

1.06
433
4
255- 257

P16
6-ethylsulfonyl-1-methyl-3- (methylsulfonylmethyl)-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]benzimidazol-2-one

embedded image

0.84
532
4
284- 286

P17
6-ethylsulfonyl-1-methyl-3- (methylsulfanylmethyl)-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]benzimidazol-2-one

embedded image

0.95
500
4
214- 216

P18
5-ethylsulfonyl-1-(methoxy- methyl)-3-methyl-6-[3-methyl- 6-(trifluoromethyl)imidazo[4,5- b]pyridine-2-yl]benzimidazol-2- one

embedded image

0.91
484
4
166- 168

P19
6-ethylsulfonyl-1-methyl-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2-yl]-3- (2,2,2-trifluoroethyl) benzimidazol-2-one

embedded image

1.03
522
4
238- 240

P20
1-(cyclopropanecarbonyl)-5- ethylsulfonyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]benzimidazol-2-one

embedded image

1.09
508
4
258- 260

P-21
6-ethylsulfonyl-1,3-dimethyl-5- [7-methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]imidazo[4,5-b]pyridine-2-one

embedded image

0.84
456
4
255- 257

P22
6-ethylsulfonyl-1,3-dimethyl-5- [3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]imidazo[4,5-b]pyridine-2-one

embedded image

0.90
455
4

P23
ethyl 5-ethylsulfonyl-3-methyl- 6-[3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2-yl]-2- oxo-benzimidazole-1- carboxylate

embedded image

0.99
512
4
242- 244

P24
6-ethylsulfanyl-1,3-dimethyl-5- [3-methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]imidazo[4,5-b]pyridine-2-one

embedded image

0.99
423
4

P25
5-ethylsulfonyl-1,3-dimethyl-6- [5-(trifluoromethylsulfonyl)-1,3- benzoxazol-2-yl]benzimidazol- 2-one

embedded image

1.13
504
4
216- 218

P26
6-ethylsulfonyl-1,3-dimethyl-5- [5-(trifluoromethylsulfonyl)-1,3- benzoxazol-2-yl]imidazo[4,5- b]pyridine-2-one

embedded image

1.03
505
4
247- 249

P27
5-ethylsulfanyl-1,3-dimethyl-6- [7-methyl-3-(trifluoromethyl) imidazo[4,5-c]pyridazin-6- yl]benzimidazol-2-one

embedded image

0.93
423
4

P28
5-ethylsulfanyl-1,3-dimethyl-6- [5-(trifluoromethylsulfanyl)-1,3- benzoxazol-2-yl]benzimidazol- 2-one

embedded image

1.43
440
4
206- 208

P29
5-ethylsulfonyl-1,3-dimethyl-6- [5-(trifluoromethylsulfanyl)-1,3- benzoxazol-2-yl]benzimidazol- 2-one

embedded image

1.18
472
4
234- 236

P30
1-cyclopropylsulfonyl-5- ethylsulfanyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]benzimidazol-2-one

embedded image

1.08
512
4

P31
5-ethylsulfanyl-1-(methoxy- methyl)-3-methyl-6-[3-methyl- 6-(trifluoromethyl)imidazo[4,5- b]pyridine-2-yl]benzimidazol-2- one

embedded image

1.04
452
4

P32
6-ethylsulfanyl-1-methyl-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2-yl]-3- (2,2,2-trifluoroethyl) benzimidazol-2-one

embedded image

1.09
490
4

P33
1-(cyclopropanecarbonyl)-5- ethylsulfanyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridine-2- yl]benzimidazol-2-one

embedded image

1.19
476
4

P34
6-ethylsulfanyl-1-methyl-3- (methylsulfanylmethyl)-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzimidazol-2-one

embedded image

1.10
468
4

P35
6-ethylsulfonyl-1,3-dimethyl-5- [5-(trifluoromethylsulfanyl)-1,3- benzoxazol-2-yl]imidazo[4,5- b]pyridin-2-one

embedded image

1.49
473
3
246- 248

P36
5-ethylsulfonyl-1,3-dimethyl-6- [1-methyl-5-(trifluoromethyl- sulfanyl)benzimidazol-2- yl]benzimidazol-2-one

embedded image

1.02
485
4
189- 191

P37
5-ethylsulfonyl-1,3-dimethyl-6- [1-methyl-5-(trifluoromethyl- sulfonyl)benzimidazol-2- yl]benzimidazol-2-one

embedded image

0.99
517
4
142- 144

P38
6-ethylsulfonyl-1,3-dimethyl-5- [1-methyl-5-(trifluoromethyl- sulfanyl)benzimidazol-2- yl]imidazo[4,5-b]pyridin-2-one

embedded image

1.07
486
4

P39
6-ethylsulfonyl-1,3-dimethyl-5- [1-methyl-5-(trifluoromethyl- sulfonyl)benzimidazol-2- yl]imidazo[4,5-b]pyridine-2-one

embedded image

1.02
518
4

P40
5-ethylsulfonyl-1,3-dimethyl-6- [5-(trifluoromethyl)-1,3- benzoxazol-2-yl]benzimidazol- 2-one

embedded image

1.04
440
4
236- 238

P41
5-ethylsulfanyl-1,3-dimethyl-6- [5-(trifluoromethyl)-1,3- benzoxazol-2-yl]benzimidazol- 2-one

embedded image

1.58
408
3
205- 207

P42
5-ethylsulfanyl-1,3-dimethyl-6- [1-methyl-5-(trifluoromethyl- sulfanyl)benzimidazol-2- yl]benzimidazol-2-one

embedded image

1.10
453
4

P43
6-ethylsulfonyl-1,3-dimethyl-5- [1-methyl-5-(trifluoromethyl- sulfinyl)benzimidazol-2- yl]imidazo[4,5-b]pyridin-2-one

embedded image

0.91
502
4

P44
5-ethylsulfonyl-1,3-dimethyl-6- [1-methyl-5-(trifluoromethyl- sulfinyl)benzimidazol-2- yl]benzimidazol-2-one

embedded image

0.90
501
4
144- 146

P45
6-ethylsulfonyl-1,3-dimethyl-5- [5-(trifluoromethylsulfinyl)-1,3- benzoxazol-2-yl]imidazo[4,5- b]pyridin-2-one

embedded image

0.95
489
4
230- 232

TABLE I

Examples of intermediate compounds of formula I-b, II-b, III, IV, V, VI,

XI, XIII, XIV, XV, XVI, XVII, XVIII, XIX, XX, XXI, XXII and XXIII

LCMS or ¹H NMR

[M +

H]⁺

R_t
(meas-

Mp

No.
IUPAC name
Structures
(min)
ured)
Method
(° C.)

I1
4-chloro-2-ethylsulfanyl-N-[2- (methylamino)-5- (trifluoromethyl)-3-pyridyl]-5- nitro-benzamide

embedded image

0.94
435/ 437
4
220- 222

I2
2-(4-chloro-2-ethylsulfanyl-5- nitro-phenyl)-3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridine

embedded image

1.03
417/ 419
4

I3
5-ethylsulfanyl-N-methyl-4-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-2- nitro-aniline

embedded image

0.96
412
4
181- 183

I4
4-ethylsulfanyl-N2-methyl-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzene-1,2-diamine

embedded image

0.85
382
4
164- 166

I5
5-ethylsulfanyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-1H- benzimidazol-2-one

embedded image

0.81
408
4
248- 250

I6
4-chloro-2-ethylsulfanyl-N-[5- (methylamino)-2- (trifluoromethyl)-4-pyridyl]-5- nitro-benzamide

embedded image

0.97
435/ 437
1

I7
2-(4-chloro-2-ethylsulfanyl-5- nitro-phenyl)-3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridine

embedded image

1.06
417/ 419
1

I8
N-ethyl-5-ethylsulfanyl-4-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]-2- nitro-aniline

embedded image

1.05
426
1

I9
N2-ethyl-4-ethylsulfanyl-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]benzene-1,2-diamine

embedded image

0.96
396
1

I10
5-ethylsulfonyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-1H- benzimidazol-2-one

embedded image

0.71
440
4
>280

I11
N-ethyl-5-ethylsulfanyl-4-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-2- nitro-aniline

embedded image

1.22
426
4

I12
N2-ethyl-4-ethylsulfanyl-5-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2- yl]benzene-1,2-diamine

embedded image

1.05
396
4

I13
3-ethyl-5-ethylsulfanyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-b]pyridin-2-yl]-1H- benzimidazol-2-one

embedded image

0.99
422
4

I14
5-ethylsulfanyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]-1H- benzimidazol-2-one

embedded image

0.87
408
4
272- 274

I15
tert-butyl N-[5-ethylsulfonyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]-3- pyridyl]carbamate

embedded image

1.08
486
4

I16
tert-butyl N-[5-ethylsulfonyl-6- [3-methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]-3- pyridyl]-N-methyl-carbamate

embedded image

1.03
500
4

I17
5-ethylsulfonyl-N-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2- yl]pyridin-3-amine

embedded image

1.48
400
3

I18
2-bromo-5-ethylsulfonyl-N- methyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridin-3-amine

embedded image

1.48
478/ 480
3

I19
5-ethylsulfonyl-N2,N3- dimethyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- c]pyridin-2-yl]pyridine-2,3- diamine

embedded image

0.93
429
4

I20
ethyl 4-chloro-2-ethylsulfanyl- 5-nitro-benzoate

embedded image

1.62
290/ 292
3

I21
ethyl 2-ethylsulfanyl-4- (methylamino)-5-nitro- benzoate

embedded image

1.12
285
4

I22
ethyl 5-amino-2-ethylsulfanyl- 4-(methylamino)benzoate

embedded image

0.83
255
4

I23
ethyl 6-ethylsulfanyl-1-methyl- 2-oxo-3H-benzimidazole-5- carboxylate

embedded image

0.85
281
4

I24
ethyl 6-ethylsulfanyl-1,3- dimethyl-2-oxo-benzimidazole- 5-carboxylate

embedded image

0.91
295
4

I25
6-ethylsulfanyl-1,3-dimethyl-2- oxo-benzimidazole-5- carboxylic acid

embedded image

0.69
267
4

I26
6-ethylsulfanyl-1,3-dimethyl-N- [5-(methylamino)-2- (trifluoromethyl)-4-pyridyl]-2- oxo-benzimidazole-5- carboxamide

embedded image

0.87
440
4

I27
5-ethylsulfonyl-3-methyl-6-[3- methyl-6-(trifluoromethyl) imidazo[4,5-c]pyridin-2-yl]-1H- benzimidazol-2-one

embedded image

0.82
440
4
320- 322

I28
5-ethylsulfanyl-6-[3-methyl-6- (trifluoromethyl)imidazo[4,5- b]pyridin-2-yl]-1,3- dihydrobenzimidazol-2-one

embedded image

0.89
394
4

I29
6-ethylsulfanyl-1,3-dimethyl-N- [3-(methylamino)-6- (trifluoromethyl)pyridazin-4-yl]- 2-oxo-benzimidazole-5- carboxamide

embedded image

0.96
441
4

I30
6-ethylsulfanyl-1,3-dimethyl-N- [2-(methylamino)-5- (trifluoromethyl)-3-pyridyl]-2- oxo-benzimidazole-5- carboxamide

embedded image

0.91
440
4

I31
6-ethylsulfanyl-N-[2-hydroxy-5- (trifluoromethylsulfanyl) phenyl]-1,3-dimethyl-2-oxo- benzimidazole-5-carboxamide

embedded image

1.24
(M− H)^-: 456
4

I32
tert-butyl 5-bromo-3- ethylsulfanyl-pyridine-2- carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.40 (t, 3H), 1.65 (s, 9H), 2.93 (q, 2H), 7.75 (d, 1H), 8.45 (d, 1H).

I33
tert-butyl 5-bromo-3- ethylsulfonyl-pyridine-2- carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.35 (t, 3H,) 1.65 (s, 9H), 3.53 (q, 2H), 8.45 (d, 1H), 8.87 (d, 1H).

I34
tert-butyl 3-ethylsulfonyl-5- (methylamino)pyridine-2- carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.37 (t, 3H), 1.63 (s, 9H), 2.94 (s, 3H), 3.59 (q, 2H), 7.27 (d, 1H), 7.39 (d, 1H), 8.3 (br s, 1H).

I35
tert-butyl 6-bromo-3- ethylsulfonyl-5- (methylamino)pyridine-2- carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.35 (t, 3H), 1.63 (s, 9H), 3.00 (s, 3H), 3.57 (q, 2H), 5.0 (br s, 1H), 7.28 (s, 1H).

I36
tert-butyl 3-ethylsulfonyl-5,6- bis(methylamino)pyridine-2- carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.32 (t, 3H), 1.63 (s, 9H), 2.86 (s, 3H), 3.04 (s, 3H), 3.40 (q, 2H), 4.76 (br s, 1H), 7.06 (s, 1H).

I37
tert-butyl 6-ethylsulfonyl-1,3- dimethyl-2-oxo-imidazo[4,5- b]pyridine-5-carboxylate

embedded image

¹H NMR (400 MHz, CDCl₃) δ ppm 1.33 (t, 3H), 1.66 (s, 9H), 3.48 (q, 2H), 3.50 (s, 3H), 3.56 (s, 3H), 7.68 (s, 1H).

I38
6-ethylsulfonyl-1,3-dimethyl-2- oxo-imidazo[4,5-b]pyridine-5- carboxylic acid

embedded image

¹H NMR (400 MHz, d₆-DMSO) δ ppm 1.19 (t, 3H), 3.38 (s, 3H), 3.44 (s, 3H), 3.49 (q, 2H), 7.92 (s, 1H).

The activity of the compositions according to the invention can be broadened considerably, and adapted to prevailing circumstances, by adding other insecticidally, acaricidally and/or fungicidally active ingredients. The mixtures of the compounds of formula I with other insecticidally, acaricidally and/or fungicidally active ingredients may also have further surprising advantages which can also be described, in a wider sense, as synergistic activity. For example, better tolerance by plants, reduced phytotoxicity, insects can be controlled in their different development stages or better behaviour during their production, for example during grinding or mixing, during their storage or during their use. Suitable additions to active ingredients here are, for example, representatives of the following classes of active ingredients: organophosphorus compounds, nitrophenol derivatives, thioureas, juvenile hormones, formamidines, benzophenone derivatives, ureas, pyrrole derivatives, carbamates, pyrethroids, chlorinated hydrocarbons, acylureas, pyridylmethyleneamino derivatives, macrolides, neonicotinoids and Bacillus thuringiensis preparations.

The following mixtures of the compounds of formula I with active ingredients are preferred (the abbreviation “TX” means “one compound selected from the group consisting of the compounds described in Tables 1 to 12 and Table P of the present invention”): an adjuvant selected from the group of substances consisting of petroleum oils (alternative name) (628)+TX,

an acaricide selected from the group of substances consisting of 1,1-bis(4-chlorophenyl)-2-ethoxyethanol (IUPAC name) (910)+TX, 2,4-dichlorophenyl benzenesulfonate (IUPAC/Chemical Abstracts name) (1059)+TX, 2-fluoro-N-methyl-N-1-naphthylacetamide (IUPAC name) (1295)+TX, 4-chlorophenyl phenyl sulfone (IUPAC name) (981)+TX, abamectin (1)+TX, acequinocyl (3)+TX, acetoprole [CCN]+TX, acrinathrin (9)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, alpha-cypermethrin (202)+TX, amidithion (870)+TX, amidoflumet [CCN]+TX, amidothioate (872)+TX, amiton (875)+TX, amiton hydrogen oxalate (875)+TX, amitraz (24)+TX, aramite (881)+TX, arsenous oxide (882)+TX, AVI 382 (compound code)+TX, AZ 60541 (compound code)+TX, azinphos-ethyl (44)+TX, azinphos-methyl (45)+TX, azobenzene (IUPAC name) (888)+TX, azocyclotin (46)+TX, azothoate (889)+TX, benomyl (62)+TX, benoxafos (alternative name) [CCN]+TX, benzoximate (71)+TX, benzyl benzoate (IUPAC name) [CCN]+TX, bifenazate (74)+TX, bifenthrin (76)+TX, binapacryl (907)+TX, brofenvalerate (alternative name)+TX, bromo-cyclen (918)+TX, bromophos (920)+TX, bromophos-ethyl (921)+TX, bromopropylate (94)+TX, buprofezin (99)+TX, butocarboxim (103)+TX, butoxycarboxim (104)+TX, butylpyridaben (alternative name)+TX, calcium polysulfide (IUPAC name) (111)+TX, camphechlor (941)+TX, carbanolate (943)+TX, carbaryl (115)+TX, carbofuran (118)+TX, carbophenothion (947)+TX, CGA 50′439 (development code) (125)+TX, chinomethionat (126)+TX, chlorbenside (959)+TX, chlordimeform (964)+TX, chlordimeform hydrochloride (964)+TX, chlorfenapyr (130)+TX, chlorfenethol (968)+TX, chlorfenson (970)+TX, chlorfensulfide (971)+TX, chlorfenvinphos (131)+TX, chlorobenzilate (975)+TX, chloromebuform (977)+TX, chloromethiuron (978)+TX, chloropropylate (983)+TX, chlorpyrifos (145)+TX, chlorpyrifos-methyl (146)+TX, chlorthiophos (994)+TX, cinerin I (696)+TX, cinerin II (696)+TX, cinerins (696)+TX, clofentezine (158)+TX, closantel (alternative name) [CCN]+TX, coumaphos (174)+TX, crotamiton (alternative name) [CCN]+TX, crotoxyphos (1010)+TX, cufraneb (1013)+TX, cyanthoate (1020)+TX, cyflumetofen (CAS Reg. No.: 400882-07-7)+TX, cyhalothrin (196)+TX, cyhexatin (199)+TX, cypermethrin (201)+TX, DCPM (1032)+TX, DDT (219)+TX, demephion (1037)+TX, demephion-O (1037)+TX, demephion-S(1037)+TX, demeton (1038)+TX, demeton-methyl (224)+TX, demeton-O (1038)+TX, demeton-O-methyl (224)+TX, demeton-S(1038)+TX, demeton-S-methyl (224)+TX, demeton-S-methylsulfon (1039)+TX, diafenthiuron (226)+TX, dialifos (1042)+TX, diazinon (227)+TX, dichlofluanid (230)+TX, dichlorvos (236)+TX, dicliphos (alternative name)+TX, dicofol (242)+TX, dicrotophos (243)+TX, dienochlor (1071)+TX, dimefox (1081)+TX, dimethoate (262)+TX, dinactin (alternative name) (653)+TX, dinex (1089)+TX, dinex-diclexine (1089)+TX, dinobuton (269)+TX, dinocap (270)+TX, dinocap-4 [CCN]+TX, dinocap-6 [CCN]+TX, dinocton (1090)+TX, dinopenton (1092)+TX, dinosulfon (1097)+TX, dinoterbon (1098)+TX, dioxathion (1102)+TX, diphenyl sulfone (IUPAC name) (1103)+TX, disulfiram (alternative name) [CCN]+TX, disulfoton (278)+TX, DNOC (282)+TX, dofenapyn (1113)+TX, doramectin (alternative name) [CCN]+TX, endosulfan (294)+TX, endothion (1121)+TX, EPN (297)+TX, eprinomectin (alternative name) [CCN]+TX, ethion (309)+TX, ethoate-methyl (1134)+TX, etoxazole (320)+TX, etrimfos (1142)+TX, fenazaflor (1147)+TX, fenazaquin (328)+TX, fenbutatin oxide (330)+TX, fenothiocarb (337)+TX, fenpropathrin (342)+TX, fenpyrad (alternative name)+TX, fenpyroximate (345)+TX, fenson (1157)+TX, fentrifanil (1161)+TX, fenvalerate (349)+TX, fipronil (354)+TX, fluacrypyrim (360)+TX, fluazuron (1166)+TX, flubenzimine (1167)+TX, flucycloxuron (366)+TX, flucythrinate (367)+TX, fluenetil (1169)+TX, flufenoxuron (370)+TX, flumethrin (372)+TX, fluorbenside (1174)+TX, fluvalinate (1184)+TX, FMC 1137 (development code) (1185)+TX, formetanate (405)+TX, formetanate hydrochloride (405)+TX, formothion (1192)+TX, formparanate (1193)+TX, gamma-HCH (430)+TX, glyodin (1205)+TX, halfenprox (424)+TX, heptenophos (432)+TX, hexadecyl cyclopropanecarboxylate (IUPAC/Chemical Abstracts name) (1216)+TX, hexythiazox (441)+TX, iodomethane (IUPAC name) (542)+TX, isocarbophos (alternative name) (473)+TX, isopropyl O-(methoxyaminothiophosphoryl)salicylate (IUPAC name) (473)+TX, ivermectin (alternative name) [CCN]+TX, jasmolin I (696)+TX, jasmolin II (696)+TX, jodfenphos (1248)+TX, lindane (430)+TX, lufenuron (490)+TX, malathion (492)+TX, malonoben (1254)+TX, mecarbam (502)+TX, mephosfolan (1261)+TX, mesulfen (alternative name) [CCN]+TX, methacrifos (1266)+TX, methamidophos (527)+TX, methidathion (529)+TX, methiocarb (530)+TX, methomyl (531)+TX, methyl bromide (537)+TX, metolcarb (550)+TX, mevinphos (556)+TX, mexacarbate (1290)+TX, milbemectin (557)+TX, milbemycin oxime (alternative name) [CCN]+TX, mipafox (1293)+TX, monocrotophos (561)+TX, morphothion (1300)+TX, moxidectin (alternative name) [CCN]+TX, naled (567)+TX, NC-184 (compound code)+TX, NC-512 (compound code)+TX, nifluridide (1309)+TX, nikkomycins (alternative name) [CCN]+TX, nitrilacarb (1313)+TX, nitrilacarb 1:1 zinc chloride complex (1313)+TX, NNI-0101 (compound code)+TX, NNI-0250 (compound code)+TX, omethoate (594)+TX, oxamyl (602)+TX, oxydeprofos (1324)+TX, oxydisulfoton (1325)+TX, pp′-DDT (219)+TX, parathion (615)+TX, permethrin (626)+TX, petroleum oils (alternative name) (628)+TX, phenkapton (1330)+TX, phenthoate (631)+TX, phorate (636)+TX, phosalone (637)+TX, phosfolan (1338)+TX, phosmet (638)+TX, phosphamidon (639)+TX, phoxim (642)+TX, pirimiphos-methyl (652)+TX, polychloroterpenes (traditional name) (1347)+TX, polynactins (alternative name) (653)+TX, proclonol (1350)+TX, profenofos (662)+TX, promacyl (1354)+TX, propargite (671)+TX, propetamphos (673)+TX, propoxur (678)+TX, prothidathion (1360)+TX, prothoate (1362)+TX, pyrethrin 1 (696)+TX, pyrethrin II (696)+TX, pyrethrins (696)+TX, pyridaben (699)+TX, pyridaphenthion (701)+TX, pyrimidifen (706)+TX, pyrimitate (1370)+TX, quinalphos (711)+TX, quintiofos (1381)+TX, R-1492 (development code) (1382)+TX, RA-17 (development code) (1383)+TX, rotenone (722)+TX, schradan (1389)+TX, sebufos (alternative name)+TX, selamectin (alternative name) [CCN]+TX, SI-0009 (compound code)+TX, sophamide (1402)+TX, spirodiclofen (738)+TX, spiromesifen (739)+TX, SSI-121 (development code) (1404)+TX, sulfiram (alternative name) [CCN]+TX, sulfluramid (750)+TX, sulfotep (753)+TX, sulfur (754)+TX, SZI-121 (development code) (757)+TX, tau-fluvalinate (398)+TX, tebufenpyrad (763)+TX, TEPP (1417)+TX, terbam (alternative name)+TX, tetrachlorvinphos (777)+TX, tetradifon (786)+TX, tetranactin (alternative name) (653)+TX, tetrasul (1425)+TX, thiafenox (alternative name)+TX, thiocarboxime (1431)+TX, thiofanox (800)+TX, thiometon (801)+TX, thioquinox (1436)+TX, thuringiensin (alternative name) [CCN]+TX, triamiphos (1441)+TX, triarathene (1443)+TX, triazophos (820)+TX, triazuron (alternative name)+TX, trichlorfon (824)+TX, trifenofos (1455)+TX, trinactin (alternative name) (653)+TX, vamidothion (847)+TX, vaniliprole [CCN] and YI-5302 (compound code)+TX,

an algicide selected from the group of substances consisting of bethoxazin [CCN]+TX, copper dioctanoate (IUPAC name) (170)+TX, copper sulfate (172)+TX, cybutryne [CCN]+TX, dichlone (1052)+TX, dichlorophen (232)+TX, endothal (295)+TX, fentin (347)+TX, hydrated lime [CCN]+TX, nabam (566)+TX, quinoclamine (714)+TX, quinonamid (1379)+TX, simazine (730)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX,

an anthelmintic selected from the group of substances consisting of abamectin (1)+TX, crufomate (1011)+TX, doramectin (alternative name) [CCN]+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, eprinomectin (alternative name) [CCN]+TX, ivermectin (alternative name) [CCN]+TX, milbemycin oxime (alternative name) [CCN]+TX, moxidectin (alternative name) [CCN]+TX, piperazine [CCN]+TX, selamectin (alternative name) [CCN]+TX, spinosad (737) and thiophanate (1435)+TX,

an avicide selected from the group of substances consisting of chloralose (127)+TX, endrin (1122)+TX, fenthion (346)+TX, pyridin-4-amine (IUPAC name) (23) and strychnine (745)+TX, a bactericide selected from the group of substances consisting of 1-hydroxy-1H-pyridine-2-thione (IUPAC name) (1222)+TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+TX, 8-hydroxyquinoline sulfate (446)+TX, bronopol (97)+TX, copper dioctanoate (IUPAC name) (170)+TX, copper hydroxide (IUPAC name) (169)+TX, cresol [CCN]+TX, dichlorophen (232)+TX, dipyrithione (1105)+TX, dodicin (1112)+TX, fenaminosulf (1144)+TX, formaldehyde (404)+TX, hydrargaphen (alternative name) [CCN]+TX, kasugamycin (483)+TX, kasugamycin hydrochloride hydrate (483)+TX, nickel bis(dimethyldithiocarbamate) (IUPAC name) (1308)+TX, nitrapyrin (580)+TX, octhilinone (590)+TX, oxolinic acid (606)+TX, oxytetracycline (611)+TX, potassium hydroxyquinoline sulfate (446)+TX, probenazole (658)+TX, streptomycin (744)+TX, streptomycin sesquisulfate (744)+TX, tecloftalam (766)+TX, and thiomersal (alternative name) [CCN]+TX,

a biological agent selected from the group of substances consisting of Adoxophyes orana GV (alternative name) (12)+TX, Agrobacterium radiobacter (alternative name) (13)+TX, Amblyseius spp. (alternative name) (19)+TX, Anagrapha falcifera NPV (alternative name) (28)+TX, Anagrus atomus (alternative name) (29)+TX, Aphelinus abdominalis (alternative name) (33)+TX, Aphidius colemani (alternative name) (34)+TX, Aphidoletes aphidimyza (alternative name) (35)+TX, Autographa californica NPV (alternative name) (38)+TX, Bacillus firmus (alternative name) (48)+TX, Bacillus sphaericus Neide (scientific name) (49)+TX, Bacillus thuringiensis Berliner (scientific name) (51)+TX, Bacillus thuringiensis subsp. aizawai (scientific name) (51)+TX, Bacillus thuringiensis subsp. israelensis (scientific name) (51)+TX, Bacillus thuringiensis subsp. japonensis (scientific name) (51)+TX, Bacillus thuringiensis subsp. kurstaki (scientific name) (51)+TX, Bacillus thuringiensis subsp. tenebrionis (scientific name) (51)+TX, Beauveria bassiana (alternative name) (53)+TX, Beauveria brongniartii (alternative name) (54)+TX, Chrysoperla carnea (alternative name) (151)+TX, Cryptolaemus montrouzieri (alternative name) (178)+TX, Cydia pomonella GV (alternative name) (191)+TX, Dacnusa sibirica (alternative name) (212)+TX, Diglyphus isaea (alternative name) (254)+TX, Encarsia formosa (scientific name) (293)+TX, Eretmocerus eremicus (alternative name) (300)+TX, Helicoverpa zea NPV (alternative name) (431)+TX, Heterorhabditis bacteriophora and H. megidis (alternative name) (433)+TX, Hippodamia convergens (alternative name) (442)+TX, Leptomastix dactylopii (alternative name) (488)+TX, Macrolophus caliginosus (alternative name) (491)+TX, Mamestra brassicae NPV (alternative name) (494)+TX, Metaphycus helvolus (alternative name) (522)+TX, Metarhizium anisopliae var. acridum (scientific name) (523)+TX, Metarhizium anisopliae var. anisopliae (scientific name) (523)+TX, Neodiprion sertifer NPV and N. lecontei NPV (alternative name) (575)+TX, Orius spp. (alternative name) (596)+TX, Paecilomyces fumosoroseus (alternative name) (613)+TX, Phytoseiulus persimilis (alternative name) (644)+TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus (scientific name) (741)+TX, Steinernema bibionis (alternative name) (742)+TX, Steinernema carpocapsae (alternative name) (742)+TX, Steinernema feltiae (alternative name) (742)+TX, Steinernema glaseri (alternative name) (742)+TX, Steinernema riobrave (alternative name) (742)+TX, Steinernema riobravis (alternative name) (742)+TX, Steinernema scapterisci (alternative name) (742)+TX, Steinernema spp. (alternative name) (742)+TX, Trichogramma spp. (alternative name) (826)+TX, Typhlodromus occidentalis (alternative name) (844) and Verticillium lecanii (alternative name) (848)+TX,

a soil sterilant selected from the group of substances consisting of iodomethane (IUPAC name) (542) and methyl bromide (537)+TX,

a chemosterilant selected from the group of substances consisting of apholate [CCN]+TX, bisazir (alternative name) [CCN]+TX, busulfan (alternative name) [CCN]+TX, diflubenzuron (250)+TX, dimatif (alternative name) [CCN]+TX, hemel [CCN]+TX, hempa [CCN]+TX, metepa [CCN]+TX, methiotepa [CCN]+TX, methyl apholate [CCN]+TX, morzid [CCN]+TX, penfluron (alternative name) [CCN]+TX, tepa [CCN]+TX, thiohempa (alternative name) [CCN]+TX, thiotepa (alternative name) [CCN]+TX, tretamine (alternative name) [CCN] and uredepa (alternative name) [CCN]+TX,

an insect pheromone selected from the group of substances consisting of (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-ol (IUPAC name) (222)+TX, (E)-tridec-4-en-1-yl acetate (IUPAC name) (829)+TX, (E)-6-methylhept-2-en-4-ol (IUPAC name) (541)+TX, (E,Z)-tetradeca-4,10-dien-1-yl acetate (IUPAC name) (779)+TX, (Z)-dodec-7-en-1-yl acetate (IUPAC name) (285)+TX, (Z)-hexadec-11-enal (IUPAC name) (436)+TX, (Z)-hexadec-11-en-1-yl acetate (IUPAC name) (437)+TX, (Z)-hexadec-13-en-11-yn-1-yl acetate (IUPAC name) (438)+TX, (Z)-icos-13-en-10-one (IUPAC name) (448)+TX, (Z)-tetradec-7-en-1-al (IUPAC name) (782)+TX, (Z)-tetradec-9-en-1-ol (IUPAC name) (783)+TX, (Z)-tetradec-9-en-1-yl acetate (IUPAC name) (784)+TX, (7E,9Z)-dodeca-7,9-dien-1-yl acetate (IUPAC name) (283)+TX, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate (IUPAC name) (780)+TX, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate (IUPAC name) (781)+TX, 14-methyloctadec-1-ene (IUPAC name) (545)+TX, 4-methylnonan-5-ol with 4-methylnonan-5-one (IUPAC name) (544)+TX, alpha-multistriatin (alternative name) [CCN]+TX, brevicomin (alternative name) [CCN]+TX, codlelure (alternative name) [CCN]+TX, codlemone (alternative name) (167)+TX, cuelure (alternative name) (179)+TX, disparlure (277)+TX, dodec-8-en-1-yl acetate (IUPAC name) (286)+TX, dodec-9-en-1-yl acetate (IUPAC name) (287)+TX, dodeca-8+TX, 10-dien-1-yl acetate (IUPAC name) (284)+TX, dominicalure (alternative name) [CCN]+TX, ethyl 4-methyloctanoate (IUPAC name) (317)+TX, eugenol (alternative name) [CCN]+TX, frontalin (alternative name) [CCN]+TX, gossyplure (alternative name) (420)+TX, grandlure (421)+TX, grandlure I (alternative name) (421)+TX, grandlure II (alternative name) (421)+TX, grandlure III (alternative name) (421)+TX, grandlure IV (alternative name) (421)+TX, hexalure [CCN]+TX, ipsdienol (alternative name) [CCN]+TX, ipsenol (alternative name) [CCN]+TX, japonilure (alternative name) (481)+TX, lineatin (alternative name) [CCN]+TX, litlure (alternative name) [CCN]+TX, looplure (alternative name) [CCN]+TX, medlure [CCN]+TX, megatomoic acid (alternative name) [CCN]+TX, methyl eugenol (alternative name) (540)+TX, muscalure (563)+TX, octadeca-2,13-dien-1-yl acetate (IUPAC name) (588)+TX, octadeca-3,13-dien-1-yl acetate (IUPAC name) (589)+TX, orfralure (alternative name) [CCN]+TX, oryctalure (alternative name) (317)+TX, ostramone (alternative name) [CCN]+TX, siglure [CCN]+TX, sordidin (alternative name) (736)+TX, sulcatol (alternative name) [CCN]+TX, tetradec-11-en-1-yl acetate (IUPAC name) (785)+TX, trimedlure (839)+TX, trimedlure A (alternative name) (839)+TX, trimedlure Bi (alternative name) (839)+TX, trimedlure B₂(alternative name) (839)+TX, trimedlure C (alternative name) (839) and trunc-call (alternative name) [CCN]+TX,

an insect repellent selected from the group of substances consisting of 2-(octylthio)ethanol (IUPAC name) (591)+TX, butopyronoxyl (933)+TX, butoxy(polypropylene glycol) (936)+TX, dibutyl adipate (IUPAC name) (1046)+TX, dibutyl phthalate (1047)+TX, dibutyl succinate (IUPAC name) (1048)+TX, diethyltoluamide [CCN]+TX, dimethyl carbate [CCN]+TX, dimethyl phthalate [CCN]+TX, ethyl hexanediol (1137)+TX, hexamide [CCN]+TX, methoquin-butyl (1276)+TX, methylneodecanamide [CCN]+TX, oxamate [CCN] and picaridin [CCN]+TX, an insecticide selected from the group of substances consisting of 1-dichloro-1-nitroethane (IUPAC/Chemical Abstracts name) (1058)+TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane (IUPAC name) (1056), +TX, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+TX, 1-bromo-2-chloroethane (IUPAC/Chemical Abstracts name) (916)+TX, 2,2,2-trichloro-1-(3,4-dichlorophenyl)ethyl acetate (IUPAC name) (1451)+TX, 2,2-dichlorovinyl 2-ethylsulfinylethyl methyl phosphate (IUPAC name) (1066)+TX, 2-(1,3-dithiolan-2-yl)phenyl dimethylcarbamate (IUPAC/Chemical Abstracts name) (1109)+TX, 2-(2-butoxyethoxy)ethyl thiocyanate (IUPAC/Chemical Abstracts name) (935)+TX, 2-(4,5-dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate (IUPAC/Chemical Abstracts name) (1084)+TX, 2-(4-chloro-3,5-xylyloxy)ethanol (IUPAC name) (986)+TX, 2-chlorovinyl diethyl phosphate (IUPAC name) (984)+TX, 2-imidazolidone (IUPAC name) (1225)+TX, 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate (IUPAC name) (1284)+TX, 2-thiocyanatoethyl laurate (IUPAC name) (1433)+TX, 3-bromo-1-chloroprop-1-ene (IUPAC name) (917)+TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate (IUPAC name) (1283)+TX, 4-methyl(prop-2-ynyl)amino-3,5-xylyl methylcarbamate (IUPAC name) (1285)+TX, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate (IUPAC name) (1085)+TX, abamectin (1)+TX, acephate (2)+TX, acetamiprid (4)+TX, acethion (alternative name) [CCN]+TX, acetoprole [CCN]+TX, acrinathrin (9)+TX, acrylonitrile (IUPAC name) (861)+TX, alanycarb (15)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, aldrin (864)+TX, allethrin (17)+TX, allosamidin (alternative name) [CCN]+TX, allyxycarb (866)+TX, alpha-cypermethrin (202)+TX, alpha-ecdysone (alternative name) [CCN]+TX, aluminium phosphide (640)+TX, amidithion (870)+TX, amidothioate (872)+TX, aminocarb (873)+TX, amiton (875)+TX, amiton hydrogen oxalate (875)+TX, amitraz (24)+TX, anabasine (877)+TX, athidathion (883)+TX, AVI 382 (compound code)+TX, AZ 60541 (compound code)+TX, azadirachtin (alternative name) (41)+TX, azamethiphos (42)+TX, azinphos-ethyl (44)+TX, azinphos-methyl (45)+TX, azothoate (889)+TX, Bacillus thuringiensis delta endotoxins (alternative name) (52)+TX, barium hexafluorosilicate (alternative name) [CCN]+TX, barium polysulfide (IUPAC/Chemical Abstracts name) (892)+TX, barthrin [CCN]+TX, Bayer 22/190 (development code) (893)+TX, Bayer 22408 (development code) (894)+TX, bendiocarb (58)+TX, benfuracarb (60)+TX, bensultap (66)+TX, beta-cyfluthrin (194)+TX, beta-cypermethrin (203)+TX, bifenthrin (76)+TX, bioallethrin (78)+TX, bioallethrin S-cyclopentenyl isomer (alternative name) (79)+TX, bioethanomethrin [CCN]+TX, biopermethrin (908)+TX, bioresmethrin (80)+TX, bis(2-chloroethyl) ether (IUPAC name) (909)+TX, bistrifluron (83)+TX, borax (86)+TX, brofenvalerate (alternative name)+TX, bromfenvinfos (914)+TX, bromocyclen (918)+TX, bromo-DDT (alternative name) [CCN]+TX, bromophos (920)+TX, bromophos-ethyl (921)+TX, bufencarb (924)+TX, buprofezin (99)+TX, butacarb (926)+TX, butathiofos (927)+TX, butocarboxim (103)+TX, butonate (932)+TX, butoxycarboxim (104)+TX, butylpyridaben (alternative name)+TX, cadusafos (109)+TX, calcium arsenate [CCN]+TX, calcium cyanide (444)+TX, calcium polysulfide (IUPAC name) (111)+TX, camphechlor (941)+TX, carbanolate (943)+TX, carbaryl (115)+TX, carbofuran (118)+TX, carbon disulfide (IUPAC/Chemical Abstracts name) (945)+TX, carbon tetrachloride (IUPAC name) (946)+TX, carbophenothion (947)+TX, carbosulfan (119)+TX, cartap (123)+TX, cartap hydrochloride (123)+TX, cevadine (alternative name) (725)+TX, chlorbicyclen (960)+TX, chlordane (128)+TX, chlordecone (963)+TX, chlordimeform (964)+TX, chlordimeform hydrochloride (964)+TX, chlorethoxyfos (129)+TX, chlorfenapyr (130)+TX, chlorfenvinphos (131)+TX, chlorfluazuron (132)+TX, chlormephos (136)+TX, chloroform [CCN]+TX, chloropicrin (141)+TX, chlorphoxim (989)+TX, chlorprazophos (990)+TX, chlorpyrifos (145)+TX, chlorpyrifos-methyl (146)+TX, chlorthiophos (994)+TX, chromafenozide (150)+TX, cinerin I (696)+TX, cinerin II (696)+TX, cinerins (696)+TX, cis-resmethrin (alternative name)+TX, cismethrin (80)+TX, clocythrin (alternative name)+TX, cloethocarb (999)+TX, closantel (alternative name) [CCN]+TX, clothianidin (165)+TX, copper acetoarsenite [CCN]+TX, copper arsenate [CCN]+TX, copper oleate [CCN]+TX, coumaphos (174)+TX, coumithoate (1006)+TX, crotamiton (alternative name) [CCN]+TX, crotoxyphos (1010)+TX, crufomate (1011)+TX, cryolite (alternative name) (177)+TX, CS 708 (development code) (1012)+TX, cyanofenphos (1019)+TX, cyanophos (184)+TX, cyanthoate (1020)+TX, cyclethrin [CCN]+TX, cycloprothrin (188)+TX, cyfluthrin (193)+TX, cyhalothrin (196)+TX, cypermethrin (201)+TX, cyphenothrin (206)+TX, cyromazine (209)+TX, cythioate (alternative name) [CCN]+TX, d-limonene (alternative name) [CCN]+TX, d-tetramethrin (alternative name) (788)+TX, DAEP (1031)+TX, dazomet (216)+TX, DDT (219)+TX, decarbofuran (1034)+TX, deltamethrin (223)+TX, demephion (1037)+TX, demephion-O (1037)+TX, demephion-S(1037)+TX, demeton (1038)+TX, demeton-methyl (224)+TX, demeton-O (1038)+TX, demeton-O-methyl (224)+TX, demeton-S(1038)+TX, demeton-S-methyl (224)+TX, demeton-S-methylsulphon (1039)+TX, diafenthiuron (226)+TX, dialifos (1042)+TX, diamidafos (1044)+TX, diazinon (227)+TX, dicapthon (1050)+TX, dichlofenthion (1051)+TX, dichlorvos (236)+TX, dicliphos (alternative name)+TX, dicresyl (alternative name) [CCN]+TX, dicrotophos (243)+TX, dicyclanil (244)+TX, dieldrin (1070)+TX, diethyl 5-methylpyrazol-3-yl phosphate (IUPAC name) (1076)+TX, diflubenzuron (250)+TX, dilor (alternative name) [CCN]+TX, dimefluthrin [CCN]+TX, dimefox (1081)+TX, dimetan (1085)+TX, dimethoate (262)+TX, dimethrin (1083)+TX, dimethylvinphos (265)+TX, dimetilan (1086)+TX, dinex (1089)+TX, dinex-diclexine (1089)+TX, dinoprop (1093)+TX, dinosam (1094)+TX, dinoseb (1095)+TX, dinotefuran (271)+TX, diofenolan (1099)+TX, dioxabenzofos (1100)+TX, dioxacarb (1101)+TX, dioxathion (1102)+TX, disulfoton (278)+TX, dithicrofos (1108)+TX, DNOC (282)+TX, doramectin (alternative name) [CCN]+TX, DSP (1115)+TX, ecdysterone (alternative name) [CCN]+TX, EI 1642 (development code) (1118)+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, EMPC (1120)+TX, empenthrin (292)+TX, endosulfan (294)+TX, endothion (1121)+TX, endrin (1122)+TX, EPBP (1123)+TX, EPN (297)+TX, epofenonane (1124)+TX, eprinomectin (alternative name) [CCN]+TX, esfenvalerate (302)+TX, etaphos (alternative name) [CCN]+TX, ethiofencarb (308)+TX, ethion (309)+TX, ethiprole (310)+TX, ethoate-methyl (1134)+TX, ethoprophos (312)+TX, ethyl formate (IUPAC name) [CCN]+TX, ethyl-DDD (alternative name) (1056)+TX, ethylene dibromide (316)+TX, ethylene dichloride (chemical name) (1136)+TX, ethylene oxide [CCN]+TX, etofenprox (319)+TX, etrimfos (1142)+TX, EXD (1143)+TX, famphur (323)+TX, fenamiphos (326)+TX, fenazaflor (1147)+TX, fenchlorphos (1148)+TX, fenethacarb (1149)+TX, fenfluthrin (1150)+TX, fenitrothion (335)+TX, fenobucarb (336)+TX, fenoxacrim (1153)+TX, fenoxycarb (340)+TX, fenpirithrin (1155)+TX, fenpropathrin (342)+TX, fenpyrad (alternative name)+TX, fensulfothion (1158)+TX, fenthion (346)+TX, fenthion-ethyl [CCN]+TX, fenvalerate (349)+TX, fipronil (354)+TX, flonicamid (358)+TX, flubendiamide (CAS. Reg. No.: 272451-65-7)+TX, flucofuron (1168)+TX, flucycloxuron (366)+TX, flucythrinate (367)+TX, fluenetil (1169)+TX, flufenerim [CCN]+TX, flufenoxuron (370)+TX, flufenprox (1171)+TX, flumethrin (372)+TX, fluvalinate (1184)+TX, FMC 1137 (development code) (1185)+TX, fonofos (1191)+TX, formetanate (405)+TX, formetanate hydrochloride (405)+TX, formothion (1192)+TX, formparanate (1193)+TX, fosmethilan (1194)+TX, fospirate (1195)+TX, fosthiazate (408)+TX, fosthietan (1196)+TX, furathiocarb (412)+TX, furethrin (1200)+TX, gamma-cyhalothrin (197)+TX, gamma-HCH (430)+TX, guazatine (422)+TX, guazatine acetates (422)+TX, GY-81 (development code) (423)+TX, halfenprox (424)+TX, halofenozide (425)+TX, HCH (430)+TX, HEOD (1070)+TX, heptachlor (1211)+TX, heptenophos (432)+TX, heterophos [CCN]+TX, hexaflumuron (439)+TX, HHDN (864)+TX, hydramethylnon (443)+TX, hydrogen cyanide (444)+TX, hydroprene (445)+TX, hyquincarb (1223)+TX, imidacloprid (458)+TX, imiprothrin (460)+TX, indoxacarb (465)+TX, iodomethane (IUPAC name) (542)+TX, IPSP (1229)+TX, isazofos (1231)+TX, isobenzan (1232)+TX, isocarbophos (alternative name) (473)+TX, isodrin (1235)+TX, isofenphos (1236)+TX, isolane (1237)+TX, isoprocarb (472)+TX, isopropyl O-(methoxy-aminothiophosphoryl)salicylate (IUPAC name) (473)+TX, isoprothiolane (474)+TX, isothioate (1244)+TX, isoxathion (480)+TX, ivermectin (alternative name) [CCN]+TX, jasmolin 1 (696)+TX, jasmolin II (696)+TX, jodfenphos (1248)+TX, juvenile hormone I (alternative name) [CCN]+TX, juvenile hormone II (alternative name) [CCN]+TX, juvenile hormone III (alternative name) [CCN]+TX, kelevan (1249)+TX, kinoprene (484)+TX, lambda-cyhalothrin (198)+TX, lead arsenate [CCN]+TX, lepimectin (CCN)+TX, leptophos (1250)+TX, lindane (430)+TX, lirimfos (1251)+TX, lufenuron (490)+TX, lythidathion (1253)+TX, m-cumenyl methylcarbamate (IUPAC name) (1014)+TX, magnesium phosphide (IUPAC name) (640)+TX, malathion (492)+TX, malonoben (1254)+TX, mazidox (1255)+TX, mecarbam (502)+TX, mecarphon (1258)+TX, menazon (1260)+TX, mephosfolan (1261)+TX, mercurous chloride (513)+TX, mesulfenfos (1263)+TX, metaflumizone (CCN)+TX, metam (519)+TX, metam-potassium (alternative name) (519)+TX, metam-sodium (519)+TX, methacrifos (1266)+TX, methamidophos (527)+TX, methanesulfonyl fluoride (IUPAC/Chemical Abstracts name) (1268)+TX, methidathion (529)+TX, methiocarb (530)+TX, methocrotophos (1273)+TX, methomyl (531)+TX, methoprene (532)+TX, methoquin-butyl (1276)+TX, methothrin (alternative name) (533)+TX, methoxychlor (534)+TX, methoxyfenozide (535)+TX, methyl bromide (537)+TX, methyl isothiocyanate (543)+TX, methylchloroform (alternative name) [CCN]+TX, methylene chloride [CCN]+TX, metofluthrin [CCN]+TX, metolcarb (550)+TX, metoxadiazone (1288)+TX, mevinphos (556)+TX, mexacarbate (1290)+TX, milbemectin (557)+TX, milbemycin oxime (alternative name) [CCN]+TX, mipafox (1293)+TX, mirex (1294)+TX, monocrotophos (561)+TX, morphothion (1300)+TX, moxidectin (alternative name) [CCN]+TX, naftalofos (alternative name) [CCN]+TX, naled (567)+TX, naphthalene (IUPAC/Chemical Abstracts name) (1303)+TX, NC-170 (development code) (1306)+TX, NC-184 (compound code)+TX, nicotine (578)+TX, nicotine sulfate (578)+TX, nifluridide (1309)+TX, nitenpyram (579)+TX, nithiazine (1311)+TX, nitrilacarb (1313)+TX, nitrilacarb 1:1 zinc chloride complex (1313)+TX, NNI-0101 (compound code)+TX, NNI-0250 (compound code)+TX, nornicotine (traditional name) (1319)+TX, novaluron (585)+TX, noviflumuron (586)+TX, O-5-dichloro-4-iodophenyl O-ethyl ethylphosphonothioate (IUPAC name) (1057)+TX, O,O-diethyl O-4-methyl-2-oxo-2H-chromen-7-yl phosphorothioate (IUPAC name) (1074)+TX, O,O-diethyl O-6-methyl-2-propylpyrimidin-4-yl phosphorothioate (IUPAC name) (1075)+TX, O,O,O′,O′-tetrapropyl dithiopyrophosphate (IUPAC name) (1424)+TX, oleic acid (IUPAC name) (593)+TX, omethoate (594)+TX, oxamyl (602)+TX, oxydemeton-methyl (609)+TX, oxydeprofos (1324)+TX, oxydisulfoton (1325)+TX, pp′-DDT (219)+TX, para-dichlorobenzene [CCN]+TX, parathion (615)+TX, parathion-methyl (616)+TX, penfluron (alternative name) [CCN]+TX, pentachlorophenol (623)+TX, pentachlorophenyl laurate (IUPAC name) (623)+TX, permethrin (626)+TX, petroleum oils (alternative name) (628)+TX, PH 60-38 (development code) (1328)+TX, phenkapton (1330)+TX, phenothrin (630)+TX, phenthoate (631)+TX, phorate (636)+TX, phosalone (637)+TX, phosfolan (1338)+TX, phosmet (638)+TX, phosnichlor (1339)+TX, phosphamidon (639)+TX, phosphine (IUPAC name) (640)+TX, phoxim (642)+TX, phoxim-methyl (1340)+TX, pirimetaphos (1344)+TX, pirimicarb (651)+TX, pirimiphos-ethyl (1345)+TX, pirimiphos-methyl (652)+TX, polychlorodicyclopentadiene isomers (IUPAC name) (1346)+TX, polychloroterpenes (traditional name) (1347)+TX, potassium arsenite [CCN]+TX, potassium thiocyanate [CCN]+TX, prallethrin (655)+TX, precocene I (alternative name) [CCN]+TX, precocene II (alternative name) [CCN]+TX, precocene III (alternative name) [CCN]+TX, primidophos (1349)+TX, profenofos (662)+TX, profluthrin [CCN]+TX, promacyl (1354)+TX, promecarb (1355)+TX, propaphos (1356)+TX, propetamphos (673)+TX, propoxur (678)+TX, prothidathion (1360)+TX, prothiofos (686)+TX, prothoate (1362)+TX, protrifenbute [CCN]+TX, pymetrozine (688)+TX, pyraclofos (689)+TX, pyrazophos (693)+TX, pyresmethrin (1367)+TX, pyrethrin 1 (696)+TX, pyrethrin II (696)+TX, pyrethrins (696)+TX, pyridaben (699)+TX, pyridalyl (700)+TX, pyridaphenthion (701)+TX, pyrimidifen (706)+TX, pyrimitate (1370)+TX, pyriproxyfen (708)+TX, quassia (alternative name) [CCN]+TX, quinalphos (711)+TX, quinalphos-methyl (1376)+TX, quinothion (1380)+TX, quintiofos (1381)+TX, R-1492 (development code) (1382)+TX, rafoxanide (alternative name) [CCN]+TX, resmethrin (719)+TX, rotenone (722)+TX, RU 15525 (development code) (723)+TX, RU 25475 (development code) (1386)+TX, ryania (alternative name) (1387)+TX, ryanodine (traditional name) (1387)+TX, sabadilla (alternative name) (725)+TX, schradan (1389)+TX, sebufos (alternative name)+TX, selamectin (alternative name) [CCN]+TX, SI-0009 (compound code)+TX, SI-0205 (compound code)+TX, SI-0404 (compound code)+TX, SI-0405 (compound code)+TX, silafluofen (728)+TX, SN 72129 (development code) (1397)+TX, sodium arsenite [CCN]+TX, sodium cyanide (444)+TX, sodium fluoride (IUPAC/Chemical Abstracts name) (1399)+TX, sodium hexafluorosilicate (1400)+TX, sodium pentachlorophenoxide (623)+TX, sodium selenate (IUPAC name) (1401)+TX, sodium thiocyanate [CCN]+TX, sophamide (1402)+TX, spinosad (737)+TX, spiromesifen (739)+TX, spirotetrmat (CCN)+TX, sulcofuron (746)+TX, sulcofuron-sodium (746)+TX, sulfluramid (750)+TX, sulfotep (753)+TX, sulfuryl fluoride (756)+TX, sulprofos (1408)+TX, tar oils (alternative name) (758)+TX, tau-fluvalinate (398)+TX, tazimcarb (1412)+TX, TDE (1414)+TX, tebufenozide (762)+TX, tebufenpyrad (763)+TX, tebupirimfos (764)+TX, teflubenzuron (768)+TX, tefluthrin (769)+TX, temephos (770)+TX, TEPP (1417)+TX, terallethrin (1418)+TX, terbam (alternative name)+TX, terbufos (773)+TX, tetrachloroethane [CCN]+TX, tetrachlorvinphos (777)+TX, tetramethrin (787)+TX, theta-cypermethrin (204)+TX, thiacloprid (791)+TX, thiafenox (alternative name)+TX, thiamethoxam (792)+TX, thicrofos (1428)+TX, thiocarboxime (1431)+TX, thiocyclam (798)+TX, thiocyclam hydrogen oxalate (798)+TX, thiodicarb (799)+TX, thiofanox (800)+TX, thiometon (801)+TX, thionazin (1434)+TX, thiosultap (803)+TX, thiosultap-sodium (803)+TX, thuringiensin (alternative name) [CCN]+TX, tolfenpyrad (809)+TX, tralomethrin (812)+TX, transfluthrin (813)+TX, transpermethrin (1440)+TX, triamiphos (1441)+TX, triazamate (818)+TX, triazophos (820)+TX, triazuron (alternative name)+TX, trichlorfon (824)+TX, trichlormetaphos-3 (alternative name) [CCN]+TX, trichloronat (1452)+TX, trifenofos (1455)+TX, triflumuron (835)+TX, trimethacarb (840)+TX, triprene (1459)+TX, vamidothion (847)+TX, vaniliprole [CCN]+TX, veratridine (alternative name) (725)+TX, veratrine (alternative name) (725)+TX, XMC (853)+TX, xylylcarb (854)+TX, YI-5302 (compound code)+TX, zeta-cypermethrin (205)+TX, zetamethrin (alternative name)+TX, zinc phosphide (640)+TX, zolaprofos (1469) and ZXI 8901 (development code) (858)+TX, cyantraniliprole [736994-63-19+TX, chlorantraniliprole [500008-45-7]+TX, cyenopyrafen [560121-52-0]+TX, cyflumetofen [400882-07-7]+TX, pyrifluquinazon [337458-27-2]+TX, spinetoram [187166-40-1+187166-15-0]+TX, spirotetramat [203313-25-1]+TX, sulfoxaflor [946578-00-3]+TX, flufiprole [704886-18-0]+TX, meperfluthrin [915288-13-0]+TX, tetramethylfluthrin [84937-88-2]+TX, triflumezopyrim (disclosed in WO 2012/092115)+TX, fluxametamide (WO 2007/026965)+TX, epsilon-metofluthrin [240494-71-7]+TX, epsilon-momfluorothrin [1065124-65-3]+TX, fluazaindolizine [1254304-22-7]+TX, chloroprallethrin [399572-87-3]+TX, fluxametamide [928783-29-3]+TX, cyhalodiamide [1262605-53-7]+TX, tioxazafen [330459-31-9]+TX, broflanilide [1207727-04-5]+TX, flufiprole [704886-18-0]+TX, cyclaniliprole [1031756-98-5]+TX, tetraniliprole [1229654-66-3]+TX, guadipyr (described in WO2010/060231)+TX, cycloxaprid (described in WO2005/077934)+TX,

a molluscicide selected from the group of substances consisting of bis(tributyltin) oxide (IUPAC name) (913)+TX, bromoacetamide [CCN]+TX, calcium arsenate [CCN]+TX, cloethocarb (999)+TX, copper acetoarsenite [CCN]+TX, copper sulfate (172)+TX, fentin (347)+TX, ferric phosphate (IUPAC name) (352)+TX, metaldehyde (518)+TX, methiocarb (530)+TX, niclosamide (576)+TX, niclosamide-olamine (576)+TX, pentachlorophenol (623)+TX, sodium pentachlorophenoxide (623)+TX, tazimcarb (1412)+TX, thiodicarb (799)+TX, tributyltin oxide (913)+TX, trifenmorph (1454)+TX, trimethacarb (840)+TX, triphenyltin acetate (IUPAC name) (347) and triphenyltin hydroxide (IUPAC name) (347)+TX, pyriprole [394730-71-3]+TX,

a nematicide selected from the group of substances consisting of AKD-3088 (compound code)+TX, 1,2-dibromo-3-chloropropane (IUPAC/Chemical Abstracts name) (1045)+TX, 1,2-dichloropropane (IUPAC/Chemical Abstracts name) (1062)+TX, 1,2-dichloropropane with 1,3-dichloropropene (IUPAC name) (1063)+TX, 1,3-dichloropropene (233)+TX, 3,4-dichlorotetrahydrothiophene 1,1-dioxide (IUPAC/Chemical Abstracts name) (1065)+TX, 3-(4-chlorophenyl)-5-methylrhodanine (IUPAC name) (980)+TX, 5-methyl-6-thioxo-1,3,5-thiadiazinan-3-ylacetic acid (IUPAC name) (1286)+TX, 6-isopentenylaminopurine (alternative name) (210)+TX, abamectin (1)+TX, acetoprole [CCN]+TX, alanycarb (15)+TX, aldicarb (16)+TX, aldoxycarb (863)+TX, AZ 60541 (compound code)+TX, benclothiaz [CCN]+TX, benomyl (62)+TX, butylpyridaben (alternative name)+TX, cadusafos (109)+TX, carbofuran (118)+TX, carbon disulfide (945)+TX, carbosulfan (119)+TX, chloropicrin (141)+TX, chlorpyrifos (145)+TX, cloethocarb (999)+TX, cytokinins (alternative name) (210)+TX, dazomet (216)+TX, DBCP (1045)+TX, DCIP (218)+TX, diamidafos (1044)+TX, dichlofenthion (1051)+TX, dicliphos (alternative name)+TX, dimethoate (262)+TX, doramectin (alternative name) [CCN]+TX, emamectin (291)+TX, emamectin benzoate (291)+TX, eprinomectin (alternative name) [CCN]+TX, ethoprophos (312)+TX, ethylene dibromide (316)+TX, fenamiphos (326)+TX, fenpyrad (alternative name)+TX, fensulfothion (1158)+TX, fosthiazate (408)+TX, fosthietan (1196)+TX, furfural (alternative name) [CCN]+TX, GY-81 (development code) (423)+TX, heterophos [CCN]+TX, iodomethane (IUPAC name) (542)+TX, isamidofos (1230)+TX, isazofos (1231)+TX, ivermectin (alternative name) [CCN]+TX, kinetin (alternative name) (210)+TX, mecarphon (1258)+TX, metam (519)+TX, metam-potassium (alternative name) (519)+TX, metam-sodium (519)+TX, methyl bromide (537)+TX, methyl isothiocyanate (543)+TX, milbemycin oxime (alternative name) [CCN]+TX, moxidectin (alternative name) [CCN]+TX, Myrothecium verrucaria composition (alternative name) (565)+TX, NC-184 (compound code)+TX, oxamyl (602)+TX, phorate (636)+TX, phosphamidon (639)+TX, phosphocarb [CCN]+TX, sebufos (alternative name)+TX, selamectin (alternative name) [CCN]+TX, spinosad (737)+TX, terbam (alternative name)+TX, terbufos (773)+TX, tetrachlorothiophene (IUPAC/Chemical Abstracts name) (1422)+TX, thiafenox (alternative name)+TX, thionazin (1434)+TX, triazophos (820)+TX, triazuron (alternative name)+TX, xylenols [CCN]+TX, YI-5302 (compound code) and zeatin (alternative name) (210)+TX, fluensulfone [318290-98-1]+TX,

a nitrification inhibitor selected from the group of substances consisting of potassium ethylxanthate [CCN] and nitrapyrin (580)+TX,

a plant activator selected from the group of substances consisting of acibenzolar (6)+TX, acibenzolar-S-methyl (6)+TX, probenazole (658) and Reynoutria sachalinensis extract (alternative name) (720)+TX,

a rodenticide selected from the group of substances consisting of 2-isovalerylindan-1,3-dione (IUPAC name) (1246)+TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide (IUPAC name) (748)+TX, alpha-chlorohydrin [CCN]+TX, aluminium phosphide (640)+TX, antu (880)+TX, arsenous oxide (882)+TX, barium carbonate (891)+TX, bisthiosemi (912)+TX, brodifacoum (89)+TX, bromadiolone (91)+TX, bromethalin (92)+TX, calcium cyanide (444)+TX, chloralose (127)+TX, chlorophacinone (140)+TX, cholecalciferol (alternative name) (850)+TX, coumachlor (1004)+TX, coumafuryl (1005)+TX, coumatetralyl (175)+TX, crimidine (1009)+TX, difenacoum (246)+TX, difethialone (249)+TX, diphacinone (273)+TX, ergocalciferol (301)+TX, flocoumafen (357)+TX, fluoroacetamide (379)+TX, flupropadine (1183)+TX, flupropadine hydrochloride (1183)+TX, gamma-HCH (430)+TX, HCH (430)+TX, hydrogen cyanide (444)+TX, iodomethane (IUPAC name) (542)+TX, lindane (430)+TX, magnesium phosphide (IUPAC name) (640)+TX, methyl bromide (537)+TX, norbormide (1318)+TX, phosacetim (1336)+TX, phosphine (IUPAC name) (640)+TX, phosphorus [CCN]+TX, pindone (1341)+TX, potassium arsenite [CCN]+TX, pyrinuron (1371)+TX, scilliroside (1390)+TX, sodium arsenite [CCN]+TX, sodium cyanide (444)+TX, sodium fluoroacetate (735)+TX, strychnine (745)+TX, thallium sulfate [CCN]+TX, warfarin (851) and zinc phosphide (640)+TX,

a synergist selected from the group of substances consisting of 2-(2-butoxyethoxy)ethyl piperonylate (IUPAC name) (934)+TX, 5-(1,3-benzodioxol-5-yl)-3-hexylcyclohex-2-enone (IUPAC name) (903)+TX, farnesol with nerolidol (alternative name) (324)+TX, MB-599 (development code) (498)+TX, MGK 264 (development code) (296)+TX, piperonyl butoxide (649)+TX, piprotal (1343)+TX, propyl isomer (1358)+TX, S421 (development code) (724)+TX, sesamex (1393)+TX, sesasmolin (1394) and sulfoxide (1406)+TX,

an animal repellent selected from the group of substances consisting of anthraquinone (32)+TX, chloralose (127)+TX, copper naphthenate [CCN]+TX, copper oxychloride (171)+TX, diazinon (227)+TX, dicyclopentadiene (chemical name) (1069)+TX, guazatine (422)+TX, guazatine acetates (422)+TX, methiocarb (530)+TX, pyridin-4-amine (IUPAC name) (23)+TX, thiram (804)+TX, trimethacarb (840)+TX, zinc naphthenate [CCN] and ziram (856)+TX, a virucide selected from the group of substances consisting of imanin (alternative name) [CCN] and ribavirin (alternative name) [CCN]+TX,

a wound protectant selected from the group of substances consisting of mercuric oxide (512)+TX, octhilinone (590) and thiophanate-methyl (802)+TX,

and biologically active compounds selected from the group consisting of azaconazole (60207-31-0]+TX, bitertanol [70585-36-3]+TX, bromuconazole [116255-48-2]+TX, cyproconazole [94361-06-5]+TX, difenoconazole [119446-68-3]+TX, diniconazole [83657-24-3]+TX, epoxiconazole [106325-08-0]+TX, fenbuconazole [114369-43-6]+TX, fluquinconazole [136426-54-5]+TX, flusilazole [85509-19-9]+TX, flutriafol [76674-21-0]+TX, hexaconazole [79983-71-4]+TX, imazalil [35554-44-0]+TX, imibenconazole [86598-92-7]+TX, ipconazole [125225-28-7]+TX, metconazole [125116-23-6]+TX, myclobutanil [88671-89-0]+TX, pefurazoate [101903-30-4]+TX, penconazole [66246-88-6]+TX, prothioconazole [178928-70-6]+TX, pyrifenox [88283-41-4]+TX, prochloraz [67747-09-5]+TX, propiconazole [60207-90-1]+TX, simeconazole [149508-90-7]+TX, tebuconazole [107534-96-3]+TX, tetraconazole [112281-77-3]+TX, triadimefon [43121-43-3]+TX, triadimenol [55219-65-3]+TX, triflumizole [99387-89-0]+TX, triticonazole [131983-72-7]+TX, ancymidol [12771-68-5]+TX, fenarimol [60168-88-9]+TX, nuarimol [63284-71-9]+TX, bupirimate [41483-43-6]+TX, dimethirimol [5221-53-4]+TX, ethirimol [23947-60-6]+TX, dodemorph [1593-77-7]+TX, fenpropidine [67306-00-7]+TX, fenpropimorph [67564-91-4]+TX, spiroxamine [118134-30-8]+TX, tridemorph [81412-43-3]+TX, cyprodinil [121552-61-2]+TX, mepanipyrim [110235-47-7]+TX, pyrimethanil [53112-28-0]+TX, fenpiclonil [74738-17-3]+TX, fludioxonil [131341-86-1]+TX, benalaxyl [71626-11-4]+TX, furalaxyl [57646-30-7]+TX, meta-laxyl [57837-19-1]+TX, R-metalaxyl [70630-17-0]+TX, ofurace [58810-48-3]+TX, oxadixyl [77732-09-3]+TX, benomyl [17804-35-2]+TX, carbendazim [10605-21-7]+TX, debacarb [62732-91-6]+TX, fuberidazole [3878-19-1]+TX, thiabendazole [148-79-8]+TX, chlozolinate [84332-86-5]+TX, dichlozoline [24201-58-9]+TX, iprodione [36734-19-7]+TX, myclozoline [54864-61-8]+TX, procymidone [32809-16-8]+TX, vinclozoline [50471-44-8]+TX, boscalid [188425-85-6]+TX, carboxin [5234-68-4]+TX, fenfuram [24691-80-3]+TX, flutolanil [66332-96-5]+TX, mepronil [55814-41-0]+TX, oxycarboxin [5259-88-1]+TX, penthiopyrad [183675-82-3]+TX, thifluzamide [130000-40-7]+TX, guazatine [108173-90-6]+TX, dodine [2439-10-3] [112-65-2] (free base)+TX, iminoctadine [13516-27-3]+TX, azoxystrobin [131860-33-8]+TX, dimoxystrobin [149961-52-4]+TX, enestroburin {Proc. BCPC, Int. Congr., Glasgow, 2003, 1, 93}+TX, fluoxastrobin [361377-29-9]+TX, kresoxim-methyl [143390-89-0]+TX, metominostrobin [133408-50-1]+TX, trifloxystrobin [141517-21-7]+TX, orysastrobin [248593-16-0]+TX, picoxystrobin [117428-22-5]+TX, pyraclostrobin [175013-18-0]+TX, ferbam [14484-64-1]+TX, mancozeb [8018-01-7]+TX, maneb [12427-38-2]+TX, metiram [9006-42-2]+TX, propineb [12071-83-9]+TX, thiram [137-26-8]+TX, zineb [12122-67-7]+TX, ziram [137-30-4]+TX, captafol [2425-06-1]+TX, captan [133-06-2]+TX, dichlofluanid [1085-98-9]+TX, fluoroimide [41205-21-4]+TX, folpet [133-07-3]+TX, tolylfluanid [731-27-1]+TX, bordeaux mixture [8011-63-0]+TX, copperhydroxid [20427-59-2]+TX, copperoxychlorid [1332-40-7]+TX, coppersulfat [7758-98-7]+TX, copperoxid [1317-39-1]+TX, mancopper [53988-93-5]+TX, oxine-copper [10380-28-6]+TX, dinocap [131-72-6]+TX, nitrothal-isopropyl [10552-74-6]+TX, edifenphos [17109-49-8]+TX, iprobenphos [26087-47-8]+TX, isoprothiolane [50512-35-1]+TX, phosdiphen [36519-00-3]+TX, pyrazophos [13457-18-6]+TX, tolclofos-methyl [57018-04-9]+TX, acibenzo-lar-S-methyl [135158-54-2]+TX, anilazine [101-05-3]+TX, benthiavalicarb [413615-35-7]+TX, blasticidin-S [2079-00-7]+TX, chinomethionat [2439-01-2]+TX, chloroneb [2675-77-6]+TX, chlorothalonil [1897-45-6]+TX, cyflufenamid [180409-60-3]+TX, cymoxanil [57966-95-7]+TX, dichlone [117-80-6]+TX, diclocymet [139920-32-4]+TX, diclomezine [62865-36-5]+TX, dicloran [99-30-9]+TX, diethofencarb [87130-20-9]+TX, dimethomorph [110488-70-5]+TX, SYP-LI90 (Flumorph) [211867-47-9]+TX, dithianon [3347-22-6]+TX, ethaboxam [162650-77-3]+TX, etridiazole [2593-15-9]+TX, famoxadone [131807-57-3]+TX, fenamidone [161326-34-7]+TX, fenoxanil [115852-48-7]+TX, fentin [668-34-8]+TX, ferimzone [89269-64-7]+TX, fluazinam [79622-59-6]+TX, fluopicolide [239110-15-7]+TX, flusulfamide [106917-52-6]+TX, fenhexamid [126833-17-8]+TX, fosetyl-aluminium [39148-24-8]+TX, hymexazol [10004-44-1]+TX, iprovalicarb [140923-17-7]+TX, IKF-916 (Cyazofamid) [120116-88-3]+TX, kasugamycin [6980-18-3]+TX, methasulfocarb [66952-49-6]+TX, metrafenone [220899-03-6]+TX, pencycuron [66063-05-6]+TX, phthalide [27355-22-2]+TX, polyoxins [11113-80-7]+TX, probenazole [27605-76-1]+TX, propamocarb [25606-41-1]+TX, proquinazid [189278-12-4]+TX, pyroquilon [57369-32-1]+TX, quinoxyfen [124495-18-7]+TX, quintozene [82-68-8]+TX, sulfur [7704-34-9]+TX, tiadinil [223580-51-6]+TX, triazoxide [72459-58-6]+TX, tricyclazole [41814-78-2]+TX, triforine [26644-46-2]+TX, validamycin [37248-47-8]+TX, zoxamide (RH7281) [156052-68-5]+TX, mandipropamid [374726-62-2]+TX, isopyrazam [881685-58-1]+TX, sedaxane [874967-67-6]+TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (9-dichloromethylene-1,2,3,4-tetrahydro-1,4-methano-naphthalen-5-yl)-amide (disclosed in WO 2007/048556)+TX, 3-difluoromethyl-1-methyl-1H-pyrazole-4-carboxylic acid (3′,4′,5′-trifluoro-biphenyl-2-yl)-amide (disclosed in WO 2006/087343)+TX, [(3S,4R,4aR,6S,6aS,12R,12aS,12bS)-3-[(cyclopropylcarbonyl)oxy]-1,3,4,4a,5,6,6a,12,12a,12b-decahydro-6,12-dihyd roxy-4,6a, 12b-trimethyl-1-oxo-9-(3-pyridinyl)-2H, 11 Hnaphtho[2,1-b]pyrano[3,4-e]pyran-4-yl]methyl-cyclopropanecarboxylate [915972-17-7]+TX, 1,3,5-trimethyl-N-(2-methyl-1-oxopropyl)-N-[3-(2-methylpropyl)-4-[2,2,2-trifluoro-1-methoxy-1-(trifluoromethyl)ethyl]phenyl]-1H-pyrazole-4-carboxamide [926914-55-8]+TX; lancotrione [1486617-21-3]+TX, florpyrauxifen [943832-81-3]+TX, ipfentrifluconazole[1417782-08-1]+TX, mefentrifluconazole [1417782-03-6]+TX, quinofumelin [861647-84-9]+TX, chloroprallethrin [399572-87-3]+TX, cyhalodiamide [1262605-53-7]+TX, fluazaindolizine [1254304-22-7]+TX, fluxametamide [928783-29-3]+TX, epsilon-metofluthrin [240494-71-7]+TX, epsilon-momfluorothrin [1065124-65-3]+TX, pydiflumetofen [1228284-64-7]+TX, kappa-bifenthrin [439680-76-9]+TX, broflanilide [1207727-04-5]+TX, dicloromezotiaz [1263629-39-5]+TX, dipymetitrone [16114-35-5]+TX, pyraziflumid [942515-63-1]+TX, kappa-tefluthrin [391634-71-2]+TX; fenpicoxamid [517875-34-2]+TX; fluindapyr [1383809-87-7]+TX; alpha-bromadiolone [28772-56-7]+TX; flupyrimin [1689566-03-7]+TX; benzpyrimoxan [1449021-97-9]+TX; acynonapyr [1332838-17-1]+TX; inpyrfluxam [1352994-67-2]+TX, isoflucypram [1255734-28-1]+TX; rescalure [64309-03-1]+TX; aminopyrifen [1531626-08-0]+TX; tyclopyrazoflor [1477919-27-9]+TX; and spiropidion [1229023-00-0]+TX; and microbials including: Acinetobacter Iwoffii+TX, Acremonium alternatum+TX+TX, Acremonium cephalosporium+TX+TX, Acremonium diospyri+TX, Acremonium obclavatum+TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®)+TX, Agrobacterium radiobacter strain K84 (Galltrol-A®)+TX, Alternaria alternate+TX, Alternaria cassia+TX, Alternaria destruens (Smolder®)+TX, Ampelomyces quisqualis (AQ10®)+TX, Aspergillus flavus AF36 (AF36®)+TX, Aspergillus flavus NRRL 21882 (Aflaguard®)+TX, Aspergillus spp.+TX, Aureobasidium pullulans+TX, Azospirillum+TX, (MicroAZ®+TX, TAZO B®)+TX, Azotobacter+TX, Azotobacter chroocuccum (Azotomeal®)+TX, Azotobacter cysts (Bionatural Blooming Blossoms®)+TX, Bacillus amyloliquefaciens+TX, Bacillus cereus+TX, Bacillus chitinosporus strain CM-1+TX, Bacillus chitinosporus strain AQ746+TX, Bacillus licheniformis strain HB-2 (Biostart™ Rhizoboost®)+TX, Bacillus licheniformis strain 3086 (EcoGuard®+TX, Green Releaf®)+TX, Bacillus circulans+TX, Bacillus firmus (BioSafe®+TX, BioNem-WP®+TX, VOTiVO®)+TX, Bacillus firmus strain 1-1582+TX, Bacillus macerans+TX, Bacillus marismortui+TX, Bacillus megaterium+TX, Bacillus mycoides strain AQ726+TX, Bacillus papillae (Milky Spore Powder®)+TX, Bacillus pumilus spp.+TX, Bacillus pumilus strain GB34 (Yield Shield®)+TX, Bacillus pumilus strain AQ717+TX, Bacillus pumilus strain QST 2808 (Sonata®+TX, Ballad Plus®)+TX, Bacillus spahericus (VectoLex®)+TX, Bacillus spp.+TX, Bacillus spp. strain AQ175+TX, Bacillus spp. strain AQ177+TX, Bacillus spp. strain AQ178+TX, Bacillus subtilis strain QST 713 (CEASE®+TX, Serenade®+TX, Rhapsody®)+TX, Bacillus subtilis strain QST 714 (JAZZ®)+TX, Bacillus subtilis strain AQ153+TX, Bacillus subtilis strain AQ743+TX, Bacillus subtilis strain QST3002+TX, Bacillus subtilis strain QST3004+TX, Bacillus subtilis var. amyloliquefaciens strain FZB24 (Taegro®+TX, Rhizopro®)+TX, Bacillus thuringiensis Cry 2Ae+TX, Bacillus thuringiensis Cry1Ab+TX, Bacillus thuringiensis aizawai GC 91 (Agree®)+TX, Bacillus thuringiensis israelensis (BMP123®+TX, Aquabac®+TX, VectoBac®)+TX, Bacillus thuringiensis kurstaki (Javelin®+TX, Deliver®+TX, CryMax®+TX, Bonide®+TX, Scutella WP®+TX, Turilav WP®+TX, Astuto®+TX, Dipel WP®+TX, Biobit®+TX, Foray®)+TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®)+TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF/3P®)+TX, Bacillus thuringiensis strain BD #32+TX, Bacillus thuringiensis strain AQ52+TX, Bacillus thuringiensis var. aizawai (XenTari®+TX, DiPel®)+TX, bacteria spp. (GROWMEND®+TX, GROWSWEET®+TX, Shootup®)+TX, bacteriophage of Clavipacter michiganensis (AgriPhage®)+TX, Bakflor®+TX, Beauveria bassiana (Beaugenic®+TX, Brocaril WP®)+TX, Beauveria bassiana GHA (Mycotrol ES®+TX, Mycotrol O®+TX, BotaniGuard®)+TX, Beauveria brongniartii (Engerlingspilz®+TX, Schweizer Beauveria®+TX, Melocont®)+TX, Beauveria spp.+TX, Botrytis cineria+TX, Bradyrhizobium japonicum (TerraMax®)+TX, Brevibacillus brevis+TX, Bacillus thuringiensis tenebrionis (Novodor®)+TX, BtBooster+TX, Burkholderia cepacia (Deny®+TX, Intercept®+TX, Blue Circle®)+TX, Burkholderia gladii+TX, Burkholderia gladioli+TX, Burkholderia spp.+TX, Canadian thistle fungus (CBH Canadian Bioherbicide®)+TX, Candida butyri+TX, Candida famata+TX, Candida fructus+TX, Candida glabrata+TX, Candida guilliermondii+TX, Candida melibiosica+TX, Candida oleophila strain O+TX, Candida parapsilosis+TX, Candida pelliculosa+TX, Candida pulcherrima+TX, Candida reukaufii+TX, Candida saitoana (Bio-Coat®+TX, Biocure®)+TX, Candida sake+TX, Candida spp.+TX, Candida tenius+TX, Cedecea dravisae+TX, Cellulomonas flavigena+TX, Chaetomium cochliodes (Nova-Cide®)+TX, Chaetomium globosum (Nova-Cide®)+TX, Chromobacterium subtsugae strain PRAA4-1T (Grandevo®)+TX, Cladosporium cladosporioides+TX, Cladosporium oxysporum+TX, Cladosporium chlorocephalum+TX, Cladosporium spp.+TX, Cladosporium tenuissimum+TX, Clonostachys rosea (EndoFine®)+TX, Colletotrichum acutatum+TX, Coniothyrium minitans (Cotans WG®)+TX, Coniothyrium spp.+TX, Cryptococcus albidus (YIELDPLUS®)+TX, Cryptococcus humicola+TX, Cryptococcus infirmo-miniatus+TX, Cryptococcus laurentii+TX, Cryptophlebia leucotreta granulovirus (Cryptex®)+TX, Cupriavidus campinensis+TX, Cydia pomonella granulovirus (CYD-X®)+TX, Cydia pomonella granulovirus (Madex®+TX, Madex Plus®+TX, Madex Max/Carpovirusine®)+TX, Cylindrobasidium laeve (Stumpout®)+TX, Cylindrocladium+TX, Debaryomyces hansenii+TX, Drechslera hawaiinensis+TX, Enterobacter cloacae+TX, Enterobacteriaceae+TX, Entomophtora virulenta (Vektor®)+TX, Epicoccum nigrum+TX, Epicoccum purpurascens+TX, Epicoccum spp.+TX, Filobasidium floriforme+TX, Fusarium acuminatum+TX, Fusarium chlamydosporum+TX, Fusarium oxysporum (Fusaclean®/Biofox C®)+TX, Fusarium proliferatum+TX, Fusarium spp.+TX, Galactomyces geotrichum+TX, Gliocladium catenulatum (Primastop®+TX, Prestop®)+TX, Gliocladium roseum+TX, Gliocladium spp. (SoilGard®)+TX, Gliocladium virens (Soilgard®)+TX, Granulovirus (Granupom®)+TX, Halobacillus halophilus+TX, Halobacillus litoralis+TX, Halobacillus trueperi+TX, Halomonas spp.+TX, Halomonas subglaciescola+TX, Halovibrio variabilis+TX, Hanseniaspora uvarum+TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®)+TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®)+TX, Isoflavone-formononetin (Myconate®)+TX, Kloeckera apiculata+TX, Kloeckera spp.+TX, Lagenidium giganteum (Laginex®)+TX, Lecanicillium longisporum (Vertiblast®)+TX, Lecanicillium muscarium (Vertikil®)+TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®)+TX, Marinococcus halophilus+TX, Meira geulakonigii+TX, Metarhizium anisopliae (Met52®)+TX, Metarhizium anisopliae (Destruxin WP®)+TX, Metschnikowia fruticola (Shemer@)+TX, Metschnikowia pulcherrima+TX, Microdochium dimerum (Antibot®)+TX, Micromonospora coerulea+TX, Microsphaeropsis ochracea+TX, Muscodor albus 620 (Muscudor@)+TX, Muscodor roseus strain A3-5+TX, Mycorrhizae spp. (AMykor@+TX, Root Maximizer@)+TX, Myrothecium verrucaria strain AARC-0255 (DiTera®)+TX, BROS PLUS®+TX, Ophiostoma piliferum strain D97 (Sylvanex®)+TX, Paecilomyces farinosus+TX, Paecilomyces fumosoroseus (PFR-97®+TX, PreFeRal®)+TX, Paecilomyces linacinus (Biostat WP®)+TX, Paecilomyces lilacinus strain 251 (MeloCon WG®)+TX, Paenibacillus polymyxa+TX, Pantoea agglomerans (BlightBan C9-1®)+TX, Pantoea spp.+TX, Pasteuria spp. (Econem®)+TX, Pasteuria nishizawae+TX, Penicillium aurantiogriseum+TX, Penicillium billai (Jumpstart®+TX, TagTeam®)+TX, Penicillium brevicompactum+TX, Penicillium frequentans+TX, Penicillium griseofulvum+TX, Penicillium purpurogenum+TX, Penicillium spp.+TX, Penicillium viridicatum+TX, Phlebiopsis gigantean (Rotstop®)+TX, phosphate solubilizing bacteria (Phosphomeal®)+TX, Phytophthora cryptogea+TX, Phytophthora palmivora (Devine®)+TX, Pichia anomala+TX, Pichia guilermondii+TX, Pichia membranaefaciens+TX, Pichia onychis+TX, Pichia stipites+TX, Pseudomonas aeruginosa+TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®)+TX, Pseudomonas cepacia+TX, Pseudomonas chlororaphis (AtEze®)+TX, Pseudomonas corrugate+TX, Pseudomonas fluorescens strain A506 (BlightBan A506®)+TX, Pseudomonas putida+TX, Pseudomonas reactans+TX, Pseudomonas spp.+TX, Pseudomonas syringae (Bio-Save®)+TX, Pseudomonas viridiflava+TX, Pseudomons fluorescens (Zequanox®)+TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®)+TX, Puccinia canaliculata+TX, Puccinia thlaspeos (Wood Warrior@)+TX, Pythium paroecandrum+TX, Pythium oligandrum (Polygandron®+TX, Polyversum®)+TX, Pythium periplocum+TX, Rhanella aquatilis+TX, Rhanella spp.+TX, Rhizobia (Dormal®+TX, Vault®)+TX, Rhizoctonia+TX, Rhodococcus globerulus strain AQ719+TX, Rhodosporidium diobovatum+TX, Rhodosporidium toruloides+TX, Rhodotorula spp.+TX, Rhodotorula glutinis+TX, Rhodotorula graminis+TX, Rhodotorula mucilagnosa+TX, Rhodotorula rubra+TX, Saccharomyces cerevisiae+TX, Salinococcus roseus+TX, Sclerotinia minor+TX, Sclerotinia minor (SARRITOR®)+TX, Scytalidium spp.+TX, Scytalidium uredinicola+TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X®+TX, Spexit®)+TX, Serratia marcescens+TX, Serratia plymuthica+TX, Serratia spp.+TX, Sordaria fimicola+TX, Spodoptera littoralis nucleopolyhedrovirus (Littovir®)+TX, Sporobolomyces roseus+TX, Stenotrophomonas maltophilia+TX, Streptomyces ahygroscopicus+TX, Streptomyces albaduncus+TX, Streptomyces exfoliates+TX, Streptomyces galbus+TX, Streptomyces griseoplanus+TX, Streptomyces griseoviridis (Mycostop®)+TX, Streptomyces lydicus (Actinovate®)+TX, Streptomyces lydicus WYEC-108 (ActinoGrow®)+TX, Streptomyces violaceus+TX, Tilletiopsis minor+TX, Tilletiopsis spp.+TX, Trichoderma asperellum (T34 Biocontrol®)+TX, Trichoderma gamsii (Tenet®)+TX, Trichoderma atroviride (Plantmate®)+TX, Trichoderma hamatum TH 382+TX, Trichoderma harzianum rifai (Mycostar@)+TX, Trichoderma harzianum T-22 (Trianum-P®+TX, PlantShield HC®+TX, RootShield®+TX, Trianum-G®)+TX, Trichoderma harzianum T-39 (Trichodex®)+TX, Trichoderma inhamatum+TX, Trichoderma koningii+TX, Trichoderma spp. LC 52 (Sentinel®)+TX, Trichoderma lignorum+TX, Trichoderma Iongibrachiatum+TX, Trichoderma polysporum (Binab T®)+TX, Trichoderma taxi+TX, Trichoderma virens+TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®)+TX, Trichoderma viride+TX, Trichoderma viride strain ICC 080 (Remedier@)+TX, Trichosporon pullulans+TX, Trichosporon spp.+TX, Trichothecium spp.+TX, Trichothecium roseum+TX, Typhula phacorrhiza strain 94670+TX, Typhula phacorrhiza strain 94671+TX, Ulocladium atrum+TX, Ulocladium oudemansii (Botry-Zen®)+TX, Ustilago maydis+TX, various bacteria and supplementary micronutrients (Natural II®)+TX, various fungi (Millennium Microbes®)+TX, Verticillium chlamydosporium+TX, Verticillium lecanii (Mycotal®+TX, Vertalec®)+TX, Vip3Aa20 (VIPtera®)+TX, Virgibaclillus marismortui+TX, Xanthomonas campestris pv. Poae (Camperico®)+TX, Xenorhabdus bovienii+TX, Xenorhabdus nematophilus; and

Plant extracts including: pine oil (Retenol®)+TX, azadirachtin (Plasma Neem Oil®+TX, AzaGuard®+TX, MeemAzal®+TX, Molt-X®+TX, Botanical IGR (Neemazad®+TX, Neemix®)+TX, canola oil (Lilly Miller Vegol®)+TX, Chenopodium ambrosioides near ambrosioides (Requiem®)+TX, Chrysanthemum extract (Crisant®)+TX, extract of neem oil (Trilogy@)+TX, essentials oils of Labiatae (Botania®)+TX, extracts of clove rosemary peppermint and thyme oil (Garden insect killer@)+TX, Glycinebetaine (Greenstim®)+TX, garlic+TX, lemongrass oil (GreenMatch®)+TX, neem oil+TX, Nepeta cataria (Catnip oil)+TX, Nepeta catarina+TX, nicotine+TX, oregano oil (MossBuster@)+TX, Pedaliaceae oil (Nematon®)+TX, pyrethrum+TX, Quillaja saponaria (NemaQ®)+TX, Reynoutria sachalinensis (Regalia®+TX, Sakalia®)+TX, rotenone (Eco Roten®)+TX, Rutaceae plant extract (Soleo®)+TX, soybean oil (Ortho Ecosense®)+TX, tea tree oil (Timorex Gold®)+TX, thymus oil+TX, AGNIQUE® MMF+TX, BugOil®+TX, mixture of rosemary sesame pepermint thyme and cinnamon extracts (EF 300®)+TX, mixture of clove rosemary and peppermint extract (EF 400®)+TX, mixture of clove pepermint garlic oil and mint (Soil Shot®)+TX, kaolin (Screen®)+TX, storage glucam of brown algae (Laminarin®); and

pheromones including: blackheaded fireworm pheromone (3M Sprayable Blackheaded Fireworm Pheromone®)+TX, Codling Moth Pheromone (Paramount dispenser-(CM)/Isomate C-Plus®)+TX, Grape Berry Moth Pheromone (3M MEC-GBM Sprayable Pheromone®)+TX, Leafroller pheromone (3M MEC-LR Sprayable Pheromone®)+TX, Muscamone (Snip7 Fly Bait®+TX, Starbar Premium Fly Bait®)+TX, Oriental Fruit Moth Pheromone (3M oriental fruit moth sprayable Pheromone®)+TX, Peachtree Borer Pheromone (Isomate-P®)+TX, Tomato Pinworm Pheromone (3M Sprayable Pheromone®)+TX, Entostat powder (extract from palm tree) (Exosex CM®)+TX, (E+TX,Z+TX,Z)-3+TX,8+TX,11 Tetradecatrienyl acetate+TX, (Z+TX,Z+TX,E)-7+TX,11+TX,13-Hexadecatrienal+TX, (E+TX,Z)-7+TX,9-Dodecadien-1-yl acetate+TX, 2-Methyl-1-butanol+TX, Calcium acetate+TX, Scenturion®+TX, Biolure®+TX, Check-Mate®+TX, Lavandulyl senecioate; and

Macrobials including: Aphelinus abdominalis+TX, Aphidius ervi (Aphelinus-System®)+TX, Acerophagus papaya+TX, Adalia bipunctata (Adalia-System®)+TX, Adalia bipunctata (Adaline®)+TX, Adalia bipunctata (Aphidalia®)+TX, Ageniaspis citricola+TX, Ageniaspis fuscicollis+TX, Amblyseius andersoni (Anderline®+TX, Andersoni-System®)+TX, Amblyseius californicus (Amblyline®+TX, Spical®)+TX, Amblyseius cucumeris (Thripex®+TX, Bugline cucumeris®)+TX, Amblyseius fallacis (Fallacis®)+TX, Amblyseius swirskii (Bugline Swirskii®+TX, Swirskii-Mite®)+TX, Amblyseius womersleyi (WomerMite®)+TX, Amitus hesperidum+TX, Anagrus atomus+TX, Anagyrus fusciventris+TX, Anagyrus kamali+TX, Anagyrus loecki+TX, Anagyrus pseudococci (Citripar®)+TX, Anicetus benefices+TX, Anisopteromalus calandrae+TX, Anthocoris nemoralis (Anthocoris-System®)+TX, Aphelinus abdominalis (Apheline®+TX, Aphiline®)+TX, Aphelinus asychis+TX, Aphidius colemani (Aphipar®)+TX, Aphidius ervi (Ervipar®)+TX, Aphidius gifuensis+TX, Aphidius matricariae (Aphipar-M®)+TX, Aphidoletes aphidimyza (Aphidend®)+TX, Aphidoletes aphidimyza (Aphidoline®)+TX, Aphytis lingnanensis+TX, Aphytis melinus+TX, Aprostocetus hagenowii+TX, Atheta coriaria (Staphyline®)+TX, Bombus spp.+TX, Bombus terrestris (Natupol Beehive®)+TX, Bombus terrestris (Beeline®+TX, Tripol®)+TX, Cephalonomia stephanoderis+TX, Chilocorus nigritus+TX, Chrysoperla carnea (Chrysoline®)+TX, Chrysoperla carnea (Chrysopa®)+TX, Chrysoperla rufilabris+TX, Cirrospilus ingenuus+TX, Cirrospilus quadristriatus+TX, Citrostichus phyllocnistoides+TX, Closterocerus chamaeleon+TX, Closterocerus spp.+TX, Coccidoxenoides perminutus (Planopar®)+TX, Coccophagus cowperi+TX, Coccophagus lycimnia+TX, Cotesia flavipes+TX, Cotesia plutellae+TX, Cryptolaemus montrouzieri (Cryptobug®+TX, Cryptoline®)+TX, Cybocephalus nipponicus+TX, Dacnusa sibirica+TX, Dacnusa sibirica (Minusa®)+TX, Diglyphus isaea (Diminex®)+TX, Delphastus catalinae (Delphastus®)+TX, Delphastus pusillus+TX, Diachasmimorpha krausii+TX, Diachasmimorpha Iongicaudata+TX, Diaparsis jucunda+TX, Diaphorencyrtus aligarhensis+TX, Diglyphus isaea+TX, Diglyphus isaea (Miglyphus®+TX, Digline®)+TX, Dacnusa sibirica (DacDigline®+TX, Minex®)+TX, Diversinervus spp.+TX, Encarsia citrina+TX, Encarsia formosa (Encarsia Max®+TX, Encarline®+TX, En-Strip®)+TX, Eretmocerus eremicus (Enermix®)+TX, Encarsia guadeloupae+TX, Encarsia haitiensis+TX, Episyrphus balteatus (Syrphidend®)+TX, Eretmoceris siphonini+TX, Eretmocerus californicus+TX, Eretmocerus eremicus (Ercal®+TX, Eretline e®)+TX, Eretmocerus eremicus (Bemimix®)+TX, Eretmocerus hayati+TX, Eretmocerus mundus (Bemipar®+TX, Eretline m®)+TX, Eretmocerus siphonini+TX, Exochomus quadripustulatus+TX, Feltiella acarisuga (Spidend®)+TX, Feltiella acarisuga (Feltiline®)+TX, Fopius arisanus+TX, Fopius ceratitivorus+TX, Formononetin (Wirless Beehome®)+TX, Franklinothrips vespiformis (Vespop®)+TX, Galendromus occidentalis+TX, Goniozus legneri+TX, Habrobracon hebetor+TX, Harmonia axyridis (HarmoBeetle®)+TX, Heterorhabditis spp. (Lawn Patrol®)+TX, Heterorhabditis bacteriophora (NemaShield HB®+TX, Nemaseek®+TX, Terranem-Nam®+TX, Terranem®+TX, Larvanem®+TX, B-Green®+TX, NemAttack®+TX, Nematop®)+TX, Heterorhabditis megidis (Nemasys H®+TX, BioNem H®+TX, Exhibitline hm®+TX, Larvanem-M®)+TX, Hippodamia convergens+TX, Hypoaspis aculeifer (Aculeifer-System®+TX, Entomite-A®)+TX, Hypoaspis miles (Hypoline m®+TX, Entomite-M®)+TX, Lbalia leucospoides+TX, Lecanoideus floccissimus+TX, Lemophagus errabundus+TX, Leptomastidea abnormis+TX, Leptomastix dactylopii (Leptopar@)+TX, Leptomastix epona+TX, Lindorus lophanthae+TX, Lipolexis oregmae+TX, Lucilia caesar (Natufly®)+TX, Lysiphlebus testaceipes+TX, Macrolophus caliginosus (Mirical-N®+TX, Macroline c®+TX, Mirical®)+TX, Mesoseiulus longipes+TX, Metaphycus flavus+TX, Metaphycus lounsburyi+TX, Micromus angulatus (Milacewing®)+TX, Microterys flavus+TX, Muscidifurax raptorellus and Spalangia cameroni (Biopar@)+TX, Neodryinus typhlocybae+TX, Neoseiulus californicus+TX, Neoseiulus cucumeris (THRYPEX®)+TX, Neoseiulus fallacis+TX, Nesideocoris tenuis (NesidioBug®+TX, Nesibug®)+TX, Ophyra aenescens (Biofly®)+TX, Orius insidiosus (Thripor-I®+TX, Oriline i®)+TX, Orius laevigatus (Thripor-L®+TX, Oriline I®)+TX, Orius majusculus (Oriline m®)+TX, Orius strigicollis (Thripor-S®)+TX, Pauesia juniperorum+TX, Pediobius foveolatus+TX, Phasmarhabditis hermaphrodita (Nemaslug®)+TX, Phymastichus coffea+TX, Phytoseiulus macropilus+TX, Phytoseiulus persimilis (Spidex®+TX, Phytoline p®)+TX, Podisus maculiventris (Podisus®)+TX, Pseudacteon curvatus+TX, Pseudacteon obtusus+TX, Pseudacteon tricuspis+TX, Pseudaphycus maculipennis+TX, Pseudleptomastix mexicana+TX, Psyllaephagus pilosus+TX, Psyttalia concolor (complex)+TX, Quadrastichus spp.+TX, Rhyzobius lophanthae+TX, Rodolia cardinalis+TX, Rumina decollate+TX, Semielacher petiolatus+TX, Sitobion avenae (Ervibank®)+TX, Steinernema carpocapsae (Nematac C®+TX, Millenium®+TX, BioNem C®+TX, NemAttack®+TX, Nemastar@+TX, Capsanem®)+TX, Steinernema feltiae (NemaShield®+TX, Nemasys F®+TX, BioNem F®+TX, Steinernema-System®+TX, NemAttack®+TX, Nemaplus®+TX, Exhibitline sf®+TX, Scia-rid®+TX, Entonem®)+TX, Steinernema kraussei (Nemasys L®+TX, BioNem L®+TX, Exhibitline srb®)+TX, Steinernema riobrave (BioVector@+TX, BioVektor@)+TX, Steinernema scapterisci (Nematac S®)+TX, Steinernema spp.+TX, Steinernematid spp. (Guardian Nematodes®)+TX, Stethorus punctillum (Stethorus®)+TX, Tamarixia radiate+TX, Tetrastichus setifer+TX, Thripobius semiluteus+TX, Torymus sinensis+TX, Trichogramma brassicae (Tricholine b®)+TX, Trichogramma brassicae (Tricho-Strip®)+TX, Trichogramma evanescens+TX, Trichogramma minutum+TX, Trichogramma ostriniae+TX, Trichogramma platneri+TX, Trichogramma pretiosum+TX, Xanthopimpla stemmator; and

other biologicals including: abscisic acid+TX, bioSea®+TX, Chondrostereum purpureum (Chontrol Paste®)+TX, Colletotrichum gloeosporioides (Collego®)+TX, Copper Octanoate (Cueva®)+TX, Delta traps (Trapline d®)+TX, Erwinia amylovora (Harpin) (ProAct®+TX, Ni-HIBIT Gold CST®)+TX, Ferri-phosphate (Ferramol®)+TX, Funnel traps (Trapline y@)+TX, Gallex®+TX, Grower's Secret®+TX, Homo-brassonolide+TX, Iron Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait®)+TX, MCP hail trap (Trapline f®)+TX, Microctonus hyperodae+TX, Mycoleptodiscus terrestris (Des-X®)+TX, BioGain®+TX, Aminomite®+TX, Zenox®+TX, Pheromone trap (Thripline ams®)+TX, potassium bicarbonate (MilStop®)+TX, potassium salts of fatty acids (Sanova®)+TX, potassium silicate solution (Sil-Matrix®)+TX, potassium iodide+potassiumthiocyanate (Enzicur®)+TX, SuffOil-X®+TX, Spider venom+TX, Nosema locustae (Semaspore Organic Grasshopper Control®)+TX, Sticky traps (Trapline YF®+TX, Rebell Amarillo®)+TX and Traps (Takitrapline y+b®)+TX;

or a biologically active compound or agent selected from: Brofluthrinate+TX, Diflovidazine+TX, Flometoquin+TX, Fluhexafon+TX, Plutella xylostella Granulosis virus+TX, Cydia pomonella Granulosis virus+TX, Imicyafos+TX, Heliothis virescens Nucleopolyhedrovirus+TX, Heliothis punctigera Nucleopolyhedrovirus+TX, Helicoverpa zea Nucleopolyhedrovirus+TX, Spodoptera frugiperda Nucleopolyhedrovirus+TX, Plutella xylostella Nucleopolyhedrovirus+TX, p-cymene+TX, Pyflubumide+TX, Pyrafluprole+TX, QRD 420+TX, QRD 452+TX, QRD 460+TX, Terpenoid blends+TX, Terpenoids+TX, Tetraniliprole+TX, and α-terpinene+TX;

or an active substance referenced by a code+TX, such as code AE 1887196 (BSC-BX60309)+TX, code NNI-0745 GR+TX, code IKI-3106+TX, code JT-L001+TX, code ZNQ-08056+TX, code IPPA152201+TX, code HNPC-A9908 (CAS: [660411-21-2])+TX, code HNPC-A2005 (CAS: [860028-12-2])+TX, code JS118+TX, code ZJ0967+TX, code ZJ2242+TX, code JS7119 (CAS: [929545-74-4])+TX, code SN-1172+TX, code HNPC-A9835+TX, code HNPC-A9955+TX, code HNPC-A3061+TX, code Chuanhua 89-1+TX, code IPP-10+TX, code ZJ3265+TX, code JS9117+TX, code ZJ3757+TX, code ZJ4042+TX, code ZJ4014+TX, code ITM-121+TX, code DPX-RAB55 (DKI-2301)+TX, code NA-89+TX, code MIE-1209+TX, code MCI-8007+TX, code BCS-CL73507+TX, code S-1871+TX, code DPX-RDS63+TX, Quinofumelin+TX, mefentrifluconazol+TX, fenpicoxamid+TX, fluindapyr+TX, inpyrfluxam+TX or indiflumetpyr+TX, isoflucypram+TX, pyrapropoyne+TX, florylpicoxamid+TX, metyltetraprole+TX, ipflufenoquin+TX, pyridachlometyl+TX or chlopyridiflu+TX, tetrachlorantraniliprole+TX, tetrachloraniliprole+TX, Tyclopyrazoflor+TX, flupyrimin+TX or pyrifluramide+TX, benzpyrimoxan+TX, Benzosufyl+TX or oxazosulfyl+TX, etpyrafen+TX, acynonapyr+TX or pyrinonafen+TX, oxotrione+TX, bixlozone+TX or clofendizone+TX or dicloroxizone+TX, cyclopyranil+TX or pyrazocyclonil+TX or cyclopyrazonil+TX, alpha-bromadiolone+TX, and code AKD-1193+TX.

The references in brackets behind the active ingredients, e.g. [3878-19-1] refer to the Chemical Abstracts Registry number. The above described mixing partners are known. Where the active ingredients are included in “The Pesticide Manual” [The Pesticide Manual—A World Compendium; Thirteenth Edition; Editor: C. D. S. TomLin; The British Crop Protection Council], they are described therein under the entry number given in round brackets hereinabove for the particular compound; for example, the compound “abamectin” is described under entry number (1). Where “[CCN]” is added hereinabove to the particular compound, the compound in question is included in the “Compendium of Pesticide Common Names”, which is accessible on the internet [A. Wood; Compendium of Pesticide Common Names, Copyright© 1995-2004]; for example, the compound “acetoprole” is described under the internet address http://www.alanwood.net/pesticides/acetoprole.html.

Most of the active ingredients described above are referred to hereinabove by a so-called “common name”, the relevant “ISO common name” or another “common name” being used in individual cases. If the designation is not a “common name”, the nature of the designation used instead is given in round brackets for the particular compound; in that case, the IUPAC name, the IUPAC/Chemical Abstracts name, a “chemical name”, a “traditional name”, a “compound name” or a “develoment code” is used or, if neither one of those designations nor a “common name” is used, an “alternative name” is employed. “CAS Reg. No” means the Chemical Abstracts Registry Number.

The active ingredient mixture of the compounds of formula I selected from Tables 1 to 12 and Table P with active ingredients described above comprises a compound selected from Tables 1 to 12 and Table P and an active ingredient as described above preferably in a mixing ratio of from 100:1 to 1:6000, especially from 50:1 to 1:50, more especially in a ratio of from 20:1 to 1:20, even more especially from 10:1 to 1:10, very especially from 5:1 and 1:5, special preference being given to a ratio of from 2:1 to 1:2, and a ratio of from 4:1 to 2:1 being likewise preferred, above all in a ratio of 1:1, or 5:1, or 5:2, or 5:3, or 5:4, or 4:1, or 4:2, or 4:3, or 3:1, or 3:2, or 2:1, or 1:5, or 2:5, or 3:5, or 4:5, or 1:4, or 2:4, or 3:4, or 1:3, or 2:3, or 1:2, or 1:600, or 1:300, or 1:150, or 1:35, or 2:35, or 4:35, or 1:75, or 2:75, or 4:75, or 1:6000, or 1:3000, or 1:1500, or 1:350, or 2:350, or 4:350, or 1:750, or 2:750, or 4:750. Those mixing ratios are by weight.

The mixtures as described above can be used in a method for controlling pests, which comprises applying a composition comprising a mixture as described above to the pests or their environment, with the exception of a method for treatment of the human or animal body by surgery or therapy and diagnostic methods practised on the human or animal body.

The mixtures comprising a compound of formula I selected from Tables 1 to 12 and Table P and one or more active ingredients as described above can be applied, for example, in a single “ready-mix” form, in a combined spray mixture composed from separate formulations of the single active ingredient components, such as a “tank-mix”, and in a combined use of the single active ingredients when applied in a sequential manner, i.e. one after the other with a reasonably short period, such as a few hours or days. The order of applying the compounds of formula I selected from Tables 1 to 12 and Table P and the active ingredients as described above is not essential for working the present invention.

The compositions according to the invention can also comprise further solid or liquid auxiliaries, such as stabilizers, for example unepoxidized or epoxidized vegetable oils (for example epoxidized coconut oil, rapeseed oil or soya oil), antifoams, for example silicone oil, preservatives, viscosity regulators, binders and/or tackifiers, fertilizers or other active ingredients for achieving specific effects, for example bactericides, fungicides, nematocides, plant activators, molluscicides or herbicides.

The compositions according to the invention are prepared in a manner known per se, in the absence of auxiliaries for example by grinding, screening and/or compressing a solid active ingredient and in the presence of at least one auxiliary for example by intimately mixing and/or grinding the active ingredient with the auxiliary (auxiliaries). These processes for the preparation of the compositions and the use of the compounds I for the preparation of these compositions are also a subject of the invention.

The application methods for the compositions, that is the methods of controlling pests of the abovementioned type, such as spraying, atomizing, dusting, brushing on, dressing, scattering or pouring-which are to be selected to suit the intended aims of the prevailing circumstances- and the use of the compositions for controlling pests of the abovementioned type are other subjects of the invention. Typical rates of concentration are between 0.1 and 1000 ppm, preferably between 0.1 and 500 ppm, of active ingredient. The rate of application per hectare is generally 1 to 2000 g of active ingredient per hectare, in particular 10 to 1000 g/ha, preferably 10 to 600 g/ha.

A preferred method of application in the field of crop protection is application to the foliage of the plants (foliar application), it being possible to select frequency and rate of application to match the danger of infestation with the pest in question. Alternatively, the active ingredient can reach the plants via the root system (systemic action), by drenching the locus of the plants with a liquid composition or by incorporating the active ingredient in solid form into the locus of the plants, for example into the soil, for example in the form of granules (soil application). In the case of paddy rice crops, such granules can be metered into the flooded paddy-field.

The compounds of the invention and compositions thereof are also be suitable for the protection of plant propagation material, for example seeds, such as fruit, tubers or kernels, or nursery plants, against pests of the abovementioned type. The propagation material can be treated with the compound prior to planting, for example seed can be treated prior to sowing. Alternatively, the compound can be applied to seed kernels (coating), either by soaking the kernels in a liquid composition or by applying a layer of a solid composition. It is also possible to apply the compositions when the propagation material is planted to the site of application, for example into the seed furrow during drilling. These treatment methods for plant propagation material and the plant propagation material thus treated are further subjects of the invention. Typical treatment rates would depend on the plant and pest/fungi to be controlled and are generally between 1 to 200 grams per 100 kg of seeds, preferably between 5 to 150 grams per 100 kg of seeds, such as between 10 to 100 grams per 100 kg of seeds.

The term seed embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corns, bulbs, fruit, tubers, grains, rhizomes, cuttings, cut shoots and the like and means in a preferred embodiment true seeds.

The present invention also comprises seeds coated or treated with or containing a compound of formula I. The term “coated or treated with and/or containing” generally signifies that the active ingredient is for the most part on the surface of the seed at the time of application, although a greater or lesser part of the ingredient may penetrate into the seed material, depending on the method of application. When the said seed product is (re)planted, it may absorb the active ingredient. In an embodiment, the present invention makes available a plant propagation material adhered thereto with a compound of formula (I). Further, it is hereby made available, a composition comprising a plant propagation material treated with a compound of formula (I).

Seed treatment comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking and seed pelleting. The seed treatment application of the compound formula (I) can be carried out by any known methods, such as spraying or by dusting the seeds before sowing or during the sowing/planting of the seeds.

Biological Examples

The Examples which follow serve to illustrate the invention. Certain compounds of the invention can be distinguished from known compounds by virtue of greater efficacy at low application rates, which can be verified by the person skilled in the art using the experimental procedures outlined in the Examples, using lower application rates if necessary, for example 50 ppm, 25 ppm, 12.5 ppm, 6 ppm, 3 ppm, 1.5 ppm, 0.8 ppm, 0.2 ppm or 0.05 ppm.

Example B1: Activity Against Spodoptera littoralis (Egyptian Cotton Leaf Worm)

Cotton leaf discs were placed onto agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with five L1 larvae. The samples were assessed for mortality, anti-feeding effect, and growth inhibition in comparison to untreated samples 3 days after infestation. Control of Spodoptera littoralis by a test sample is given when at least one of the categories mortality, anti-feedant effect, and growth inhibition is higher than the untreated sample.

The following compounds resulted in at least 80% control at an application rate of 200 ppm: P3, P5, P6, P19, P22, P25, P26, P29, P35, P38, P39, P45.

Example B2: Activity Against Spodoptera littoralis (Egyptian Cotton Leaf Worm)

Test compounds were applied by pipette from 10′000 ppm DMSO stock solutions into 24-well plates and mixed with agar. Lettuce seeds were placed onto the agar and the multi well plate was closed by another plate which contained also agar. After 7 days the compound was absorbed by the roots and the lettuce grew into the lid plate. The lettuce leaves were then cut off into the lid plate. Spodoptera eggs were pipetted through a plastic stencil onto a humid gel blotting paper and the lid plate was closed with it. The samples were assessed for mortality, anti-feedant effect and growth inhibition in comparison to untreated samples 6 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the three categories (mortality, anti-feeding, or growth inhibition) at a test rate of 12.5 ppm: P3 and P5.

Example B3: Activity Against Plutella xylostella (Diamond Back Moth)

24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions by pipetting. After drying, the plates were infested with L2 larvae (10 to 15 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P3, P4, P5, P6, P7, P8, P18, P21, P22.

Example B4: Activity Against Diabrotica Balteata (Corn Root Worm)

Maize sprouts placed onto an agar layer in 24-well microtiter plates were treated with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions by spraying. After drying, the plates were infested with L2 larvae (6 to 10 per well). The samples were assessed for mortality and growth inhibition in comparison to untreated samples 4 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P3, P4, P5, P6, P7, P18, P19, P22, P23, P24, P25, P26, P29, P35, P36, P38, P45.

Example B5: Activity Against Myzus persicae (Green Peach Aphid)

Sunflower leaf discs were placed on agar in a 24-well microtiter plate and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying, the leaf discs were infested with an aphid population of mixed ages. The samples were assessed for mortality 6 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P3, P4, P5, P6, P8, P9, P11, P13, P14, P16, P17, P18, P19, P20, P21, P22, P23, P36, P37, P38, P39, P43, P44.

Example B6: Activity Against Myzus persicae (Green Peach Aphid)

Roots of pea seedlings infested with an aphid population of mixed ages were placed directly in the aqueous test solutions prepared from 10′000 DMSO stock solutions. The samples were assessed for mortality 6 days after placing seedlings in test solutions.

The following compounds resulted in at least 80% mortality at a test rate of 24 ppm: P3, P4, P5, P6, P8, P9, P11, P13, P14, P16, P17, P18, P19, P21, P22, P23, P36, P38, P39, P43, P44, P45.

Example B7: Activity Against Bemisia tabaci (Cotton White Fly)

Cotton leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with adult white flies. The samples were checked for mortality 6 days after incubation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P3, P5, P6, P8, P22, P36, P38, P39.

Example B8: Activity Against Frankliniella occidentalis (Western Flower Thrips)

Sunflower leaf discs were placed on agar in 24-well microtiter plates and sprayed with aqueous test solutions prepared from 10′000 DMSO stock solutions. After drying the leaf discs were infested with a Frankliniella population of mixed ages. The samples were assessed for mortality 7 days after infestation.

The following compounds resulted in at least 80% mortality at an application rate of 200 ppm: P3, P4, P5, P8, P9, P14, P16, P21, P22, P38, P45.

Example B9: Activity Against Euschistus heros (Neotropical Brown Stink Bug)

Soybean leaf on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf were infested with N2 nymphs. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 5 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P3, P4, P5, P6, P7, P8, P9, P10, P11, P14, P16, P17, P18, P19, P21, P22, P25, P29, P36, P37, P39, P42, P43, P44, P45.

Example B10: Activity Against Tetranychus urticae (Two-Spotted Spider Mite)

Bean leaf discs on agar in 24-well microtiter plates were sprayed with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions. After drying the leaf discs were infested with a mite population of mixed ages. The samples were assessed for mortality on mixed population (mobile stages) 8 days after infestation.

The following compound resulted in at least 80% mortality at an application rate of 200 ppm: P6.

Example B11: Activity Against Aedes Aevypti (Yellow Fever Mosquito)

Test solutions, at an application rate of 200 ppm in ethanol, were applied to 12 well tissue culture plates. Once the deposits were dry, five, two to five day old adult female Aedes aegypti were added to each well, and sustained with a 10% sucrose solution in a cotton wool plug. Assessment of knockdown was made one hour after introduction, and mortality was assessed at 24 and 48 hours after introduction.

The following compound gave at least 80% control of Aedes aegypti after 48 h and/or 24 h: P3.

Example B12: Activity Against Plutella xylostella (Diamond Back Moth)

24-well microtiter plates with artificial diet were treated with aqueous test solutions prepared from 10′000 ppm DMSO stock solutions by pipetting. After drying, Plutella eggs were pipetted through a plastic stencil onto a gel blotting paper and the plate was closed with it. The samples were assessed for mortality and growth inhibition in comparison to untreated samples 8 days after infestation.

The following compounds gave an effect of at least 80% in at least one of the two categories (mortality or growth inhibition) at an application rate of 200 ppm: P25, P26, P29, P35, P36, P37, P38, P39, P40, P42, P43, P44, P45.

PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFUR CONTAINING SUBSTITUENTS

Information

Publication Number

Date Filed

Date Published

Inventors

Original Assignees

CPC

International Classifications

Abstract

Description

Claims

Priority Claims (1)

PCT Information